
<html lang="en"     class="pb-page"  data-request-id="388753b6-4126-4cbb-a0eb-2b14c53d560f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm201428a;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Oxaphosphinanes: New Therapeutic Perspectives for Glioblastoma" /></meta><meta name="dc.Creator" content="Ludovic  Clarion" /></meta><meta name="dc.Creator" content="Carine  Jacquard" /></meta><meta name="dc.Creator" content="Odile  Sainte-Catherine" /></meta><meta name="dc.Creator" content="Séverine  Loiseau" /></meta><meta name="dc.Creator" content="Damien  Filippini" /></meta><meta name="dc.Creator" content="Marie-Hélène  Hirlemann" /></meta><meta name="dc.Creator" content="Jean-Noël  Volle" /></meta><meta name="dc.Creator" content="David  Virieux" /></meta><meta name="dc.Creator" content="Marc  Lecouvey" /></meta><meta name="dc.Creator" content="Jean-Luc  Pirat" /></meta><meta name="dc.Creator" content="Norbert  Bakalara" /></meta><meta name="dc.Description" content="This paper reports the design and the synthesis of a new family of compounds, the phostines, belonging to the [1,2]oxaphosphinane family. Twenty-six compounds have been screened for their antiproli..." /></meta><meta name="Description" content="This paper reports the design and the synthesis of a new family of compounds, the phostines, belonging to the [1,2]oxaphosphinane family. Twenty-six compounds have been screened for their antiproli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 14, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201428a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201428a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201428a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201428a" /></link>
        
    
    

<title>Oxaphosphinanes: New Therapeutic Perspectives for Glioblastoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201428a" /></meta><meta property="og:title" content="Oxaphosphinanes: New Therapeutic Perspectives for Glioblastoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0016.jpeg" /></meta><meta property="og:description" content="This paper reports the design and the synthesis of a new family of compounds, the phostines, belonging to the [1,2]oxaphosphinane family. Twenty-six compounds have been screened for their antiproliferative activity against a large panel of NCI cancer cell lines. Because of its easy synthesis and low EC50 value (500 nM against the C6 rat glioma cell line), compound 3.1a was selected for further biological study. Moreover, the specific biological effect of 3.1a on the glioblastoma phylogenetic cluster from the NCI is dependent on its stereochemistry. Within that cluster, 3.1a has a higher antiproliferative activity than Temozolomide and is more potent than paclitaxel for the SF295 and SNB75 cell lines. In constrast with paclitaxel and vincristine, 3.1a is devoid of astrocyte toxicity. The original activity spectrum of 3.1a on the NCI cancer cell line panel allows the development of this family for use in association with existing drugs, opening new therapeutic perspectives." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201428a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201428a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201428a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201428a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201428a&amp;href=/doi/10.1021/jm201428a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2196-2211</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201475u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201480u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Oxaphosphinanes: New Therapeutic Perspectives for Glioblastoma</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ludovic++Clarion">Ludovic Clarion</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carine++Jacquard">Carine Jacquard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Odile++Sainte-Catherine">Odile Sainte-Catherine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9verine++Loiseau">Séverine Loiseau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Filippini">Damien Filippini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie-H%C3%A9l%C3%A8ne++Hirlemann">Marie-Hélène Hirlemann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-No%C3%ABl++Volle">Jean-Noël Volle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Virieux">David Virieux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Lecouvey">Marc Lecouvey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Luc++Pirat">Jean-Luc Pirat</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norbert++Bakalara">Norbert Bakalara</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">INSERM U-1051, Institut des Neurosciences de Montpellier, 80 rue Augustin Fliche 34091 Montpellier, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">UMR 5253, ICG Montpellier, Equipe AM2N, ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier cedex 5, France</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">UMR 7244 CSPBAT, Equipe CBS Université Paris 13, 74 rue Marcel Cachin, 93017 Bobigny cedex, France</span></div><div class="corresp-info"><strong>*</strong>Tel: +33 467 147 243. Fax: +33 467 144 319. E-mail: <a href="/cdn-cgi/l/email-protection#224847434c0f4e57410c524b50435662474c51414f0c4450"><span class="__cf_email__" data-cfemail="6d07080c034001180e431d041f0c192d08031e0e00430b1f">[email protected]</span></a> (J.-L.P.). Tel: +33 607 106 844. Fax: +33 499 636 020. E-mail: <a href="/cdn-cgi/l/email-protection#a6c8c9d4c4c3d4d288c4c7cdc7cac7d4c7e6c3c8d5c5cb88c0d4"><span class="__cf_email__" data-cfemail="67090815050215134905060c060b06150627020914040a490115">[email protected]</span></a> (N.B.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201428a&amp;href=/doi/10.1021%2Fjm201428a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2196–2211</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 23, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 November 2011</li><li><span class="item_label"><b>Published</b> online</span>14 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201428a" title="DOI URL">https://doi.org/10.1021/jm201428a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2196%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLudovic%2BClarion%252C%2BCarine%2BJacquard%252C%2BOdile%2BSainte-Catherine%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D5%26contentID%3Djm201428a%26title%3DOxaphosphinanes%253A%2BNew%2BTherapeutic%2BPerspectives%2Bfor%2BGlioblastoma%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2211%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201428a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1519</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201428a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Oxaphosphinanes: New Therapeutic Perspectives for Glioblastoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ludovic&quot;,&quot;last_name&quot;:&quot;Clarion&quot;},{&quot;first_name&quot;:&quot;Carine&quot;,&quot;last_name&quot;:&quot;Jacquard&quot;},{&quot;first_name&quot;:&quot;Odile&quot;,&quot;last_name&quot;:&quot;Sainte-Catherine&quot;},{&quot;first_name&quot;:&quot;Séverine&quot;,&quot;last_name&quot;:&quot;Loiseau&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Filippini&quot;},{&quot;first_name&quot;:&quot;Marie-Hélène&quot;,&quot;last_name&quot;:&quot;Hirlemann&quot;},{&quot;first_name&quot;:&quot;Jean-Noël&quot;,&quot;last_name&quot;:&quot;Volle&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Virieux&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Lecouvey&quot;},{&quot;first_name&quot;:&quot;Jean-Luc&quot;,&quot;last_name&quot;:&quot;Pirat&quot;},{&quot;first_name&quot;:&quot;Norbert&quot;,&quot;last_name&quot;:&quot;Bakalara&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;2196-2211&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201428a&quot;},&quot;abstract&quot;:&quot;This paper reports the design and the synthesis of a new family of compounds, the phostines, belonging to the [1,2]oxaphosphinane family. Twenty-six compounds have been screened for their antiproliferative activity against a large panel of NCI cancer cell lines. Because of its easy synthesis and low EC50 value (500 nM against the C6 rat glioma cell line), compound 3.1a was selected for further biological study. Moreover, the specific biological effect of 3.1a on the glioblastoma phylogenetic cluster from the NCI is dependent on its stereochemistry. Within that cluster, 3.1a has a higher antiproliferative activity than Temozolomide and is more potent than paclitaxel for the SF295 and SNB75 cell lines. In constrast with paclitaxel and vincristine, 3.1a is devoid of astrocyte toxicity. The original activity spectrum of 3.1a on the NCI cancer cell line panel allows the development of this family for use in association with existing drugs, opening new therapeutic perspectives.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201428a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201428a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201428a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201428a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201428a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201428a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201428a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201428a&amp;href=/doi/10.1021/jm201428a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201428a" /></input><a href="/doi/pdf/10.1021/jm201428a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201428a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201428a%26sid%3Dliteratum%253Aachs%26pmid%3D22268526%26genre%3Darticle%26aulast%3DClarion%26date%3D2012%26atitle%3DOxaphosphinanes%253A%2BNew%2BTherapeutic%2BPerspectives%2Bfor%2BGlioblastoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D2196%26epage%3D2211%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">This paper reports the design and the synthesis of a new family of compounds, the phostines, belonging to the [1,2]oxaphosphinane family. Twenty-six compounds have been screened for their antiproliferative activity against a large panel of NCI cancer cell lines. Because of its easy synthesis and low EC<sub>50</sub> value (500 nM against the C6 rat glioma cell line), compound <b>3.1a</b> was selected for further biological study. Moreover, the specific biological effect of <b>3.1a</b> on the glioblastoma phylogenetic cluster from the NCI is dependent on its stereochemistry. Within that cluster, <b>3.1a</b> has a higher antiproliferative activity than Temozolomide and is more potent than paclitaxel for the SF295 and SNB75 cell lines. In constrast with paclitaxel and vincristine, <b>3.1a</b> is devoid of astrocyte toxicity. The original activity spectrum of <b>3.1a</b> on the NCI cancer cell line panel allows the development of this family for use in association with existing drugs, opening new therapeutic perspectives.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">L.C. and C.J. equally contributed to the paper.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malignant gliomas are the most frequent primary brain tumors. Glioblastomas (WHO grade IV) account for 60–70% of primary malignant gliomas with poor prognosis. Moreover, low-grade glioma will inescapably become malignant. The best treatment, which consists of surgical resection followed by chemotherapy with Temozolomide (TMZ) and radiotherapy, gives a median survival of 15 months as compared to 55 days with biopsy alone.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> We therefore realize the need of developing new drugs with antiproliferative activity on glioblastoma cells. So far, molecular agents currently in clinical trial for high-grade glioma have emerged from existing molecules selected for other types of cancer. Mainly, these molecules target intracellular signaling pathways relative to either growth or angiogenesis and have been efficient in preclinical models of gliomas.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nevertheless, systemic antiangiogenic treatment can increase glioblastoma invasion in patients and induce side effects like intracranial hemorrhage and ischemic stroke.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Moreover, inhibition of tyrosine kinase-coupled growth factor receptors by small chemical compounds (Gefitinib) or monoclonal antibodies (cetuximab) adds little in terms of overall survival or progression free survival.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Innovative aspects of glioblastoma treatment lie in combinations of molecules such as PCV (procarbazine, lomustine, and vincristine)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and in local chemotherapy with biodegradable carmustine wafers (Gliadel).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Improvements have been attained at the surgery level by the use of magnetic resonance imaging (MRI)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and fluorescent-guided surgery<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> to increase the extent of resection. To develop a new antiglioma therapy, we decided to design and synthesize a new family of compounds screened for their antiproliferative activity, in a first intention on commonly reported glioblastoma cell line such as the C6 one and in a second step against the human National Cancer Institute (NCI) cell line panel.</div><div class="NLM_p">Phostines are a set of compounds that present an 1,2-oxaphosphinane heterocyclic core and are considered as mimes of glycosides. We thought that the phosphinolactone structure possesses unique and unexploited features: besides purely physical and geometrical considerations, the phosphinolactone group can be regarded as a surrogate of lactol and could present an opportunity for medicinal chemists to explore uncovered regions of chemical space.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In addition to its isosteric relationship with the lactol group, phosphinolactone is an outstanding hydrogen bond acceptor and metal-complexing agent, which makes it an attractive structural motif for drug discovery. Whatever the nature of the phosphoryl bond (P═O), such compounds exhibit high Lewis/Bronsted basicity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> As observed with glycopyranoside derivatives, phosphorus six-membered rings show also stereoelectronic-dependent interactions with phosphorus atoms that are closely related to the anomeric effect.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Another important feature of oxaphosphinanes is that such phosphorus heterocycles are considerably more resistant to the ring-opening/closure occurring between the open-chain and the cyclic pyranose forms.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><div class="NLM_p">Similar modifications of lactol groups have already been exploited in <i>C-</i>glycosides and aza- or thio-sugars, leading to compounds of therapeutic interests.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> However, these compounds are different from the phostone<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> family because of the exocyclic P–C bond, which confers to the molecules a higher stability. In this paper, we describe the synthesis<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> of a new family of compounds, the phostines, obtained from the reaction of <i>H</i>-phosphinates with protected furanosyl glycosides in the presence of a base. The antiproliferative properties of the phostines were screened on C6 glial cells.</div><div class="NLM_p last">The toxicity of the best compound, <b>3.1a</b>, was compared with its diastereoisomer <b>3.1b</b> on cancer cell lines from different tissues and species, C6 glial cells, and nonproliferative brain cells. This study shows that <b>3.1a</b> is an antiglioma compound with low glial cell toxicity and leads us to think that it can be a therapeutic compound in preclinical glioma models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2 Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1 Oxaphosphinane Synthesis</h3><div class="NLM_p">Phostines were specifically designed as a combination of glycopyranosides and <i>C</i>-aryglycosides, and their synthesis was achieved by the reaction of tris(<i>O</i>-benzyl protected)-<span class="smallcaps smallerCapital">d</span>-arabinofuranose <b>1</b> with various ethyl arylphosphinates <b>2</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in the presence of catalytic amount of potassium <i>t</i>-butoxide (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a> This tandem sequence involved first the nucleophilic Pudovik addition of <i>H</i>-phosphinate anions <b>2</b> to the open-chain form of arabinofuranose. The second step consisted of a subsequent prototropy and a 6-<i>exotet</i> cyclization, affording the six-membered ring phosphinolactones (21–67% yield, Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This procedure offered an easy tuning of the aryl substituent directly bound to the phosphorus atom. Four enantiopure diastereomers <b>3.a</b>–<b>d</b> were formed, arising from the creation of two chiral centers with moderate diastereoselectivities. The reaction appeared general, and oxaphosphinanes <b>3.1</b>–<b>3.6</b> were initially tested as a mixture of stereoisomers. When the IC<sub>50</sub> values were lower than 15 μM, they were separated by preparative reverse phase high-performance liquid chromatography (HPLC) and tested separately.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to hydroxy-oxaphosphinanes <b>3.1</b>-<b>3.7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When the Ar group was a phenyl, the diastereomers <b>3.1a</b>–<b>d</b> were obtained in 28/26/19/27 proportion. The four stereoisomers were fully characterized, allowing the attribution of all of the stereogenic centers. The first two diastereomers <b>3.1a</b> and <b>3.1b</b> are epimer at carbon 2, and they correspond, respectively, to phosphino-α-<span class="smallcaps smallerCapital">d</span>-glucose and phosphino-α-<span class="smallcaps smallerCapital">d</span>-mannose.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The two other, <b>3.1c</b> and <b>3.1d</b>, can be perceived as the β-anomers, but they were revealed to be less configurationally stable at the phosphorus center due to the presence of the phenyl ring in axial position. So, only the <b>3.1a</b> and <b>3.1b</b> isomers were finally tested.</div><div class="NLM_p">In a second set of reactions, different chemical modifications were introduced on the carbon adjacent to the phosphorus atom. Then, amino and urea derivatives <b>6a</b> and <b>7a</b> were synthesized starting from the mannose-like stereoisomer, <b>3.1b</b>. The transformation of the alcohol function into a good leaving group led to the mesylate <b>4.1b</b> in 50% yield. Substitution by trimethylsilylazide gave the azido derivative <b>5.1a</b> with inversion of configuration. As expected, the Staudinger reaction furnished the glucoselike oxaphosphinane <b>6.1a</b>. Finally, when <b>6.1a</b> was reacted with phenylisocyanate, the corresponding urea <b>7.1a</b> was isolated in 53% yield. Starting from the glucoselike stereoisomer <b>3.1a</b>, a similar scheme allowed the formation of the phosphino-α-<span class="smallcaps smallerCapital">d</span>-mannose analogues <b>4.1a</b>, <b>5.1b</b>, and <b>6.1b</b> in, respectively, 46, 86, and 54% yields (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to the α-<span class="smallcaps smallerCapital">d</span>-Amino-glucose Analogues <b>6a</b> and <b>7a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To estimate whether or not the presence of the free hydroxy group affects the IC<sub>50</sub>, the corresponding deoxyphosphinolactone <b>9</b> was also synthesized. This oxaphosphinane <b>9</b> was directly accessible from the mixture of diastereomers <b>3.1a</b> and <b>3.1b</b> by the Barton–McCombie deoxygenation. The dithiocarbonate intermediates <b>8.1a</b> and <b>8.1b</b> were separated to further test them (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Deoxyphosphinosugar <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other modifications on the hydroxy group were introduced by the formation of the corresponding ester and ether derivatives. Starting from the diastereoisomer <b>3.1a</b>, the desired targets were prepared by Williamson or by acylation reactions (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the α-<span class="smallcaps smallerCapital">d</span>-Glucose Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Direct synthesis of amino-oxaphosphinanes can be performed starting from the alkylamino-arabinofuranose. Thus, <b>15</b> and <b>15′</b> were obtained quantitatively by treatment of 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose with an excess of benzylamine or allylamine.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></div><div class="NLM_p">Then, the phostines <b>16</b> and <b>17</b> were synthesized according to the conditions of reaction mentioned above. Only one enantiopure stereoisomer <b>16.1a</b> and <b>17.1a</b> (among the four diastereomers) was isolated after purification in 12 and 7% yield, respectively (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes of the α-<span class="smallcaps smallerCapital">d</span>-Glucose Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.2 Antiproliferative and Stereoselective Activity of <b>3.1a</b> on Brain Cancer Cell Lines</h3><div class="NLM_p">Phostines were screened on the C6 rat glioblastoma cell line using a dimethylthiazolyl-2,5-diphenyltetrazolium bromide (MTT) test. Compounds <b>3.1a</b> and <b>16.1a</b> proved to be the most potent inhibitors of C6 cell growth (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, the following studies were carried out with <b>3.1a</b>, which is readily synthesized in yields that are better than for <b>16.1a</b>. Moreover, a promising diastereoselective synthesis to increase the yield of <b>3.1a</b> even further is already under investigation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antiproliferative Values of the Phostines on C6<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0015.gif" alt="" id="fx32" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">Values were calculated from at least three independent experiments, and for each set of experiments, each point was repeated six times. EC<sub>50</sub> estimation was determined with Prism 4.0 software using the Hill equation.</p></div></div><div></div></div><div class="NLM_p">In all cancer cell lines derived from other tissue than brain (i.e., skin, liver, intestine, prostate, and breast) <b>3.1a</b> at 1 and 10 μM is always less toxic and has a higher lower toxic concentration (LTC) and half maximal effective concentration (EC<sub>50</sub>) values (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), suggesting specificity for cancers that form from brain tissue. That hypothesis is reinforced by the low sensitivity of DU-145 (65 ± 8 μM) to <b>3.1a</b>. As a matter of fact, DU-145 is a metastatic brain tumor that started from a primary prostate cancer (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Furthermore, because <b>3.1a</b> always has a higher antiproliferative effect than <b>3.1b</b> at 10 μM and lower LTC and EC<sub>50</sub> values (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) on skin cancer cell lines (MDA-MB-435, B16F10, and A431), colorectal cancer cells (CaCo2) and breast cancer cells (MDA-MB-231), a stereodependent mode of action of <b>3.1a</b> is suggested. Conversely, <b>3.1b</b> has greater antiproliferative activity on the hepatocarcinoma cell line (Huh7, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antiproliferative activities of <b>3.1a</b> and <b>3.1b</b>. Antiproliferative activities were measured by MTT reduction, 48 h after drug addition (<b>3.1a</b> and <b>3.1b</b>) on different cell lines on rat C6 glioblastoma cells (C6) and brain metastasis of prostatic cells (DU-145). OD 570 nm, optical density measured at 570 nm; C, concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activities of <b>3.1a</b> and <b>3.1b</b> on Different Cell Lines<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">tissues</th><th class="colsep0 rowsep0" align="center">brain</th><th class="colsep0 rowsep0" colspan="3" align="center">skin</th><th class="colsep0 rowsep0" align="center">liver</th><th class="colsep0 rowsep0" align="center">intestine</th><th class="colsep0 rowsep0" align="center">prostate</th><th class="colsep0 rowsep0" align="center">breast</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left" valign="bottom">cell types</td><td class="colsep0 rowsep0" align="left" valign="bottom">glioma</td><td class="colsep0 rowsep0" colspan="2" align="left" valign="bottom">melanoma</td><td class="colsep0 rowsep0" align="left" valign="bottom">epidermoid carcinoma</td><td class="colsep0 rowsep0" align="left" valign="bottom">hepato-carcinoma</td><td class="colsep0 rowsep0" align="left" valign="bottom">colorectal adeno-carcinoma</td><td class="colsep0 rowsep0" align="left" valign="bottom">prostatic carcinoma (brain metastasis)</td><td class="colsep0 rowsep0" align="left" valign="bottom">adeno-carcinoma (pleural metastasis)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left" valign="bottom">cell lines</td><td class="colsep0 rowsep0" align="left" valign="bottom">C6</td><td class="colsep0 rowsep0" align="left" valign="bottom">MDAMB-435</td><td class="colsep0 rowsep0" align="left" valign="bottom">B16F10</td><td class="colsep0 rowsep0" align="left" valign="bottom">A431</td><td class="colsep0 rowsep0" align="left" valign="bottom">HuH7</td><td class="colsep0 rowsep0" align="left" valign="bottom">CaCo2</td><td class="colsep0 rowsep0" align="left" valign="bottom">DU145</td><td class="colsep0 rowsep0" align="left" valign="bottom">MDAMB-231</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left" valign="bottom">species</td><td class="colsep0 rowsep0" align="left" valign="bottom">rat</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td><td class="colsep0 rowsep0" align="left" valign="bottom">mouse</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td><td class="colsep0 rowsep0" align="left" valign="bottom">human</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>3.1a</b></td><td class="colsep0 rowsep0" align="left">LTC<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (μM)</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 μM toxicity (%)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">82 ± 1</td><td class="colsep0 rowsep0" align="left">42 ± 0</td><td class="colsep0 rowsep0" align="left">73 ± 0</td><td class="colsep0 rowsep0" align="left">32 ± 1</td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left">43 ± 1</td><td class="colsep0 rowsep0" align="left">40 ± 0</td><td class="colsep0 rowsep0" align="left">30 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 μM toxicity (%)</td><td class="colsep0 rowsep0" align="left">63 ± 1</td><td class="colsep0 rowsep0" align="left">22 ± 1</td><td class="colsep0 rowsep0" align="left">25 ± 0</td><td class="colsep0 rowsep0" align="left">18 ± 1</td><td class="colsep0 rowsep0" align="left">16 ± 1</td><td class="colsep0 rowsep0" align="left">10 ± 1</td><td class="colsep0 rowsep0" align="left">Nt<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">17 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><b>0.5 ± 0.1</b><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">13.9 ± 0.5</td><td class="colsep0 rowsep0" align="left"><b>4.9 ± 0.3</b></td><td class="colsep0 rowsep0" align="left">14.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">30 ± 3</td><td class="colsep0 rowsep0" align="left">57 ± 8</td><td class="colsep0 rowsep0" align="left">65 ± 8</td><td class="colsep0 rowsep0" align="left">Nqe<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>3.1b</b></td><td class="colsep0 rowsep0" align="left">LTC (μM)</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 μM toxicity (%)</td><td class="colsep0 rowsep0" align="left">31 ± 1</td><td class="colsep0 rowsep0" align="left">43 ± 0</td><td class="colsep0 rowsep0" align="left">Nt</td><td class="colsep0 rowsep0" align="left">33 ± 1</td><td class="colsep0 rowsep0" align="left">55 ± 1</td><td class="colsep0 rowsep0" align="left">15 ± 1</td><td class="colsep0 rowsep0" align="left">14 ± 1</td><td class="colsep0 rowsep0" align="left">18 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Values were calculated from at least three independent experiments, and for each set of experiments, each point was repeated six times. Data are results of MTT assay, 48 h after product addition.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">LTC is calculated after mean comparison between vehicle and product and ANOVA posthoc Fisher test (<i>p</i> < 0.0001).</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Toxicity (10 μM) was calculated as the percentage of MTT absorbance loss as compared to the vehicle.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Nt, no toxicity.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">EC<sub>50</sub> estimation was determined with Prism 4.0 software using Hill equation with four parameters and with the bottom fixed with Triton X-100 2% and the top fixed with vehicle.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">EC<sub>50</sub> values under 10 μM are in bold.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Nqe, no quantified estimation.</p></div></div></div><div class="NLM_p last">In a next step, we investigated whether or not the brain tumor specificity and stereospecificity of <b>3.1a</b> hold also for other human primary cell lines (ie. Leukemia, lung, ovarian, etc.). For that purpose, a screen test on the NCI human cancer cell lines has been performed.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.3 Higher Antiproliferative Activity of <b>3.1a</b> Than <b>3.1b</b> against a Large Panel of Human Cancer Cell Lines and Brain Specificity</h3><div class="NLM_p">The NCI quantified the effects of <b>3.1a</b> and <b>3.1b</b> at 10 μM on the growth of 57 cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A,B) using the sulforhodamine test. The results obtained by this test on the MDA-MB-435, MDA-MB-231, and DU-145 cell lines show similar levels of antiproliferative activity as those initially observed with the MTT test (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This confirms on the one hand that <b>3.1a</b> has a greater antiproliferative activity than <b>3.1b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A–C) and on the other hand its brain selectivity. As a matter of fact, the median growth percent (GP) value of <b>3.1a</b> is inferior to 50% only for the central nervous system (CNS) cell line cluster (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Negative GP values, indicating a cytotoxic effect, were found for two CNS cell lines, SF-295 and SNB75 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Interestingly, Hs-578T is the only breast cancer cell line highly sensitive to <b>3.1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Other cell lines are moderately sensitive to <b>3.1a</b> (i.e., 0 < GP < 50). They include CNS cell lines (SF-268 and U251), nonsmall lung cancer cells (HOP-62 and NCI-H522), ovarian cell line (SK-OV-3), and one breast cancer cell line (MDA-MB-468). The GP mean of 81% ± 18 of <b>3.1b</b> indicates that it has a generally weak antiproliferative activity. Because the median GP values in different tissues are similar, we concluded that it is not tissue specific. Nevertheless, two cell lines are moderately sensitive to <b>3.1b</b> with GP values comprised between 45 and 50%: a melanoma cell line (LOX-IMVI) and a renal cell line (UO-31).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oxaphosphinanes effect on NCI60 GP and effects comparison with paclitaxel on the CNS cell lines. (A and B) Growth percentage of NCI-60 cell lines after 48 h of incubation of 10 μM <b>3.1a</b> (A) or 10 μM <b>3.1b</b> (B) as quantified with sulforhodamine B assay. Gray circles represent NCI 60 CNS cell lines and cell lines used for the MTT test in the primary screening (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). (C) Oxaphosphinanes, TMZ, and paclitaxel effects on brain cell lines growth percentage. Comparison of CNS cell lines growth percentage with 10 μM <b>3.1a</b>, <b>3.1b</b>, TMZ, and paclitaxel. Black, <b>3.1a</b>; white, <b>3.1b</b>; black and gray, paclitaxel; and white and gray, TMZ. Nsc, nonsmall cell; CNS, central nervous system; 1, SF-295; 2, SNB-75; 3, U-251; 4, SF-268; 5, SNB-19; 6, SF-539; a, MDA-MB-435; b, DU-145; and c, MDA-MB-231.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, the sensitivities of six CNS cell lines to paclitaxel, TMZ, and <b>3.1a</b> were compared. The antiproliferative activity of <b>3.1a</b> used at 10 μM is higher than 10 μM paclitaxel on the two cell lines, SF-295 and SNB75, and higher to 10 μM TMZ on the six cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). These last data prompted us to compare the antiproliferative activities of <b>3.1a</b> and <b>3.1b</b> with reference drugs used in the treatment of malignant glioma.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">2.4 Comparison of the Antiproliferative Activities of <b>3.1a</b> and <b>3.1b</b> and Reference Drugs Used in the Treatment of Malignant Glioma on the C6 Glioma Model</h3><div class="NLM_p">To evaluate the position of the most active compound of the new phostine family, the antiproliferative activity of <b>3.1a</b> was compared to <b>3.1b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) and to some therapeutic agents currently prescribed or in clinical trial for glioblastoma<a onclick="showRef(event, 'ref7 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref7 ref26 ref27">(7, 26, 27)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). By measuring neutral red accumulation, we confirmed the data obtained with MTT, which indicates that <b>3.1a</b> is more active on the C6 cell line than its diastereoisomer <b>3.1b</b>. We can see that the antiproliferative activity of <b>3.1a</b> is lower than the antimitotic drugs paclitaxel and vincristine used at 0.1, 1, or 10 μM concentration. By adding 100 μM TMZ, a slight antiproliferative activity on C6 cells appeared, but it still remained lower than for 10 μM <b>3.1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). In conclusion, although <b>3.1a</b> is less active than the alkylating agent carmustine, it shows a higher activity than TMZ, the alkylat agent used in first line for primary and recurrent glioblastoma.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the antiproliferative activities of phostines with clinical drugs on C6 cells. Neutral red incorporation in C6 cells was measured 48 h after product addition. The percentage of toxicity was calculated in comparison to vehicle. nt, no toxicity. Results in bold are above 50% of toxicity. OD, optical density.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To evaluate if the best antiproliferative phostine, <b>3.1a</b>, is less toxic for normal than clinical drugs and if the antiproliferative activity occurs at lower concentrations than for toxicity, we next measured its effect on primary culture of nonproliferative brain cells.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.5 Comparison of Toxicity between <b>3.1a</b> and Clinical Drugs on Nonproliferative Astrocytes in Primary Culture</h3><div class="NLM_p">Twenty-one day primary cell cultures of astrocytes were not proliferative because they were not sensitive to cytabarine (AraC) as measured by neutral red test (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), Hoechst nuclei staining (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), and propidium iodide incorporation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C) and expressed markers of differentiated cells like glial fibrillary acidic protein (GFAP) (data not shown). At all concentrations, <b>3.1a</b> has no toxic effect on nonproliferative astrocytes, the major brain cell population. In contrast, vincristine used at 1 and 10 μM induced a significant decrease of viability (60% in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), which was associated with its cytotoxicity as shown by the incorporation of propidium iodide (PI) in the majority of the remaining cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). However, at 0.1 μM, vincristine induced cytotoxicity without a decrease of cell number (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A–C). Paclitaxel used at 10 μM induced a weak decrease of viability of 28% (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) and a dose-dependent cytotoxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C) without affecting cell number (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Like <b>3.1a</b>, TMZ and carmustine used at 0.1 and 100 μM neither induced cytotoxicity nor decreased viability (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A–C).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the toxicity of OXP430.1 with clinical drugs on nonproliferative astrocytes. Astrocyte viability was quantified 48 h after drug addition on nonproliferative cells maintained in cell culture during 3 weeks after isolation from mouse pups cortical brain. (A and B) Graphics with means ± standard deviations (statview) show neutral red incorporation level (A) and Hoechst 33342 (5 μg/mL) cytofluor intensity measurement. The mean fluorescence was then calculated from three different wells per condition. (C) Dual labeling for PI and Hoechst was performed using the Cellomics array scan vti (Thermofisher). The object detection was fixed on the Hoechst 33342 channel, and the graph shows the percentage of Hoechst 33342 cells stained with PI. The control fluorescence intensities were measured on Triton X-100 (2%)-treated cells. The mean percentage of PI incorporation was calculated from three different wells per condition. OD, optical density; and FU, fluorescent unit. *, significant activity (<i>p</i> < 0.05); ***, significant activity (<i>p</i> < 0.001); and $, significant activity (<i>p</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taken together, these data indicate that <b>3.1a</b> has a better antiproliferative activity on glioma than TMZ and a lower toxicity than paclitaxel and a comparable one to carmustine on 21 day astrocytes. With no toxicity at 100 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and an antiproliferative activity starting at 1 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), <b>3.1a</b> shows a good in vitro “therapeutic index”.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">2.6 Cytotoxic Effect of <b>3.1a</b> and <b>3.1b</b> on C6 Cells</h3><div class="NLM_p">To evaluate if the antiproliferative effects of the two diastereisomers could be due to their cytotoxicity, we measured the release of lactate dehydrogenase (LDH) in the cell medium. This test shows that <b>3.1a</b> and <b>3.1b</b> are toxic for the C6 glioblastoma cell line and that at 10 μM <b>3.1a</b> is more toxic than <b>3.1b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). It has to be noticed that the LTC values measured with the MTT test were 0.001 and 0.1 μM for <b>3.1a</b> and <b>3.1b</b>, respectively. These values are much lower than the 10 and 25 μM measured using the LDH release test. Although the LDH test is known as an insensitive assay, these differences indicate that the MTT test measured inhibition of proliferation rather than cell lysis.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxic activity of <b>3.1a</b> and <b>3.1b</b> on C6 cells. The graph shows the mean ± standard deviation (statview) optical density measured at 490 nm 48 h after product addition on C6 glial cells. $, significant activity (<i>p</i> < 0.0001); and ***, significant activity (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">2.7 Time–Course Effects of <b>3.1a</b> on C6 Cells Viability</h3><div class="NLM_p">To estimate the effect of <b>3.1a</b> on cell density in time, we measured impedance (cell index value) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Compound <b>3.1a</b> cytotoxicity is confirmed at 25, 50, and 100 μM because the cell index value measured at these concentrations was lower than at <i>t</i> = 0. With 100 μM, the cell index value decreased as soon as 1 h after drug addition. At 50 and 25 μM, a decrease of the cell index value was only detected 2 and 3 h after <b>3.1a</b> addition. With 10 μM, the cell index value remained constant throughout the experiment and below vehicle. This result suggests that at 10 μM, <b>3.1a</b> is cytostatic. The cell index value still decreases with 5 μM <b>3.1a</b>, while no decrease is observable with 1 μM.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time–course effect of <b>3.1a</b> on C6 cell growth. Compound <b>3.1a</b> was used at concentrations ranging between 100 nM and 100 μM, and impedance was measured 25 h after plating (<i>t</i> = 0) for 44 h. The electrode impedance is displayed as a cell index (CI) value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">3 Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">From a chemical point of view, a two-step sequence starting from aryl-<i>H</i>-phosphinates and substituted arabinofuranoses afforded the synthesis of structurally diverse phostines. The purification of the active compounds was achieved either by a direct selective precipitation of phostines from the crude mixture or by reverse-phase preparative HPLC. This methodology allowed an easy scale-up and offered the opportunities to introduce stereochemical modifications leading to different phostines. Qualification and/or quantification of the biological effects perceived on the modified 2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinanes allowed the selection of five active phosphino-heterocycles (<b>3.1a</b>, <b>3.7b</b>, <b>11.1a</b>, <b>16.1a</b>, and <b>17.1a</b>) with IC<sub>50</sub> values lower than 5 μM. Interestingly, the activity profile was affected both by the nature of the substituent and by their relative stereochemistry. The combination of these two features has motivated the synthesis of the small focused library presented in this paper. Refinement of our lead compounds into a drug will require the extension of the chemical space. Then, our work will be focused on the determination of a quantitative structure–activity relationship to choose the best drug candidate.</div><div class="NLM_p">This study has evidenced that phostine drugs exhibit stereospecific antiproliferative properties with respect to CNS cell lines and, very importantly, that these drugs are devoid of toxicity on normal astrocytes. Such an unusual brain tumor specificity has been previously described for 2-methyl-9-methoxyellipticinium.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Also, when compared to paclitaxel, <b>3.1a</b> has a different action on the CNS cell lines (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), indicating different and potentially complementary modes of action of these compounds.</div><div class="NLM_p">In addition to CNS cell lines, <b>3.1a</b> inhibits the growth of the breast cancer HS578T and the nonsmall cell cancer lung HOP-62 cell lines. Phylogenetic trees of the 57 NCI cell lines indicate that these two cell lines cluster with the CNS mesenchymal cell line cluster.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Because microRNA expression has been shown to be related to the chemosensitivity of tumor cells,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> we looked into the microRNA expression of the NCI cancer cell lines. By this analysis, HS578T also clusters with the CNS cell lines cluster.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Moreover, the HOP-62 also clusters with the CNS cell lines (in dendrograms based on drug sensitivity).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Although HS578T did not group with the CNS cluster on a dendrogram-based cell line drug sensitivities,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> it appeared to be sensitive to <b>3.1a</b>. Therefore, we conclude that the drug sensitivity of the CNS cell lines, HOP-62 and HS-578T, can be attributed to a common biochemical mechanism depending on a set of genes commonly expressed by these cell lines. Running the COMPARE program from the NCI evidenced no other clinically used standard agents with a similar profile as <b>3.1a</b>. Taken together, these data suggest that <b>3.1a</b> inhibits a biochemical process that has not been targeted by standard anticancer agents. Otherwise, the selective cytotoxicity to this cell line cluster might be the consequence of a preferential uptake in the sensitive lines. Thus, in such a way, stereoselectivity will play a central role in a metabolism where enzymes are involved.</div><div class="NLM_p">Finally, it is important to note that <b>3.1a</b> is toxic for different cell types identified as drug-resistant. Compound <b>3.1a</b> kills one multidrug-resistant CNS cell line (SF-295) and reduces the cell growth of two other MDR cell types: the nonsmall cell lung tumor cell line (HOP-62) and to a lesser extent the renal tumor cell line (RXF-393).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Moreover, a greater sensitivity to carmustine was reported for SF-268 than for SF-295,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and we observe a greater toxicity of <b>3.1a</b> on SF-295 than on SF-268. This last result suggests that <b>3.1a</b> could be used on strains developing resistance against alkylating agents.</div><div class="NLM_p">When taken into account, the results from the different viability tests on C6 glioblastoma cells, the effects of <b>3.1a</b> are dual. At concentrations higher than or equal to 10 μM, <b>3.1a</b> induces necrosis as revealed by LDH release. At concentrations below 5 μM, we observed stable cell index values, a decrease of MTT reduction, a decrease of neutral red accumulation, and no LDH release. These data suggest that at least two different effects are mediated by the drugs. At high concentrations, <b>3.1a</b> is toxic, whereas at medium concentrations (between 1 and 10 μM), a cytostatic effect is observed.</div><div class="NLM_p last">In conclusion, this work characterized a new family of compounds targeting CNS cancer without affecting normal astrocytes. The easy tuning of the substituent groups at the phosphorus and carbon 2 atoms of phostines will allow the development of this family for therapeutic use.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">4 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.1 Chemistry</h3><div class="NLM_p">Commercial reagents were purified by distillation or sublimation, and 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose was purchased from Carbosynth and dried under vacuum before use. The analytical method used to determine the purity of all of the compounds described in this paper has been determined by phosphorus and proton NMR confirming a purity ≥95%. Analytical and preparative HPLC show a purity ≥99% for the compounds <b>3.1a</b> and <b>3.1b</b> for which the biological activities have been described.</div><div class="NLM_p">All reactions were carried out under dry nitrogen in flame-dried glassware. Solvents were dried according to current method, distilled, and stored under nitrogen atmosphere.</div><div class="NLM_p">Nuclear magnetic resonance (<sup>1</sup>H, <sup>31</sup>P, <sup>13</sup>C, and <sup>19</sup>F NMR) spectra were recorded at 400.13 MHz for proton, 161.97 MHz for phosphorus, 100.6 MHz for carbon, and 376.50 for fluorine (Bruker DRX 400). Chemical shifts are reported in ppm relative to the solvent signals [<sup>1</sup>H: chloroform-<i>d</i><sub>1</sub> (7.26 ppm), acetone-<i>d</i><sub>6</sub> (2.05 ppm), dimethylsulfoxide (DMSO)-<i>d</i><sub>6</sub> (2.50 ppm), D<sub>2</sub>O (4.79 ppm), or methanol-<i>d</i><sub>4</sub> (3.31 ppm); <sup>31</sup>P: H<sub>3</sub>PO<sub>4</sub> 85%; <sup>13</sup>C: chloroform-<i>d</i><sub>1</sub> (77.16 ppm), acetone-<i>d</i><sub>6</sub> (29.84 ppm), DMSO-<i>d</i><sub>6</sub> (39.52 ppm), or methanol-<i>d</i><sub>4</sub> (49.00 ppm); <sup>19</sup>F: reported from CFCl<sub>3</sub>]. NMR coupling constants are noted <i>J</i> and reported in Hertz (Hz). These abbreviations are used for express the multiplicity: s (singulet), d (doublet), t (triplet), q (quadruplet), qu (quintuplet), m (multiplet), and b (broad).</div><div class="NLM_p last">Low- and high-resolution mass spectra were acquired using a WATERS Micromass Q-Tof spectrometer with as internal reference H<sub>3</sub>PO<sub>4</sub> (0.1% in water/acetonitrile, 1/1) in positive mode (ESI). Flash chromatography was performed using a CombiFlash Companion/TS with prepacked column (6–120 g scale) with particle size of 35–70 μm. Analytical HPLC (column, Waters SunFire C18, 5 μm, 4.6 mm × 250 mm; eluent, acetonitrile/water (63:34); flow, 1 mL min<sup>–1</sup>). Preparative HPLC (Waters SunFire Prep C18 OBD; column, Waters SunFire C18, 50 mm × 250 mm; flow, 17 mL min<sup>–1</sup>).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">4.2 General Procedure for Oxaphosphinane Synthesis: Compounds <b>3</b></h3><div class="NLM_p">Ethyl arylphosphinate was prepared using the method described in the literature by our group.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Under dry nitrogen, 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (1 equiv) was added under nitrogen to a solution of ethyl arylphosphinate (1 equiv) in THF (1.4 mmol/mL), and then, freshly sublimated potassium <i>tert</i>-butoxide (0.2 equiv) was added to the solution. The reaction mixture was stirred at room temperature for 15 h. After evaporation of the solvent under vacuum, chloroform (3 mmol/mL) was added to the crude oil. The organic solution was washed with a saturated aqueous solution of ammonium chloride (3 × 1.5 mmol/mL). The organic layer was dried over sodium sulfate and filtered, and the solvent was evaporated under vacuum.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">4.2.1 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.1</b>)</h4><div class="NLM_p last">From ethyl phenylphosphinate (8.5 g, 50 mmol), a yellow oil residue containing a mixture of four diastereomers was obtained (25.7 g, 28/26/19/27). The solid was purified by normal phase chromatography on silica gel with a mixture of chloroform/ethyl acetate (60/40) as the eluent to give a mixture of four diastereomers <b>3.1a</b>–<b>d</b> (18.3 g, 67%). After chromatography on preparative reverse-phase HPLC with a Waters SunFire column C18, 50 mm × 250 mm, and with a mixture of acetonitrile/water (60:40, flow of 17 mL min<sup>–1</sup>) as the eluent, <b>3.1a</b>, <b>3.1b</b>, <b>3.1c</b>, and <b>3.1d</b> were all separated and recovered purely.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">4.2.2 (<i>S<sub>P</sub>SSSR</i>)-3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.1a</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0017.gif" alt="" id="fx1" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ = 36.1 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ = 3.69 (dd, 1H, <i>J</i> = 11.1, 2.3 Hz), 3.88 (ddd, 1H, <i>J</i> = 11.1, 2.7, 2.5 Hz), 3.90 (dd, 1H, <i>J</i> = 9.5, 9.3 Hz), 3.93 (dd, 1H, <sup>3</sup><i>J</i> = 9.8, 2.0 Hz), 4.10 (ddd, 1H, <i>J</i> = 9.8, 9.5, 2.6 Hz), 4.46 (dddd, 1H, <i>J</i> = 9.3, 3.1, 2.7, 2.3 Hz), 4.46 (d, 1H, <i>J</i> = 12.1 Hz), 4.54 (d, 1H, <i>J</i> = 12.1 Hz), 4.59 (d, 1H, <i>J</i> = 10.8 Hz), 4.83 (d, 1H, <i>J</i> = 11.1 Hz), 4.84 (d, 1H, <i>J</i> = 10.8 Hz), 4.88 (d, 1H, <i>J</i> = 11.1 Hz), 7.38–7.43 (m, 15H), 7.50–7.55 (m, 3H), 7.75–7.80 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ = 68.64 (d, <i>J</i> = 9.2 Hz), 72.19 (d, <i>J</i> = 97.3 Hz), 73.45, 75.24 (d, <i>J</i> = 5.2 Hz), 75.50, 76.25, 77.65, 84.34 (d, <i>J</i> = 6.9 Hz), 127.65, 127.76, 127.82, 127.84, 128.15, 128.45, 127.49 (d, <i>J</i> = 135.8 Hz), 128.71 (d, <i>J</i> = 13.4 Hz), 131.91 (d, <i>J</i> = 10.4 Hz), 133.30 (d, <i>J</i> = 2.8 Hz), 137.92, 137.98, 138.37 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>34</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 545.2093; found, 545.2089. Analytical HPLC: column Waters SunFire C18, 5 μm, 4.6 mm × 250 mm, acetonitrile/water (63/37); flow, 1 mL min<sup>–1</sup>; retention time = 18.53 min.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.2.3 (<i>S<sub>P</sub>RSSR</i>)-3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.1b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0018.gif" alt="" id="fx2" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ = 36.6 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ = 2.67 (s, 1H), 3.80 (dd, 1H, <i>J</i> = 11.3, 2.0 Hz), 4.00 (ddd, 1H, <i>J</i> = 11.3, 3.3, 3.2 Hz), 4.30 (dd, 1H, <i>J</i> = 9.5, 2.8 Hz), 4.36 (dd, 1H, <i>J</i> = 9.5, 2.8 Hz), 4.43 (dd, 1H, <i>J</i> = 3.5, 2.8 Hz), 4.56 (dddd, 1H, <i>J</i> = 10.0, 3.3, 3.2, 2.0 Hz), 4.59 (d, 1H, <i>J</i> = 12.1 Hz), 4.62–4.80 (m, 4H), 4.93 (d, 1H, <i>J</i> = 10.8 Hz), 7.24–7.38 (m, 15H), 7.48–7.54 (m, 2H), 7.62–7.68 (m, 1H,), 7.96–8.03 (m, 2H) ppm. <sup>13</sup>C NMR (161.99 MHz, CDCl<sub>3</sub>): δ = 66.81 (d, <i>J</i> = 105.1 Hz), 68.91 (d, <i>J</i> = 8.8 Hz), 72.48, 73.43, 73.74 (d, <i>J</i> = 2.2 Hz), 75.46 (d, <i>J</i> = 5.6 Hz), 75.64, 81.38 (d, <i>J</i> = 2.9 Hz), 126.53 (d, <i>J</i> = 138.8 Hz), 127.23, 127.68, 127.80, 127.84, 127.98, 128.20, 128.31 (d, <i>J</i> = 13.4 Hz), 128.42, 128.65, 132.99 (d, <i>J</i> = 9.9 Hz), 133.34 (d, <i>J</i> = 2.8 Hz), 137.32, 138.07, 138.09 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>34</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 545.2093; found, 545.2092. Analytical HPLC: column Waters SunFire C18, 5 μm, 4.6 mm × 250 mm, acetonitrile/water (63/37); flow, 1 mL min<sup>–1</sup>; retention time = 15.97 min.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.2.4 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[3-methylpheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.2a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0019.gif" alt="" id="fx3" /></img>From ethyl 3-methylphenylphosphinate (3.00 g, 16.3 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (6.85 g, 16.3 mmol), and freshly sublimated potassium <i>tert</i>-butoxide (0.37 g, 3.3 mmol), <b>3.2</b> was isolated as a yellow oil containing a mixture of four diastereomers (26/29/16/29, 2.54 g, 28%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 37.37, 35.68, 33.41, 32.35 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 559.2250; found, 559.2243.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.2.5 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[3-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.3a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0020.gif" alt="" id="fx4" /></img>From ethyl 3-methoxyphenylphosphinate (4.0 g, 20.0 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (8.4 g, 20.0 mmol) and freshly sublimated potassium <i>tert</i>-butoxide (0.45 g, 4.0 mmol), <b>3.3</b> was isolated as a yellow oil containing a mixture of four diastereomers (23/26/31/20, 3.56 g, 31%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 37.8, 36.6, 34.4, 34.2 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 575.2199; found, 575.2228.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.2.6 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[3-fluoropheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.4a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0021.gif" alt="" id="fx5" /></img>From ethyl 3-fluorophenylphosphinate (0.85 g, 4.5 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (1.89 g, 4.5 mmol) and freshly sublimated potassium <i>tert</i>-butoxide (0.10 g, 0.9 mmol), <b>3.4</b> was isolated as a yellow oil containing a mixture of four diastereomers (27/29/18/26, 0.53 g, 21%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 34.9 (d, <i>J</i> = 7.9 Hz), 34.1 (d, <i>J</i> = 7.9 Hz), 32.3 (d, <i>J</i> = 1.9 Hz), 29.8 (d, <i>J</i> = 5.9 Hz) ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>33</sub>FO<sub>6</sub>P (M + H)<sup>+</sup>, 563.1967; found, 563.1964.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">4.2.7 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[3-trifluoromethylpheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.5a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0022.gif" alt="" id="fx6" /></img>From ethyl 3-trifluoromethylphenylphosphinate (1.07 g, 4.5 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (1.89 g, 4.5 mmol) and freshly sublimated potassium <i>tert</i>-butoxide (0.10 g, 0.9 mmol), <b>3.5</b> was isolated as a yellow oil containing a mixture of four diastereomers (26/32/19/23, 0.63 g, 23%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 35.0, 34.3, 32.3, 30.1 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>33</sub>F<sub>3</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 613.1886; found, 613.3000.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.2.8 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methylpheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.6a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0023.gif" alt="" id="fx7" /></img>From ethyl 4-methylphenylphosphinate (3.68 g, 20.0 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (8.40 g, 20.0 mmol) and freshly sublimated potassium <i>tert</i>-butoxide (0.45 g, 4.0 mmol), <b>3.6</b> was isolated as a yellow oil containing a mixture of four diastereomers (30/25/15/30, 3.83 g, 34%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 37.1, 35.7, 33.3, 32.1 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 559.2250; found, 559.2245.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.2.9 3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.7a</b>–<b>d</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0024.gif" alt="" id="fx8" /></img>From ethyl 4-methoxylphenylphosphinate (4.42 g, 22.1 mmol), 2,3,5-tri-<i>O</i>-benzyl-<span class="smallcaps smallerCapital">d</span>-arabinofuranose (9.27 g, 22.1 mmol) and freshly sublimated potassium <i>tert</i>-butoxide (0.49 g, 4.4 mmol), <b>3.7</b> was isolated as a yellow oil containing a mixture of four diastereomers (27/25/18/30, 6.32 g, 50%). <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 37.3, 37.1, 35.2, 32.5 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 575.2199; found, 575.2206.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.2.10 (<i>S<sub>P</sub>SSSR</i>)-3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.7a</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0025.gif" alt="" id="fx9" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 37.6 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.68 (dd, 1H, <i>J</i> = 11.1, 2.1 Hz), 3.77 (s, 3H), 3.85–3.91 (m, 3H), 4.09 (dd, 1H, <i>J</i> = 25.5, 9.1 Hz), 4.44–4.60 (m, 4H), 4.81–4.89 (m, 3H), 6.88–7.72 (m, 19H) ppm. <sup>13</sup>C NMR (100.61 MHz, CDCl<sub>3</sub>): δ 55.43, 68.58, 72.57, 73.47, 75.09, 75.44, 76.15, 77.69, 113.66, 114.27, 114.41, 127.64, 127.75, 127.82, 127.85, 127.89, 128.06, 128.44, 128.46 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 575.2199; found, 575.2193. Analytical HPLC: column Waters SunFire C18, 5 μm 4.6 mm × 250 mm, acetonitrile/water (60:40); flow, 1 mL min<sup>–1</sup>; retention time = 23.51 min.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.2.11 (<i>S<sub>P</sub>RSSR</i>)-3-Hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>3.7b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0026.gif" alt="" id="fx10" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 36.9 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.60–3.79 (m, 2H), 3.87 (s, 3H), 3.9 (d, 1H, <i>J</i> = 9.6 Hz), 4.20–4.35 (m, 4H), 4.40–4.90 (m, 6H), 4.83 (d, 1H, <i>J</i> = 10.6 Hz), 6.90 (dd, 2H, <i>J</i> = 8.6, 2.9 Hz), 7.00–7.35 (m, 15H), 7.83 (dd, 2H, <i>J</i> = 11.5, 8.8 Hz) ppm. <sup>13</sup>C NMR (100.61 MHz, CDCl<sub>3</sub>): δ 55.39, 68.92, 69.00, 72.42, 73.42, 73.76, 75.33, 75.61, 76.75, 77.07, 77.39, 81.46, 113.87, 114.01, 127.68, 127.78, 127.99, 128.17, 128.42, 128.64, 135.02, 135.12, 137.40, 138.12, 163.67 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 575.2199; found, 575.2191. Analytical HPLC: column Waters SunFire C18, 5 μm, 4.6 mm × 250 mm, acetonitrile/water (60:40); flow, 1 mL min<sup>–1</sup>; retention time = 20.12 min.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.2.12 3-<i>O</i>-Trifluoromethanesulfonyl-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>4a</b>,<b>b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0027.gif" alt="" id="fx11" /></img>Under dry nitrogen, pyridine (0.63 g, 0.64 mL, 8.0 mmol) and trifluoromethanesulfonic anhydride (1.13 g, 0.66 mL, 4.0 mmol) were added to a solution of a mixture of <b>3.1a</b>/<b>3.1b</b> (1.09 g, 2.0 mmol, 60/40) in dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) (20 mL) at 0 °C. The reaction mixture was stirred for 2 h, and then, water (10 mL) was added. The aqueous layer was extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum to give yellow oil. The oily residue was purified by normal-phase chromatography on silica gel with a mixture of <i>n</i>-heptane/ethyl acetate (60/20) as the eluent, and a mixture of <b>4.1a</b>/<b>4.1b</b> (60/40) was obtained in 46% yield. <sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 24.29, 27.92 ppm.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.2.13 (<i>S<sub>P</sub>SSSR</i>)-3-<i>O</i>-Trifluoromethanesulfonyl-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>4.1a</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0028.gif" alt="" id="fx12" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 28.1 ppm. <sup>19</sup>F NMR (376.50 MHz, CDCl<sub>3</sub>): δ −75.00 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.68 (dd, 1H, <i>J</i> = 11.2, 2.0 Hz), 3.88 (dt, 1H, <i>J</i> = 11.1, 2.5 Hz), 4.09 (t, 1H, <i>J</i> = 9.7 Hz), 4.36 (m, 1H), 4.40–4.60 (m, 4H), 4.80 (d, 2H, <i>J</i> = 10.6 Hz), 4.900 (d, 1H, <i>J</i> = 10.4 Hz), 4.98 (dd, 1H, <i>J</i> = 10.4, 1.0 Hz), 7.00–7.30 (m, 15H), 7.49 (m, 2H), 7.62 (m, 1H), 7.80 (m, 2H) ppm. <sup>13</sup>C NMR (100.61 MHz, CDCl<sub>3</sub>): δ 67.85, 67.95, 73.51, 75.52, 75.58, 75.64, 78.49, 80.31, 80.35, 80.94, 81.90, 116.38, 119.56, 124.10, 125.54, 127.58, 127.67, 127.71, 127.80, 127.92, 127.93, 128.01, 128.10, 128.37, 128.52, 128.60, 128.62, 128.96, 129.10, 132.37, 132.48, 134.48, 134.51, 137.03, 137.32, 137.55. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>33</sub>O<sub>8</sub>PF<sub>3</sub>S (M + H)<sup>+</sup>, 677.1586; found, 677.1582.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.2.14 (<i>S<sub>P</sub>RSSR</i>)-3-<i>O</i>-Trifluoromethanesulfonyl-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>4.1b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0029.gif" alt="" id="fx13" /></img><sup>31</sup>P NMR (161.97 MHz, DMSO-<i>d</i><sub>6</sub>): δ 33.4 ppm.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.2.15 (<i>S<sub>P</sub>SSSR</i>)-3-Azido-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>5.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0030.gif" alt="" id="fx14" /></img>Under dry nitrogen, trimethylsilyl azide (0.173 g, 0.197 mL, 1.5 mmol) and a solution of tetrabutylammonium fluoride (1.5 mmol) in THF (15 mL) were added to a solution of <b>4.1a</b>/<b>4.1b</b> (0.406 g, 0.6 mmol, 40/60) in THF (20 mL). The reaction was stirred at 65 °C overnight, and then, the solvent was evaporated under vacuum to give a yellow oil. The residue was purified by chromatography on silica gel with as eluent a mixture of <i>n</i>-heptane/ethyl acetate (60/40) to give <b>5.1b</b> and <b>5.1a</b> in an overall yield of 62%.</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 31.9 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.61 (dd, 1H, <i>J</i> = 10.6, 5.8 Hz), 3.70 (dd, 1H, <i>J</i> = 11.1, 2.0 Hz), 3.91 (dt, 1H, <i>J</i> = 11.1, 2.5 Hz), 4.00 (t, 1H, <i>J</i> = 9.7 Hz), 4.21 (m, 1H, <i>J</i> = 10.6, 9.3, 2.5 Hz), 4.40–4.70 (m, 4H), 4.80–4.90 (m, 3H), 7.10–7.35 (m, 15H), 7.42–7.52 (m, 2H), 7.55–7.63 (m, 1H), 7.78–7.86 (m, 1H) ppm. <sup>13</sup>C NMR (100.61 MHz, CDCl<sub>3</sub>): δ 61.65, 62.60, 68.32, 68.41, 73.50, 75.27, 75.33, 75.53, 76.25, 78.41, 81.74, 81.77, 126.26, 127.63, 127.66, 127.67, 127.85, 127.94, 128.05, 128.11, 128.49, 128.52, 128.90, 129.04, 131.92, 132.02, 133.77, 133.80, 137.43, 137.67, 137.78 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>P (M + H)<sup>+</sup>, 570.2158; found, 570.2151.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.2.16 (<i>S<sub>P</sub>RSSR</i>)-3-Azido-4,5-bis-benzyloxy-6-benzyloxymethyl-2-[4-methoxypheny]l-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>5.1b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0031.gif" alt="" id="fx15" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 33.4 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.77 (dd, 1H, <i>J</i> = 11.2, 1.9 Hz), 3.97 (dt, 1H, <i>J</i> = 11.2, 2.9, Hz), 4.26 (dd, 1H, <i>J</i> = 8.2, 3.2 Hz), 4.30 (d, 1H, <i>J</i> = 9.5 Hz), 4.50 (dd, 1H, <i>J</i> = 9.5, 3.2 Hz), 4.54 (dm, 1H, <i>J</i> = 9.9 Hz), 4.59 (d, 1H, <i>J</i> = 12.4 Hz), 4.64 (d, 1H, <i>J</i> = 10.6 Hz), 4.72 (d, 1H, <i>J</i> = 12.4 Hz), 4.79 (s, 2H), 4.94 (d, 1H, <i>J</i> = 10.9 Hz), 7.18–7.42 (m, 15 H), 7.52–7.60 (m, 2H), 7.68 (tq, 1H, <i>J</i> = 7.7, 1.3 Hz), 7.93–8.00 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 59.04, 60.00, 68.67, 68.77, 68.72, 72.99, 73.41, 74.06, 74.08, 75.74, 76.01, 76.07, 80.81, 80.84, 127.69, 127.74, 127.84, 127.90, 127.93, 128.11, 128.42, 128.45, 128.54, 128.62, 128.68 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>P (M + H)<sup>+</sup>, 570.2167; found, 570.2158.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.2.17 (<i>S<sub>P</sub>SSSR</i>)-3-Amino-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>6.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0032.gif" alt="" id="fx16" /></img>Under dry nitrogen, polymer-bound triphenylphosphine (3 mmol.g<sup>–1</sup>, 0.17 g, 0.510 mmol) and water (0.03 g, 0.03 mL, 1.67 mmol) were added to a solution of <b>5.1a</b> (0.095 g, 0.167 mmol) in THF (2.5 mL). The reaction mixture was stirred at 60 °C for 3 h, cooled at room temperature, and filtered through microporous filter. The solvent was evaporated under vacuum to give <b>6.1a</b> as colorless oil (0.074 g, 82%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 38.7 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>) δ 1.46 (s, 2H), 2.97 (dd, 1H, <i>J</i> = 10.1, 9.8 Hz), 3.70 (dd, <i>J</i> = 11.8, 2.0 Hz), 3.82 (m, 1H, <i>J</i> = 10.1, 9.0, 2.5 Hz), 3.90 (dd, 1H, <i>J</i> = 9.6, 9.0 Hz), 3.92 (ddd, 1H, <i>J</i> = 11.8, 4.3, 2.5 Hz), 4.44–5.10 (m, 7H), 7.05–7.18 (m, 15H), 7.41–7.5 (m, 2H), 7.5–7.62 (m, 1H), 7.79–7.90 (m, 1H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 53.82, 54.79, 68.61, 68.70, 73.49, 75.32, 75.36, 75.41, 76.35, 76.72, 78.82, 84.76, 84.82, 127.24, 127.66, 127.77, 127.82, 127.92, 127.99, 128.07, 128.45, 128.52, 128.59, 128.68, 128.73, 132.95, 133.05, 133.13, 133.11, 137.84, 137.93, 138.08 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>35</sub>NO<sub>5</sub>P (M + H)<sup>+</sup>, 544.2253; found, 544.2258.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.2.18 (<i>S<sub>P</sub>RSSR</i>)-3-Amino-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>6.1b</b>). Starting from <b>5.1b</b></h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0033.gif" alt="" id="fx18" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 39.5 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 1.65 (s, 2H, N<u class="uu">H</u><sub>2</sub>), 3.71 (dd, 1H, <i>J</i> = 11.1, 2.0 Hz), 3.77 (dd, 1H, <i>J</i> = 5.8, 3.3 Hz), 3.88 (ddd, 1H, <i>J</i> = 11.1, 3.0, 2.5 Hz), 4.25–4.31 (m, 2H, 4.41–4.65 (m, 6H), 4.84 (d, 1H, <i>J</i> = 10.84 Hz), 7.05–7.21 (m, 15H), 7.43–7.48 (m, 2H), 7.54–7.60 (m, 1H), 7.77–7.93 (m, 2H, <i>J</i> = 11.6, 7.4, 1.5 Hz) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 49.37, 50.34, 68.94, 69.04, 72.14, 73.29, 73.32, 73.40, 75.42, 75.60, 75.65, 80.99, 127.74, 127.87, 127.95, 128.39, 128.44, 128.54, 128.57, 132.69, 132.79, 133.16, 133.19, 137.75, 138.04, 138.14 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>35</sub>NO<sub>5</sub>P (M + H)<sup>+</sup>, 544.2253; found, 544.2245.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.2.19 (<i>S<sub>P</sub>RSSR</i>)-3-Phenylureido-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>7.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0034.gif" alt="" id="fx19" /></img>Under dry nitrogen, phenyl isocyanate (0.024 g, 0.20 mmol) was added to a solution of <b>6.1a</b> (0.100 g, 0.18 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL). The reaction mixture was stirred at room temperature overnight, and then, the solvent was evaporated under vacuum. The residue was purified by chromatography on silica gel with as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>7.1a</b> (0.063 g, 53%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 39.0 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.81 (dd, 1H, <i>J</i> = 11.1, 1.8 Hz), 3.94 (ddd, 1H, <i>J</i> = 10.9, 2.8, 2.5 Hz), 4.07 (ddd, 1H, <i>J</i> = 10.6, 9.4, 2.8 Hz), 4.18 (dd, 1H, <i>J</i> = 9.3, 9.3 Hz), 4.53–4.83 (m, 8H), 6.87–8.49 (m, 25H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 50.73 (d, <i>J</i> = 97.3 Hz), 68.65 (d, <i>J</i> = 9.5 Hz), 73.36, 75.45, 76.27 (d, <i>J</i> = 5.9 Hz), 76.63, 78.30, 82.97 (d, <i>J</i> = 8.8 Hz), 118.25, 121.86, 125.47–128.73 (m, 15C), 127.10 (d, <i>J</i> = 23.6 Hz), 129.12 (d, <i>J</i> = 13.2 Hz), 131.74 (d, <i>J</i> = 11.0 Hz), 133.87, 137.59, 137.80, 137.87, 139.71, 155.22 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>40</sub>N<sub>2</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 663.2631; found, 663.2624.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.2.20 (<i>S<sub>P</sub>SSSR</i>)-3-Dithiocarbonyl-S-methylester-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>8.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0035.gif" alt="" id="fx20" /></img>Under dry nitrogen, carbon disulfide (2.34 g, 1.90 mL, 30.7 mmol) and sodium hydride (60% in oil, 0.16 g, 4.0 mmol) were added to a solution of a mixture <b>3.1a</b>/<b>3.1b</b> (1.69 g, 3.1 mmol, 40/60) in DMF (15 mL). The reaction mixture was stirred at room temperature for 30 min, and then, methyl iodide (4.36 g, 1.90 mL, 30.7 mmol) was added. After 1 h of stirring, water (30 mL) was added, and the aqueous layer was extracted with ethyl acetate (3 × 30 mL). The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum to give a white solid (1.70 g). The solid was purified by normal-phase chromatography on silica gel with a mixture of <i>n</i>-heptane/ethyl acetate (70/30) as the eluent to give <b>8.1a</b> and <b>8.1b</b> (overall yield, 75%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 30.1 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 2.39 (s, 3H), 3.69 (dd, 1H, <i>J</i> = 11.1, 1.5 Hz), 3.91 (d, 1H, <i>J</i> = 11.2 Hz), 4.08 (t, 1H, <i>J</i> = 9.7 Hz), 4.38–4.50 (m, 2H), 4.51–4.65 (m, 3H), 4.7 (s, 2H), 4.80 (d, 1H, <i>J</i> = 10.9 Hz), 6.52 (d, 1H, <i>J</i> = 10.3 Hz), 7.18–7.25 (m, 15H), 7.35–7.43 (m, 2H), 7.45–7.58 (m, 1H), 7.72–7.83 (m, 2H). <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 19.50, 68.31, 68.40, 73.50, 75.12, 75.17, 75.68, 76.28, 78.05, 78.20, 79.19, 81.92, 81.98, 126.30, 127.68, 127.78, 127.82, 127.87, 127.90, 128.08, 128.39, 128.48, 128.70, 128.83, 129.22, 130.80, 130.87, 132.05, 132.16, 133.68, 133.71, 137.66, 137.79, 193.66, 193.94, 194.70, 194.76, 215.47 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>36</sub>O<sub>6</sub>PS<sub>2</sub> (M + H)<sup>+</sup>, 635.1691; found, 635.1682.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.2.21 (<i>S<sub>P</sub>RSSR</i>)-3-Dithiocarbonyl-<i>S</i>-methylester-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>8.1b</b>)</h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0036.gif" alt="" id="fx21" /></img><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 32.1 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 2.30 (s, 3H), 3.75 (dd, 1H, <i>J</i> = 11.1, 1.8 Hz), 3.95 (dt, 1H, <i>J</i> = 11.1, 2.8 Hz), 4.25 (t, 1H, <i>J</i> = 9.9 Hz), 4.45 (dd, 1H, <i>J</i> = 9.6, 2.5 Hz), 4.48 (d, 1H, <i>J</i> = 11.1 Hz), 4.50 (d, 1H, <i>J</i> = 11.9 Hz), 4.53 (d, 1H, <i>J</i> = 11.1 Hz), 4.57 (m, 1H), 4.77 (d, 1H, <i>J</i> = 11.1 Hz), 4.85 (d, 1H, <i>J</i> = 11.1 Hz), 6.88 (dd, 1H, <i>J</i> = 3.78, 2.78 Hz), 7.23–7.40 (m, 17H), 7.50 (m, 1H), 7.78 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 18.02, 28.67, 67.85, 67.94, 71.11, 73.10, 73.25, 73.26, 74.06, 74.67, 75.05, 75.11, 78.67, 78.72, 123.82, 125.26, 126.53, 126.66, 126.76, 126.87, 126.92, 127.19, 127.35, 127.37, 127.39, 127.51, 131.72, 131.83, 132.59, 132.61, 136.18, 136.93, 137.10, 213.38 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>36</sub>O<sub>6</sub>PS<sub>2</sub> (M + H)<sup>+</sup>, 635.1691; found, 635.1698.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.2.22 (<i>S<sub>P</sub>SSR</i>)-4,5-Bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>9</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0037.gif" alt="" id="fx22" /></img>Tributyltin hydride (0.23 g, 0.21 mL, 0.79 mmol) and AIBN (0.002 g, 0.0122 mmol) were added to a solution of <b>8.1a</b>/<b>8.1b</b> (0.39 g, 0.61 mmol) in toluene (8 mL) at room temperature. The reaction mixture was stirred at 115 °C for 3 h. The solvent was evaporated affording a yellow oil. The residue was purified by chromatography on silica gel with a mixture of <i>n</i>-heptane/ethyl acetate (60:40) as the eluent to give <b>9</b> as a white solid (0.094 g, 29%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 37.9 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 1.92 (m, 1H), 2.62 (dt, 1H, <i>J</i> = 13.6, 4.5 Hz), 3.68 (dd, 1H, <i>J</i> = 11.1, 2.0 Hz), 3.93 (m, 2H), 4.25 (m, 1H), 4.40–4.50 (m, 2H), 4.50–4.65 (m, 4H), 4.88 (d, 1H, <i>J</i> = 10.6 Hz), 7.25–7.30 (m, 15H), 7.30–7.47 (m, 2H), 7.49–7.58 (m, 1H), 7.70–7.78 (m, 2H) ppm. <sup>13</sup>C NMR (400.13 MHz, CDCl<sub>3</sub>): δ 32.47, 33.29, 68.96, 69.05, 72.14, 73.42, 75.44, 75.50, 75.53, 127.64, 127.69, 127.75, 127.80, 127.85, 127.90, 129.13, 130.51, 131.42, 131.53, 132.95, 132.98, 137.87, 138.09, 138.13 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>34</sub>O<sub>5</sub>P (M + H)<sup>+</sup>, 529.2144; found, 529.2136.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.2.23 (<i>S<sub>P</sub>SSSR</i>)-3-Methoxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>10.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0038.gif" alt="" id="fx23" /></img>Under dry nitrogen, sodium hydride (50% in oil, 0.01 g, 0.021 mmol) was added to a solution of <b>3.1a</b> (0.10 g, 0.18 mmol) in dry THF (3 mL). The reaction mixture was stirred at room temperature for 30 min, and then, methyl iodide (13 μL, 0.21 mmol) was added. The reaction mixture was stirred for one night. After solvent evaporation under vacuum, ethyl acetate (3 mL) was poured into the crude oil. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel using a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) as the eluent to give <b>10.1a</b> as a white solid (0.015 g, 15%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ = 32.8 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3,23 (s, 3H), 3.63 (d, 1H, <i>J</i> = 10.0 Hz), 3.67 (dd, 1H, <i>J</i> = 11.1, 1.8 Hz), 3.88 (ddd, 1H, <i>J</i> = 11.1, 2.6, 2.4 Hz), 3.94 (dd, 1H, <i>J</i> = 9.8, 9.6 Hz), 4.17 (ddd, 1H, <i>J</i> = 9.8, 9.6, 2.6 Hz), 4.43–4.62 (m, 3H), 4.78–4.89 (m, 2H), 7.12–7.24 (m, 15H), 7.43–7.57 (m, 3H), 7.81–7.85 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 61.19, 68.59, 73.43, 74.85, 75.55, 76.43, 77.83, 81.30, 82.31, 83.46, 83.53, 127.59, 127.73, 127.77, 127.81, 127.99, 128.42, 128.44, 128.78, 128.91,131.78, 131.88, 133.25, 137.98, 138.32 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>36</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 559.2250; found, 559.2250.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.2.24 (<i>S<sub>P</sub>SSSR</i>)-3-Benzyloxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>11.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0039.gif" alt="" id="fx24" /></img>Under dry nitrogen, sodium hydride (50% oil, 0.01 g, 0.21 mmol) was added to a solution of <b>3.1a</b> (0.10 g, 0.18 mmol) in dry THF (3 mL). The reaction mixture was stirred at room temperature for 30 min. Benzyl chloride (25 μL, 0.22 mmol) was added, and the reaction mixture was stirred for one night. After solvent evaporation under vacuum, ethyl acetate (3 mL) was added to the crude oil. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel using as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>11.1a</b> as a white solid (0.045 g, 39%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ = 33.4 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.65 (dd, 1H, <i>J</i> = 11.2, 2.0 Hz), 3.85 (d, 1H, <i>J</i> = 10.2 Hz), 3.88 (ddd, 1H, <i>J</i> = 11.2, 2.6, 2.3 Hz), 3.92 (dd, 1H, <i>J</i> = 9.8, 9.6 Hz), 4.28 (ddd, 1H, <i>J</i> = 10.0, 9.8, 2.7 Hz), 4.39–4.61 (m, 6H), 4.84 (d, 1H, <i>J</i> = 10.7), 4.91 (d, 1H, <i>J</i> = 10.7), 6.80–6.90 (m, 2H), 6.95–7.05 (m, 2H), 7.05–7.15 (m, 3H), 7.15–7.25 (m, 13H), 7.35–7.45 (m, 2H), 7.05–7.15 (m, 3H), 7.50–7.55 (m, 1H), 7.65–7.75 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 68.52, 68.61, 73.44, 74.42, 74.46, 74.74, 75.54, 76.39, 77.43, 78.03, 78.43, 83.72, 83.79, 127.72, 127.86, 128.14, 128.17, 128.42, 128.44, 128.69, 128.82, 131.88, 131.98 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>40</sub>O<sub>6</sub>P (M + H)<sup>+</sup>, 635.2563; found, 635.2559.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.2.25 (<i>S<sub>P</sub>SSSR</i>)-3-Acetoxy<b>-</b>4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>12.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0040.gif" alt="" id="fx25" /></img>Under dry nitrogen, acetic anhydride (0.062 g, 57 μL, 0.61 mmol), pyridine (30 μL, 0.41 mmol), and DMAP (0.005 g, 0.041 mmol) were added to a solution of <b>3.1a</b> (0.225 g, 0.41 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The reaction mixture was stirred for one night. After solvent evaporation under vacuum, ethyl acetate (10 mL) was added to the crude oil. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by normal-phase chromatography on silica gel using as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>12.1a</b> (0.154 g, 64%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 32.1 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 1.82 (s, 3H), 3.67 (dd, 1H, <i>J</i> = 11.2, 2.0 Hz), 3.90 (ddd, 1H, <i>J</i> = 11.2, 2.7, 2.4 Hz), 4.04 (t, 1H, <i>J</i> = 9.7 Hz), 4.23 (ddd, 1H, <i>J</i> = 10.4, 9.4, 2.9 Hz), 4.44–4.83 (m, 7H), 5.42 (dd, 1H, <i>J</i> = 10.4, 1.0 Hz), 7.12–7.25 (m, 15H), 7.40–7.50 (m, 2H), 7.50–7.60 (m, 1H), 7.74–7.80 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 20.46, 68.31, 68.40, 70.16, 71.17, 73.46, 75.20, 75.25, 75.59, 76.21, 78.21, 81.77, 81.82, 127.60, 127.63, 127.87, 127.93, 128.49, 128.69, 131.82, 133.61, 133.64, 137.70, 137.83, 137.97, 169.54, 169.58 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>34</sub>H<sub>36</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 587.2199; found, 587.2186.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.2.26 (<i>S<sub>P</sub>SSSR</i>)-3-Trifluoroacetoxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>13.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0041.gif" alt="" id="fx26" /></img>Under dry nitrogen, trifluoroacetic anhydride (0.084 g, 56 μL, 0.40 mmol), pyridine (0.021 g, 21 μL, 0.27 mmol), and DMAP (0.003 g, 0.027 mmol) were added to a solution of <b>3.1a</b> (0.150 g, 0.27 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (3 mL). The reaction mixture was stirred during night. Ethyl acetate (5 mL) was added to the crude mixture, and the mixture was washed with water saturated with NaCl. The organic layer was dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel with as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>13.1a</b> (0.069 g, 40%).</div><div class="NLM_p last"><sup>19</sup>F NMR (376.46 MHz, CDCl<sub>3</sub>): δ −74.4 ppm. <sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 28.7 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): 3.81 (d, 1H, <i>J</i> = 11.2 Hz), 4.00 (d, 1H, <i>J</i> = 11.0 Hz), 4.18 (dd, 1H, <i>J</i> = 9.8, 9.6 Hz), 4.46 (dd, 1H, <i>J</i> = 9.4, 8.4 Hz), 4.50–5.00 (m, 5H), 5.48 (d, 1H, <i>J</i> = 10.6 Hz), 7.15–7.45 (m, 15H), 7.50–7.63 (m, 2H), 7.65–7.75 (m, 1H), 7.80–7.95 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 68.05, 68.13, 73.51, 74.11, 75.09, 75.42, 75.47, 75.67, 76.47, 78.17, 80.67, 127.66, 127.70, 127.74, 128.05, 128.53, 129.00, 129.14, 131.81, 131.91, 134.17, 137.16, 137.45, 137.64 ppm. MS (ESI) <i>m</i>/<i>z</i> for C<sub>34</sub>H<sub>33</sub>F<sub>3</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 641.2.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.2.27 (<i>S<sub>P</sub>SSSR</i>)-3-Benzoate<b>-</b>4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>14.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0042.gif" alt="" id="fx27" /></img>Under dry nitrogen, benzoic anhydride (0.090 g, 0.40 mmol), pyridine (0.021 g, 21 μL, 0.27 mmol), and DMAP (0.003 mg, 0.027 mmol) were added to a solution of <b>3.1a</b> (0.150 g, 0.27 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (3 mL). The reaction mixture was stirred during night. Ethyl acetate (5 mL) was added to the crude mixture and washed with water saturated with NaCl. The organic layer was dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel with a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) as the eluent to give <b>14.1a</b> (0.054 g, 31%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ 31.8 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): δ 3.72 (d, 1H, <i>J</i> = 11.2 Hz), 3.92 (d, 1H, <i>J</i> = 11.0 Hz), 4.11 (t, 1H, <i>J</i> = 9.6 Hz), 4.41 (m,1H), 4.46–4.65 (m, 5H), 4.74 (d, 1H, <i>J</i> = 11.0 Hz), 4.84 (d, 1H, <i>J</i> = 11.0 Hz), 5.70 (d, 1H, <i>J</i> = 10.4 Hz), 6.90–7.60 (m, 21H), 7.70–7.85 (m, 2H), 7.94 (d, 1H, <i>J</i> = 7.2 Hz) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 68.35, 68.44, 73.46, 75.29, 75.60, 76.33, 78.29, 81.60, 127.64, 127.83, 127.98, 128.27, 128.42, 128.48, 128.73, 128.87, 130.06, 131.90, 133.48, 137.43, 137.77, 137.85 ppm. MS (ESI) <i>m</i>/<i>z</i> for C<sub>39</sub>H<sub>38</sub>O<sub>7</sub>P (M + H)<sup>+</sup>, 649.3.</div></div><div id="sec800" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.2.28 Compound <b>15.1</b></h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0043.gif" alt="" id="fx28" /></img>The synthesis was according to Cipolla et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec801" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.2.29 Compound <b>15.2</b></h4><div class="NLM_p last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0044.gif" alt="" id="fx29" /></img>The synthesis was according to Cipolla et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.2.30 (<i>S<sub>P</sub>SSSR</i>)-3-Allylamino-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>16.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0001.gif" alt="" id="fx30" /></img>Under dry nitrogen, compound <b>15.1</b> (10.0 g, 21.7 mmol) was added to a solution of ethyl phenylphosphinate (3.7 g, 21.7 mmol) in THF (250 mL), and then, freshly sublimated potassium <i>tert</i>-butoxide (0.7 g, 6.24 mmol) was poured to the solution. The reaction mixture was stirred at room temperature for one night. The crude mixture was washed with water saturated with NaCl. The organic layer was dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel with as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>16.1a</b> (1.60 g, 12%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CD<sub>3</sub>C(O)CD<sub>3</sub>): δ 35.5 ppm. <sup>1</sup>H NMR (400.13 MHz, CDCl<sub>3</sub>): 3.08–3.23 (m, 3H), 3.77 (dd, 1H, <i>J</i> = 11.0, 2.2 Hz), 3.98–4.15 (m, 3H), 4.45–5.05 (m, 9H), 5.45–5.65 (m, 1H), 7.20–7.40 (m, 15H), 7.46–7.56 (m, 1H), 7.58–7.66 (m, 1H), 7.85–7.95 (m, 2H) ppm. Analytical HPLC [column, Waters SunFire C18, 5 μm, 4.6 mm × 250 mm; eluent, acetonitrile/water (80:20); flow, 1 mL min<sup>–1</sup>; retention time = 13.66 min (99%)]. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>35</sub>H<sub>39</sub>NO<sub>5</sub>P (M + H)<sup>+</sup>, 584.2566; found, 584.2565.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.2.31 (<i>S<sub>P</sub>SSSR</i>)-3-Benzylamino-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ<sup>5</sup>-[1,2]oxaphosphinane (<b>17.1a</b>)</h4><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0002.gif" alt="" id="GRAPHIC-d1712e3823-autogenerated" /></img>Under dry nitrogen, compound <b>15.2</b> (10.20 g, 19.6 mmol) was added to a solution of ethyl phenylphosphinate (3.34 g, 19.6 mmol) in THF (250 mL), and then, freshly sublimated potassium <i>tert</i>-butoxide (0.65 g, 5.8 mmol) was poured into the solution. The reaction mixture was stirred at room temperature for one night. The crude mixture was washed with a saturated aqueous solution of NaCl. The organic layer was dried over magnesium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel with as eluent a mixture of <i>n</i>-heptane/ethyl acetate (100/0 to 0/100) to give <b>17.1a</b> (0.97 g, 7%).</div><div class="NLM_p last"><sup>31</sup>P NMR (161.97 MHz, CDCl<sub>3</sub>): δ = 36.8 ppm. <sup>1</sup>H NMR (400.13 MHz, CD<sub>3</sub>C(O)CD<sub>3</sub>): 3.08 (dd, 1H, <i>J</i> = 10.1, 5.5 Hz), 3.64–3.70 (m, 3H), 3.844.10 (m, 3H), 4.30–5.00 (m, 7H), 6.61–6.90 (m, 2H), 6.90–7.05 (m, 3H), 7.05–7.15 (m, 2H), 7.15–7.30 (m, 13H), 7.30–7.45 (m, 2H), 7.45–7.60 (m, 2H), 7.70–7.85 (m, 2H) ppm. <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>): δ 52.58, 52.65, 53.62, 58.63, 60.09, 68.69, 68.84, 71.76, 74.94, 75.02, 75.35, 76.47, 76.62, 77.12, 78.76, 83.96, 84.08, 126.88, 127.63, 127.71, 127.76, 127.84, 128.08, 128.13, 128.42, 128.47, 128.48, 128.59, 128.64, 128.80, 130.75, 131.87, 132.04, 132.98, 133.02 ppm. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>39</sub>H<sub>41</sub>NO<sub>5</sub>P (M + H)<sup>+</sup>, 634.2722; found, 634.2724.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53">4.3 Cell Cultures</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.3.1 Cell Lines</h4><div class="NLM_p last">A431, MDA-MB-231, DU145, MDA-MB-435, B16F10, CacO2, and HuH7 cells were obtained from the American Type Culture Collection. The C6 cells were a gift from M. Mersel (Institut des neurosciences de Montpellier, INM). These cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 1 mM sodium pyruvate, and 50 U mL<sup>–1</sup> streptomycin.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.3.2 Astrocytes</h4><div class="NLM_p last">Astrocytes were isolated from newborn mice (day 2) cortex as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(35)</a></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56">4.4 Drug Addition</h3><div class="NLM_p last">TMZ, carmustine, vincristine, paclitaxel, cytosine arabinoside (AraC), MTT, neutral red, phosphate-buffered saline (PBS), triton X 100, Hoechst 33342, and PI were from Sigma. Phostine solutions were prepared in ethanol/DMSO (80/20 v/v). For TMZ and paclitaxel, solutions at 100 mM were prepared in 100% DMSO. Carmustine was at 100 mM in ethanol. Vincristine (100 mM) was dissolved, and AraC (10 μM) was prepared in PBS.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57">4.5 Measurements of the Oxaphosphinane Effects on C6 and Astrocytes in Primary Culture</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.5.1 MTT Assay</h4><div class="NLM_p last">The MTT assay was carried out as previously described<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> 48 h after drug addition.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.5.2 Neutral Red Assay</h4><div class="NLM_p last">The neutral red assay was carried out as previously described<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> 24 and 48 h after drug addition.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a></div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.5.3 LDH Assay</h4><div class="NLM_p last">LDH release was measured using the LDH kit from Roche for 60 min and according to the manufacturer's instructions.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">4.5.4 NCI Assay</h4><div class="NLM_p last">The NCI assays were carried out at 10 μM performing a sulforhodamine test at 24 h.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.5.5 Hoechst 33342 and Propidium Iodide Fluorescence Measurements and Impedance Measurement</h4><div class="NLM_p">After 48 h of OXP treatment, 5 μg/mL Hoechst 33342 and 10 μM PI were added in the culture medium for 30 min at 37 °C. Cells were then washed in PBS and fixed during 10 min with 4% paraformaldehyde. The mean fluorescence at four positions in each well at 460 nm was measured (Cytofluor multiwell plate reader 4000, Perseptive biosystems) with excitation at 360 nm and a gain of 90 dB. The mean fluorescence of three wells per condition was then calculated.</div><div class="NLM_p last">Dual labeling with PI and Hoechst 33342 was performed using the Cellomics array scan vti (Thermofisher). Fluorescence was detected with an ORCA camera (ORCA ER;0.63), a 20× objective, and a XF 93 filter, gain of 25 dB, and exposure times were 24 and of 280 ms for Hoechst 33342 and PI, respectively. Images were analyzed using the array scan vti 6.0 software. The object detection was fixed on the Hoechst 33342 channel with a threshold intensity of 400. The object area was fixed between 10 and 160 to separate nuclei. The object counting validation was fixed at 2500/well counting less than 15 fields containing a minimum of five objects. Control fluorescence intensities for red and blue staining were measured on Triton X-100 (2%)-treated cells. The mean percentage of PI incorporation was calculated from three different wells per condition.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">4.5.6 Impedance Measurement</h4><div class="NLM_p last">The Xcelligence system, kindly lent by Roche diagnostics (Meylan, France), measured the electrical impedance across interdigitated microelectrodes integrated on the bottom of tissue culture E-Plates (ACEA biosciences). Impedance was recorded for 69 h using RTCA software every 10 min. The effects of OXP (1 nM to 100 μM) were measured 25 h after plating (<i>t</i> = 0) for 44 h. The electrode impedance was displayed as a cell index (CI) value. The mean CI value calculated from triplicate measurements was normalized to vehicle-treated cells. The primary effects of OXP were determined by a statistical analysis of the 0–5 h interval after drug addition. Indeed, when plates were coated with an inhibitor of cell adhesion like polyhydoxymethacrylate (data not shown), the CI value remained constant over time. The primary effects of <b>3.1a</b> were determined by a statistical analysis on the 0–5 h interval after drug addition.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64">4.6 Statistical Analyses</h3><div class="NLM_p last">EC<sub>50</sub> values were calculated using the Hill equation of the dose–log response curves using Prism 5.0 software (Graphpad) using the vehicle as the top value and Triton X-100 as the bottom value. For group comparison, one-way ANOVA followed by Fisher's posthoc PLSD test was performed using the Statview 5.0 software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/jm201428a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">All spectra and analyses. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201428a/suppl_file/jm201428a_si_001.pdf">jm201428a_si_001.pdf (4.22 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201428a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Luc Pirat</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1b717e7a7536776e78356b72697a6f5b7e75687876357d693b757469797e696f35797a707a777a697a5b7e75687876357d69"><span class="__cf_email__" data-cfemail="f29897939cdf9e8791dc829b809386b2979c81919fdc9480">[email protected]</span> <span class="__cf_email__" data-cfemail="e38d8c9181869197cd818288828f829182a3868d90808ecd8591">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norbert Bakalara</span> - <span class="hlFld-Affiliation affiliation">INSERM U-1051, Institut des Neurosciences de Montpellier, 80 rue Augustin
Fliche 34091 Montpellier, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#066c6367682b6a736528766f74677246636875656b28607426686974646374722864676d676a67746746636875656b286074"><span class="__cf_email__" data-cfemail="600a05010e4d0c15034e100912011420050e13030d4e0612">[email protected]</span> <span class="__cf_email__" data-cfemail="d4babba6b6b1a6a0fab6b5bfb5b8b5a6b594b1baa7b7b9fab2a6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ludovic Clarion</span> - <span class="hlFld-Affiliation affiliation">INSERM U-1051, Institut des Neurosciences de Montpellier, 80 rue Augustin
Fliche 34091 Montpellier, France</span>; 
    <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carine Jacquard</span> - <span class="hlFld-Affiliation affiliation">INSERM U-1051, Institut des Neurosciences de Montpellier, 80 rue Augustin
Fliche 34091 Montpellier, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Odile Sainte-Catherine</span> - <span class="hlFld-Affiliation affiliation">UMR 7244
CSPBAT, Equipe CBS Université Paris 13, 74 rue Marcel
Cachin, 93017 Bobigny cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Séverine Loiseau</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Filippini</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie-Hélène Hirlemann</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Noël Volle</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Virieux</span> - <span class="hlFld-Affiliation affiliation">UMR 5253, ICG Montpellier, Equipe AM2N,
ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier
cedex 5, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Lecouvey</span> - <span class="hlFld-Affiliation affiliation">UMR 7244
CSPBAT, Equipe CBS Université Paris 13, 74 rue Marcel
Cachin, 93017 Bobigny cedex, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1712e3986-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Didier Petite, Clovis Rakotoarivelo, Marcel Mersel, Omar Munoz, Marissa Teigell, and Alina Florentine Cristian for expert technical support, Romain Filhol and Julien Cau for Cellomic expertise, Nicolas Gauthier from Roche for Xcelligence system expertise, and Jan de Weille for carefully reading the manuscript and for English language. This research was supported by l'Agence Nationale de la Recherche (ANR-07-PCVI-0038-01), L'INCa (DM/FC/mc/25-03-09), l'Institut National de la Santé et de la Recherche Médicale (INSERM), and L'Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i69" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i69"> Abbreviations Used</h2><tr><td class="NLM_term">NCI</td><td class="NLM_def"><p class="first last">National Cancer Institute</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">PCV</td><td class="NLM_def"><p class="first last">procarbazine, lomustine, and vincristine</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">dimethylthiazolyl-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">LTC</td><td class="NLM_def"><p class="first last">lower toxic concentration</p></td></tr><tr><td class="NLM_term">GP</td><td class="NLM_def"><p class="first last">growth percent</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">AraC</td><td class="NLM_def"><p class="first last">cytabarine</p></td></tr><tr><td class="NLM_term">GFAP</td><td class="NLM_def"><p class="first last">glial fibrillary acidic protein</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">propidium iodide</p></td></tr><tr><td class="NLM_term">TMZ</td><td class="NLM_def"><p class="first last">Temozolomide</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">CH<sub>2</sub>Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">INM</td><td class="NLM_def"><p class="first last">Institut des neurosciences de Montpellier</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco's modified Eagle's medium</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fetal calf serum</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Bauchet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu-Daude, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro-Peray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallusseau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiebaut, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patru, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauchet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lionnet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faillot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taillandier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figarella-Branger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frappaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reme-Saumon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretarre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daures, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrousse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honnorat, J.</span><span> </span><span class="NLM_article-title">Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=725-735&author=L.+Bauchetauthor=H.+Mathieu-Daudeauthor=P.+Fabbro-Perayauthor=V.+Rigauauthor=M.+Fabbroauthor=O.+Chinotauthor=L.+Pallusseauauthor=C.+Carninauthor=K.+Laineauthor=A.+Schlamaauthor=A.+Thiebautauthor=M.+C.+Patruauthor=F.+Bauchetauthor=M.+Lionnetauthor=M.+Wagerauthor=T.+Faillotauthor=L.+Taillandierauthor=D.+Figarella-Brangerauthor=L.+Capelleauthor=H.+Loiseauauthor=D.+Frappazauthor=C.+Campelloauthor=C.+Kerrauthor=H.+Duffauauthor=M.+Reme-Saumonauthor=B.+Tretarreauthor=J.+P.+Dauresauthor=D.+Heninauthor=F.+Labrousseauthor=P.+Meneiauthor=J.+Honnorat&title=Oncological+patterns+of+care+and+outcome+for+952+patients+with+newly+diagnosed+glioblastoma+in+2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauchet%26aufirst%3DL.%26aulast%3DMathieu-Daude%26aufirst%3DH.%26aulast%3DFabbro-Peray%26aufirst%3DP.%26aulast%3DRigau%26aufirst%3DV.%26aulast%3DFabbro%26aufirst%3DM.%26aulast%3DChinot%26aufirst%3DO.%26aulast%3DPallusseau%26aufirst%3DL.%26aulast%3DCarnin%26aufirst%3DC.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DSchlama%26aufirst%3DA.%26aulast%3DThiebaut%26aufirst%3DA.%26aulast%3DPatru%26aufirst%3DM.%2BC.%26aulast%3DBauchet%26aufirst%3DF.%26aulast%3DLionnet%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DM.%26aulast%3DFaillot%26aufirst%3DT.%26aulast%3DTaillandier%26aufirst%3DL.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCapelle%26aufirst%3DL.%26aulast%3DLoiseau%26aufirst%3DH.%26aulast%3DFrappaz%26aufirst%3DD.%26aulast%3DCampello%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DC.%26aulast%3DDuffau%26aufirst%3DH.%26aulast%3DReme-Saumon%26aufirst%3DM.%26aulast%3DTretarre%26aufirst%3DB.%26aulast%3DDaures%26aufirst%3DJ.%2BP.%26aulast%3DHenin%26aufirst%3DD.%26aulast%3DLabrousse%26aufirst%3DF.%26aulast%3DMenei%26aufirst%3DP.%26aulast%3DHonnorat%26aufirst%3DJ.%26atitle%3DOncological%2520patterns%2520of%2520care%2520and%2520outcome%2520for%2520952%2520patients%2520with%2520newly%2520diagnosed%2520glioblastoma%2520in%25202004%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D725%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadjipanayis, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, J. J.</span><span> </span><span class="NLM_article-title">Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma</span> <span class="citation_source-journal">CA Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2010&pages=166-193&author=E.+G.+Van+Meirauthor=C.+G.+Hadjipanayisauthor=A.+D.+Nordenauthor=H.+K.+Shuauthor=P.+Y.+Wenauthor=J.+J.+Olson&title=Exciting+new+advances+in+neuro-oncology%3A+The+avenue+to+a+cure+for+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DHadjipanayis%26aufirst%3DC.%2BG.%26aulast%3DNorden%26aufirst%3DA.%2BD.%26aulast%3DShu%26aufirst%3DH.%2BK.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26atitle%3DExciting%2520new%2520advances%2520in%2520neuro-oncology%253A%2520The%2520avenue%2520to%2520a%2520cure%2520for%2520malignant%2520glioma%26jtitle%3DCA%2520Cancer%2520J.%2520Clin.%26date%3D2010%26volume%3D60%26spage%3D166%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gerstner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, G.</span><span> </span><span class="NLM_article-title">Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=466-472&author=E.+R.+Gerstnerauthor=P.+J.+Chenauthor=P.+Y.+Wenauthor=R.+K.+Jainauthor=T.+T.+Batchelorauthor=G.+Sorensen&title=Infiltrative+patterns+of+glioblastoma+spread+detected+via+diffusion+MRI+after+treatment+with+cediranib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerstner%26aufirst%3DE.%2BR.%26aulast%3DChen%26aufirst%3DP.%2BJ.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DSorensen%26aufirst%3DG.%26atitle%3DInfiltrative%2520patterns%2520of%2520glioblastoma%2520spread%2520detected%2520via%2520diffusion%2520MRI%2520after%2520treatment%2520with%2520cediranib%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D466%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fraum, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisl, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, F. M.</span><span> </span><span class="NLM_article-title">Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy</span> <span class="citation_source-journal">J. Neurooncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1007%2Fs11060-011-0579-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=287-289&author=T.+J.+Fraumauthor=T.+N.+Kreislauthor=J.+Sulauthor=H.+A.+Fineauthor=F.+M.+Iwamoto&title=Ischemic+stroke+and+intracranial+hemorrhage+in+glioma+patients+on+antiangiogenic+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11060-011-0579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-011-0579-4%26sid%3Dliteratum%253Aachs%26aulast%3DFraum%26aufirst%3DT.%2BJ.%26aulast%3DKreisl%26aufirst%3DT.%2BN.%26aulast%3DSul%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DH.%2BA.%26aulast%3DIwamoto%26aufirst%3DF.%2BM.%26atitle%3DIschemic%2520stroke%2520and%2520intracranial%2520hemorrhage%2520in%2520glioma%2520patients%2520on%2520antiangiogenic%2520therapy%26jtitle%3DJ.%2520Neurooncol.%26date%3D2011%26volume%3D105%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Uhm, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballman, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheithauer, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakhill, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeckle, K. A.</span><span> </span><span class="NLM_article-title">Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074</span> <span class="citation_source-journal">Int. J. Radiat. Oncol. Biol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2Fj.ijrobp.2010.01.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20510539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=347-353&author=J.+H.+Uhmauthor=K.+V.+Ballmanauthor=W.+Wuauthor=C.+Gianniniauthor=J.+C.+Kraussauthor=J.+C.+Bucknerauthor=C.+D.+Jamesauthor=B.+W.+Scheithauerauthor=R.+J.+Behrensauthor=P.+J.+Flynnauthor=P.+L.+Schaeferauthor=S.+R.+Dakhillauthor=K.+A.+Jaeckle&title=Phase+II+Evaluation+of+Gefitinib+in+Patients+With+Newly+Diagnosed+Grade+4+Astrocytoma%3A+Mayo%2FNorth+Central+Cancer+Treatment+Group+Study+N0074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074</span></div><div class="casAuthors">Uhm, Joon H.; Ballman, Karla V.; Wu, Wenting; Giannini, Caterina; Krauss, J. C.; Buckner, Jan C.; James, C. D.; Scheithauer, Bernd W.; Behrens, Robert J.; Flynn, Patrick J.; Schaefer, Paul L.; Dakhill, Shaker R.; Jaeckle, Kurt A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: Amplification of the epidermal growth factor receptor (EGFR) gene represents one of the most frequent gene alterations in glioblastoma (GBM).  In the current study, we evaluated gefitinib, a potent EGFR inhibitor, in the treatment of adults with newly diagnosed GBM.  Methods and Materials: Ninety-eight patients (96 evaluable) were accrued between May 18, 2001, and August 2, 2002.  All were newly diagnosed GBM patients who were clin. and radiog. stable/improved after radiation treatment (enrollment within 5 wk of radiation completion).  No prior chemotherapy was permitted.  EGFR amplification/mutation, as assessed by fluorescence in situ hybridization and immunohistochem., was not required for treatment with gefitinib but was studied when tissues were available.  Gefitinib was administered at 500 mg each day; for patients receiving dexamethasone or enzyme-inducing (CYP3A4) agents, dose was escalated to a max. of 1,000 mg QD.  Treatment cycles were repeated at 4-wk intervals with brain magnetic resonance imaging at 8-wk intervals.  Results: Overall survival (OS; calcd. from time of initial surgery) at 1 yr (primary end point) with gefitinib was 54.2%, which was not statistically different compared with that of historical control population (48.9%, data from three previous Phase III North Central Cancer Treatment Group studies of newly diagnosed GBM patients).  Progression-free survival (PFS) at 1 yr post-RT (16.7%) was also not significantly different to that of historical controls (30.3%).  Clin. outcome was not affected by EGFR status (amplification or vIII mutation).  Fatigue (41%), rash (62%), and loose stools (58%) constituted the most frequent adverse events, the majority of these being limited to Grade 1/2.  Of note, the occurrence of drug-related adverse effects, such as loose stools was assocd. with improved OS.  Conclusions: In our evaluation of nearly 100 patients with newly diagnosed GBM, treatment with adjuvant gefitinib post-radiation was not assocd. with significant improvement in OS or PFS.  However, patients who experienced gefitinib-assocd. adverse effects (rash/diarrhea) did demonstrate improved OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKy1I_o-zo7Vg90H21EOLACvtfcHk0lhttkzD6o3GvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhsbg%253D&md5=8ac738591fb4a3b9735c33335772f6bd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2010.01.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2010.01.070%26sid%3Dliteratum%253Aachs%26aulast%3DUhm%26aufirst%3DJ.%2BH.%26aulast%3DBallman%26aufirst%3DK.%2BV.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DKrauss%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DScheithauer%26aufirst%3DB.%2BW.%26aulast%3DBehrens%26aufirst%3DR.%2BJ.%26aulast%3DFlynn%26aufirst%3DP.%2BJ.%26aulast%3DSchaefer%26aufirst%3DP.%2BL.%26aulast%3DDakhill%26aufirst%3DS.%2BR.%26aulast%3DJaeckle%26aufirst%3DK.%2BA.%26atitle%3DPhase%2520II%2520Evaluation%2520of%2520Gefitinib%2520in%2520Patients%2520With%2520Newly%2520Diagnosed%2520Grade%25204%2520Astrocytoma%253A%2520Mayo%252FNorth%2520Central%2520Cancer%2520Treatment%2520Group%2520Study%2520N0074%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%2520Biol.%2520Phys.%26date%3D2011%26volume%3D80%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Neyns, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouttens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baurain, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Hondt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaskis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">In't Veld, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, J.</span><span> </span><span class="NLM_article-title">Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1093%2Fannonc%2Fmdp032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=19491283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADC%252BD1MrnsVGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1596-1603&author=B.+Neynsauthor=J.+Sadonesauthor=E.+Joosensauthor=F.+Bouttensauthor=L.+Verbekeauthor=J.+F.+Baurainauthor=L.+D%27Hondtauthor=T.+Strauvenauthor=C.+Chaskisauthor=P.+In%27t+Veldauthor=A.+Michotteauthor=J.+De+Greve&title=Stratified+phase+II+trial+of+cetuximab+in+patients+with+recurrent+high-grade+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma</span></div><div class="casAuthors">Neyns B; Sadones J; Joosens E; Bouttens F; Verbeke L; Baurain J-F; D'Hondt L; Strauven T; Chaskis C; In't Veld P; Michotte A; De Greve J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1596-603</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with recurrent high-grade glioma (HGG) after failure of surgery, radiation therapy, and chemotherapy.  PATIENTS AND METHODS:  In this two-arm, open-label, phase II study patients were stratified according to their epidermal growth factor receptor (EGFR) gene amplification status.  Cetuximab was administered intravenously at a dose of 400 mg/m(2) on week 1 followed by weekly dose of 250 mg/m(2).  The primary end point for this study was the response rate in both study arms separately.  RESULTS:  Fifty-five eligible patients (28 with and 27 without EGFR amplification) tolerated cetuximab well.  Three patients (5.5%) had a partial response and 16 patients (29.6%) had stable disease.  The median time to progression was 1.9 months [95% confidence interval (CI) 1.6-2.2 months].  Whereas the progression-free survival (PFS) was <6 months in the majority (n = 50/55) of patients, five patients (9.2%) had a PFS on cetuximab of >9 months.  Median overall survival was 5.0 months (95% CI 4.2-5.9 months).  No significant correlation was found between response, survival and EGFR amplification.  CONCLUSIONS:  Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG.  A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxYDzxmlDzEJHZzFRCXxVKfW6udTcc2eaRURd1ymcjmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrnsVGrtg%253D%253D&md5=8669d86d78fc3eed5c36cd1fc187d802</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdp032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdp032%26sid%3Dliteratum%253Aachs%26aulast%3DNeyns%26aufirst%3DB.%26aulast%3DSadones%26aufirst%3DJ.%26aulast%3DJoosens%26aufirst%3DE.%26aulast%3DBouttens%26aufirst%3DF.%26aulast%3DVerbeke%26aufirst%3DL.%26aulast%3DBaurain%26aufirst%3DJ.%2BF.%26aulast%3DD%2527Hondt%26aufirst%3DL.%26aulast%3DStrauven%26aufirst%3DT.%26aulast%3DChaskis%26aufirst%3DC.%26aulast%3DIn%2527t%2BVeld%26aufirst%3DP.%26aulast%3DMichotte%26aufirst%3DA.%26aulast%3DDe%2BGreve%26aufirst%3DJ.%26atitle%3DStratified%2520phase%2520II%2520trial%2520of%2520cetuximab%2520in%2520patients%2520with%2520recurrent%2520high-grade%2520glioma%26jtitle%3DAnn.%2520Oncol.%26date%3D2009%26volume%3D20%26spage%3D1596%26epage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattamaneni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span> </span><span class="NLM_article-title">Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4601</span><span class="NLM_x">–</span> <span class="NLM_lpage">4608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1200%2FJCO.2009.27.1932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20855843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaitLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=4601-4608&author=M.+Bradaauthor=S.+Stenningauthor=R.+Gabeauthor=L.+C.+Thompsonauthor=D.+Levyauthor=R.+Ramplingauthor=S.+Erridgeauthor=F.+Saranauthor=R.+Gattamaneniauthor=K.+Hopkinsauthor=S.+Beallauthor=V.+P.+Collinsauthor=S.+M.+Lee&title=Temozolomide+versus+procarbazine%2C+lomustine%2C+and+vincristine+in+recurrent+high-grade+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma</span></div><div class="casAuthors">Brada, Michael; Stenning, Sally; Gabe, Rhian; Thompson, Lindsay C.; Levy, David; Rampling, Roy; Erridge, Sara; Saran, Frank; Gattamaneni, Rao; Hopkins, Kirsten; Beall, Sarah; Collins, V. Peter; Lee, Siow-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4601-4608</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Temozolomide (TMZ) is an alkylating agent licensed for treatment of high-grade glioma (HGG).  No prospective comparison with nitrosourea-based chemotherapy exists.  We report, to our knowledge, the first randomized trial of procarbazine, lomustine, and vincristine (PCV) vs. TMZ in chemotherapy-naive patients with recurrent HGG.  447 Patients were randomly assigned to PCV (224 patients) or TMZ (sub-random assignment: TMZ-5 [200 mg/m2 for 5 days, 112 patients] or TMZ-21 [100 mg/m2 for 21 days, 111 patients]) for up to 9 mo or until progression.  The primary outcomes were survival (PCV v TMZ) and 12-wk progression-free survival (PFS; TMZ-5 v TMZ-21).  This study is registered as ISRCTN83176944.  Percentages of patients completing 9 mo of treatment in the PCV, TMZ-5, and TMZ-21 arms were 17%, 26%, and 13%, resp.  Major toxicity was similar across all three groups.  With a median follow-up time of 12 mo and 382 deaths, there was no clear survival benefit when comparing PCV with TMZ (hazard ratio [HR], 0.91; 95% CI, 0.74 to 1.11; P = .350).  For TMZ-5 vs. TMZ-21, 12-wk PFS rates were similar (63.6% and 65.7%, resp.; P = .745), but TMZ-5 improved overall PFS (HR, 1.38; 95% CI, 1.05 to 1.82; P = .023), survival (HR, 1.32; 95% CI, 0.99 to 1.75; P = .056), and global quality of life (49% v 19% improved > 10 points at 6 mo, resp.; P = .005).  Although TMZ (both arms combined) did not show a clear benefit compared with PCV, comparison of the TMZ schedules demonstrated that the 21-day schedule was inferior to the 5-day schedule in this setting.  This challenges the current understanding of increasing TMZ dose-intensity by prolonged scheduling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDovaGyNg9pbVg90H21EOLACvtfcHk0lgkieK-asA6Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaitLzP&md5=98656df63521332f218da925cecb4e37</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.1932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.1932%26sid%3Dliteratum%253Aachs%26aulast%3DBrada%26aufirst%3DM.%26aulast%3DStenning%26aufirst%3DS.%26aulast%3DGabe%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BC.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DRampling%26aufirst%3DR.%26aulast%3DErridge%26aufirst%3DS.%26aulast%3DSaran%26aufirst%3DF.%26aulast%3DGattamaneni%26aufirst%3DR.%26aulast%3DHopkins%26aufirst%3DK.%26aulast%3DBeall%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DV.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BM.%26atitle%3DTemozolomide%2520versus%2520procarbazine%252C%2520lomustine%252C%2520and%2520vincristine%2520in%2520recurrent%2520high-grade%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D4601%26epage%3D4608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilt, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivares, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnke, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaaskelainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, Z.</span><span> </span><span class="NLM_article-title">A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=79-88&author=M.+Westphalauthor=D.+C.+Hiltauthor=E.+Borteyauthor=P.+Delavaultauthor=R.+Olivaresauthor=P.+C.+Warnkeauthor=I.+R.+Whittleauthor=J.+Jaaskelainenauthor=Z.+Ram&title=A+phase+3+trial+of+local+chemotherapy+with+biodegradable+carmustine+%28BCNU%29+wafers+%28Gliadel+wafers%29+in+patients+with+primary+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DHilt%26aufirst%3DD.%2BC.%26aulast%3DBortey%26aufirst%3DE.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DOlivares%26aufirst%3DR.%26aulast%3DWarnke%26aufirst%3DP.%2BC.%26aulast%3DWhittle%26aufirst%3DI.%2BR.%26aulast%3DJaaskelainen%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DZ.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520local%2520chemotherapy%2520with%2520biodegradable%2520carmustine%2520%2528BCNU%2529%2520wafers%2520%2528Gliadel%2520wafers%2529%2520in%2520patients%2520with%2520primary%2520malignant%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2003%26volume%3D5%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sabbah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foehrenbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutertre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nioche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeDreuille, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellegou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faillot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desgeorges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoliani, Y. S.</span><span> </span><span class="NLM_article-title">Multimodal anatomic, functional, and metabolic brain imaging for tumor resection</span> <span class="citation_source-journal">Clin. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS0899-7071%2801%2900313-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=11814745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADC%252BD387gtVeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=6-12&author=P.+Sabbahauthor=H.+Foehrenbachauthor=G.+Dutertreauthor=C.+Niocheauthor=O.+DeDreuilleauthor=N.+Bellegouauthor=J.+F.+Manginauthor=C.+Levequeauthor=T.+Faillotauthor=J.+F.+Gaillardauthor=M.+Desgeorgesauthor=Y.+S.+Cordoliani&title=Multimodal+anatomic%2C+functional%2C+and+metabolic+brain+imaging+for+tumor+resection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodal anatomic, functional, and metabolic brain imaging for tumor resection</span></div><div class="casAuthors">Sabbah P; Foehrenbach H; Dutertre G; Nioche C; DeDreuille O; Bellegou N; Mangin J F; Leveque C; Faillot T; Gaillard J F; Desgeorges M; Cordoliani Y S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-12</span>
        ISSN:<span class="NLM_cas:issn">0899-7071</span>.
    </div><div class="casAbstract">OBJECTIVE:  Improvement of neurosurgical techniques with a more detailed description of brain tumors and their functional environment.  METHODS:  We performed: (1) anatomical magnetic resonance imaging (MRI) for reference, (2) functional sequences dedicated to the adjacent cortical structures (sensorimotor, visual, language paradigms), and (3) thallium 201 cerebral tomoscintigraphy to visualize active tumor invasion.  Data were transferred to a workstation for automatic registration.  RESULTS:  All data were combined into one synthetic image showing the foci of high proliferative activity, which have to be completely resected, and the peritumoral functional structures, which have to be spared in order to minimize postoperative sequelae.  This trimodal image is entered into a surgical neuronavigation computer for preoperative planning in order to outline tumoral target and functional risk areas.  All this information is displayed in the operative microscope (Zeiss MKM) optically linked to MR images.  This multimodality technique diminishes operative time by reducing electrocorticography and improves the operative short-term outcome.  CONCLUSION:  Multimodal imaging is useful for optimization of neurosurgical tumor resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaLZS5Qc80OGmbXvSEQle5fW6udTcc2ea8Ga6gXe_Of7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387gtVeqsQ%253D%253D&md5=f1957874961165695df6ddc9e172cc28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0899-7071%2801%2900313-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0899-7071%252801%252900313-8%26sid%3Dliteratum%253Aachs%26aulast%3DSabbah%26aufirst%3DP.%26aulast%3DFoehrenbach%26aufirst%3DH.%26aulast%3DDutertre%26aufirst%3DG.%26aulast%3DNioche%26aufirst%3DC.%26aulast%3DDeDreuille%26aufirst%3DO.%26aulast%3DBellegou%26aufirst%3DN.%26aulast%3DMangin%26aufirst%3DJ.%2BF.%26aulast%3DLeveque%26aufirst%3DC.%26aulast%3DFaillot%26aufirst%3DT.%26aulast%3DGaillard%26aufirst%3DJ.%2BF.%26aulast%3DDesgeorges%26aufirst%3DM.%26aulast%3DCordoliani%26aufirst%3DY.%2BS.%26atitle%3DMultimodal%2520anatomic%252C%2520functional%252C%2520and%2520metabolic%2520brain%2520imaging%2520for%2520tumor%2520resection%26jtitle%3DClin.%2520Imaging%26date%3D2002%26volume%3D26%26spage%3D6%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Stummer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichlmeier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reulen, H. J.</span><span> </span><span class="NLM_article-title">Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS1470-2045%2806%2970665-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=16648043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFWlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=392-401&author=W.+Stummerauthor=U.+Pichlmeierauthor=T.+Meinelauthor=O.+D.+Wiestlerauthor=F.+Zanellaauthor=H.+J.+Reulen&title=Fluorescence-guided+surgery+with+5-aminolevulinic+acid+for+resection+of+malignant+glioma%3A+a+randomised+controlled+multicentre+phase+III+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicenter phase III trial</span></div><div class="casAuthors">Stummer, Walter; Pichlmeier, Uwe; Meinel, Thomas; Wiestler, Otmar Dieter; Zanella, Friedhelm; Reulen, Hans-Juergen; Oppel, F.; Brune, A.; Lanksch, W.; Woiciechowsky, C.; Brock, M.; Vesper, J.; Tonn, J-C.; Goetz, C.; Mayfrank, L.; Oertel, M. F.; Seifert, V.; Franz, K.; Bink, A.; Schackert, G.; Pinzer, T.; Hassler, W.; Bani, A.; Meisel, H-J.; Kern, B. C.; Mehdorn, H. M.; Nabavi, A.; Brawanski, A.; Ullrich, W. W.; Boeker, D. K.; Winking, M.; Weber, F.; Langenbach, U.; Kaehler, U.; Arnold, H.; Knopp, U.; Grumme, T.; Stretz, T.; Stolke, D.; Wiedemayer, H.; Turowski, B.; Pietsch, T.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">5-Aminolevulinic acid is a non-fluorescent prodrug that leads to intracellular accumulation of fluorescent porphyrins in malignant gliomas-a finding that is under investigation for intraoperative identification and resection of these tumors.  We aimed to assess the effect of fluorescence-guided resection with 5-aminolevulinic acid on surgical radicality, progression-free survival, overall survival, and morbidity.  Three hundred and twenty-two patients aged 23-73 years with suspected malignant glioma amenable to complete resection of contrast-enhancing tumor were randomly assigned to 20 mg/kg bodyweight 5-aminolevulinic acid for fluorescence-guided resection (n = 161) or to conventional microsurgery with white light (n = 161).  The primary endpoints were the no. of patients without contrast-enhancing tumor on early MRI (ie, that obtained within 72 h after surgery) and 6-mo progression-free survival as assessed by MRI.  Secondary endpoints were vol. of residual tumor on postoperative MRI, overall survival, neurol. deficit, and toxic effects.  We report the results of an interim anal. with 270 patients in the full-anal. population (139 assigned 5-aminolevulinic acid, 131 assigned white light), which excluded patients with ineligible histol. and radiol. findings as assessed by central reviewers who were masked as to treatment allocation; the interim anal. resulted in termination of the study as defined by the protocol.  Primary and secondary endpoints were analyzed by intention to treat in the full-anal. population.  The study is registered at as NCT00241670.  Median follow-up was 35.4 mo (95% CI 1.0-56.7).  Contrast-enhancing tumor was reseted completely in 90 (65%) of 139 patients assigned 5-aminolevulinic acid compared with 47 (36%) of 131 assigned white light (difference between groups 29% [95% CI 17-40], p < 0.0001).  Patients allocated 5-aminolevulinic acid had higher 6-mo progression free survival than did those allocated white light (41.0% [32.8-49.2] vs. 21.1% [14.0-28.2]; difference between groups 19.9% [9.1-30.7], p = 0.0003, Z test).  Groups did not differ in the frequency of severe adverse events or adverse events in any organ system class reported within 7 days after surgery.  Tumor fluorescence derived from 5-aminolevulinic acid enables more complete resection of contrast-enhancing tumor, leading to improved progression-free survival in patients with malignant glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJkwoN_7C6LbVg90H21EOLACvtfcHk0lhNdCfZytVR6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFWlsb0%253D&md5=5f3656046a38c1f4324e4b7715d3995f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2806%2970665-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252806%252970665-9%26sid%3Dliteratum%253Aachs%26aulast%3DStummer%26aufirst%3DW.%26aulast%3DPichlmeier%26aufirst%3DU.%26aulast%3DMeinel%26aufirst%3DT.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DZanella%26aufirst%3DF.%26aulast%3DReulen%26aufirst%3DH.%2BJ.%26atitle%3DFluorescence-guided%2520surgery%2520with%25205-aminolevulinic%2520acid%2520for%2520resection%2520of%2520malignant%2520glioma%253A%2520a%2520randomised%2520controlled%2520multicentre%2520phase%2520III%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2006%26volume%3D7%26spage%3D392%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaloyanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span> </span><span class="NLM_article-title">Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1438</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1039%2Fb919345f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20204219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislKntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=1438-1444&author=J.-N.+Volleauthor=D.+Filippiniauthor=B.+Krawczykauthor=N.+Kaloyanovauthor=A.+Van+der+Leeauthor=T.+Mauriceauthor=J.-L.+Piratauthor=D.+Virieux&title=Drug+discovery%3A+Phosphinolactone%2C+in+vivo+bioisostere+of+the+lactol+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: phosphinolactone, in vivo bioisostere of the lactol group</span></div><div class="casAuthors">Volle, Jean-Noel; Filippini, Damien; Krawczy, Bartlomiej; Kaloyanov, Nikolay; Van der Lee, Arie; Maurice, Tangui; Pirat, Jean-Luc; Virieux, David</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1438-1444</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In drug discovery, structural modifications over the lead mol. are often crucial for the development of a drug.  Herein, we reported the first in vivo bioisosteric effect of phosphinolactone function in relation to the lactol group constituting the bioactive mol.: Hydroxybupropion.  The prepn. of phosphinolactone analogs and their antidepressant evaluation towards forced swimming test in mice showed that biol. activity was regained and even strengthen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-dzJEtQC5FLVg90H21EOLACvtfcHk0lhNdCfZytVR6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislKntbs%253D&md5=a642757a7a871a9d8f7606a6e6f7b458</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fb919345f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb919345f%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DKrawczyk%26aufirst%3DB.%26aulast%3DKaloyanov%26aufirst%3DN.%26aulast%3DVan%2Bder%2BLee%26aufirst%3DA.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DPirat%26aufirst%3DJ.-L.%26aulast%3DVirieux%26aufirst%3DD.%26atitle%3DDrug%2520discovery%253A%2520Phosphinolactone%252C%2520in%2520vivo%2520bioisostere%2520of%2520the%2520lactol%2520group%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D1438%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span> </span><span class="NLM_article-title">Chemical properties and reactions of phosphine chalcogenides</span>. In  <span class="citation_source-book">The Chemistry of Organophosphorus Compounds</span>; <span class="NLM_contrib-group">Hartley, F. R.</span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Chichester</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=287-408&author=F.+R.+Hartley&title=The+Chemistry+of+Organophosphorus+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DChemical%2520properties%2520and%2520reactions%2520of%2520phosphine%2520chalcogenides%26btitle%3DThe%2520Chemistry%2520of%2520Organophosphorus%2520Compounds%26aulast%3DHartley%26aufirst%3DF.%2BR.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1992%26volume%3D2%26spage%3D287%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hernández, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordillo, B.</span><span> </span><span class="NLM_article-title">Conformational analysis of six-membered ring dioxaphosphinanes. Part 1: Anancomeric thiophosphates</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">10927</span><span class="NLM_x">–</span> <span class="NLM_lpage">10941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=10927-10941&author=J.+Hern%C3%A1ndezauthor=R.+Ramosauthor=N.+Sastreauthor=R.+Mezaauthor=H.+Hommerauthor=M.+Salasauthor=B.+Gordillo&title=Conformational+analysis+of+six-membered+ring+dioxaphosphinanes.+Part+1%3A+Anancomeric+thiophosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DSastre%26aufirst%3DN.%26aulast%3DMeza%26aufirst%3DR.%26aulast%3DHommer%26aufirst%3DH.%26aulast%3DSalas%26aufirst%3DM.%26aulast%3DGordillo%26aufirst%3DB.%26atitle%3DConformational%2520analysis%2520of%2520six-membered%2520ring%2520dioxaphosphinanes.%2520Part%25201%253A%2520Anancomeric%2520thiophosphates%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D10927%26epage%3D10941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wadsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, W. D.</span><span> </span><span class="NLM_article-title">Bicyclic phosphites</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00863a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1962&pages=610-617&author=S.+Wadsworthauthor=W.+D.+Emmons&title=Bicyclic+phosphites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja00863a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00863a022%26sid%3Dliteratum%253Aachs%26aulast%3DWadsworth%26aufirst%3DS.%26aulast%3DEmmons%26aufirst%3DW.%2BD.%26atitle%3DBicyclic%2520phosphites%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1962%26volume%3D84%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monbrun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarion, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span> </span><span class="NLM_article-title">Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-Aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1402-1408&author=J.-N.+Volleauthor=D.+Virieuxauthor=M.+Starckauthor=J.+Monbrunauthor=L.+Clarionauthor=J.-L.+Pirat&title=Chiral+phosphinyl+analogues+of+2-C-arylmorpholinols%3A+2-Aryl-3%2C5-diphenyl-%5B1%2C4%2C2%5D-oxazaphosphinanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DStarck%26aufirst%3DM.%26aulast%3DMonbrun%26aufirst%3DJ.%26aulast%3DClarion%26aufirst%3DL.%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DChiral%2520phosphinyl%2520analogues%2520of%25202-C-arylmorpholinols%253A%25202-Aryl-3%252C5-diphenyl-%255B1%252C4%252C2%255D-oxazaphosphinanes%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D1402%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">McDonald, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmquist, C. R.</span><span> </span><span class="NLM_article-title">Rhodium-catalysed alkaline cyclotrimerization strategies for 6-arylglycoside synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">6605</span><span class="NLM_x">–</span> <span class="NLM_lpage">6606</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00129a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=6605-6606&author=F.+E.+McDonaldauthor=H.+Y.+H.+Zhuauthor=C.+R.+Holmquist&title=Rhodium-catalysed+alkaline+cyclotrimerization+strategies+for+6-arylglycoside+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja00129a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00129a030%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DF.%2BE.%26aulast%3DZhu%26aufirst%3DH.%2BY.%2BH.%26aulast%3DHolmquist%26aufirst%3DC.%2BR.%26atitle%3DRhodium-catalysed%2520alkaline%2520cyclotrimerization%2520strategies%2520for%25206-arylglycoside%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D6605%26epage%3D6606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harvey, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simiand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, S. G.</span><span> </span><span class="NLM_article-title">Synthesis of Cyclic Phosphonate Analogs of Ribose and arabinose</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6722</span><span class="NLM_x">–</span> <span class="NLM_lpage">6725</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9706382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVentL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=6722-6725&author=T.+C.+Harveyauthor=C.+Simiandauthor=L.+Weilerauthor=S.+G.+Withers&title=Synthesis+of+Cyclic+Phosphonate+Analogs+of+Ribose+and+arabinose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclic Phosphonate Analogs of Ribose and Arabinose</span></div><div class="casAuthors">Harvey, Thomas C.; Simiand, Cecile; Weiler, Larry; Withers, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6722-6725</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclic phosphonates of ribose and arabinose (phostones) were synthesized by a Lewis acid-catalyzed addn. of tri-Me phosphite to the partially protected D-threose I to give the acyclic phosphonate mixt. II.  This Abramov reaction was moderately stereoselective (3:1).  A base-catalyzed cyclization of the mixt. of II gave the four isomeric phosphonates III.  Two of the isomers could be crystd. from the reaction mixt.  The X-ray data and soln. NMR data indicate that these phostones and their derivs. exist exclusively in a chair conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz3dfTYwoONLVg90H21EOLACvtfcHk0lg-RSJEEOYnhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVentL4%253D&md5=9143fcd75cef548f7bbf131096d00b67</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo9706382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9706382%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DT.%2BC.%26aulast%3DSimiand%26aufirst%3DC.%26aulast%3DWeiler%26aufirst%3DL.%26aulast%3DWithers%26aufirst%3DS.%2BG.%26atitle%3DSynthesis%2520of%2520Cyclic%2520Phosphonate%2520Analogs%2520of%2520Ribose%2520and%2520arabinose%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D6722%26epage%3D6725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogel, O.</span><span> </span><span class="NLM_article-title">Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS0960-894X%2899%2900401-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10476884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2441-2446&author=S.+Hanessianauthor=O.+Rogel&title=Synthesis+of+a+phostone+glycomimetic+of+the+endothelin+converting+enzyme+inhibitor+phosphoramidon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon</span></div><div class="casAuthors">Hanessian, Stephen; Rogel, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2441-2446</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The phostone analog of phosphoramidon, an inhibitor of endothelin converting enzyme, was synthesized from L-rhamnose.  Coupling of the cyclic phosphonic acid with the dipeptide H-Leu-Trp-OMe gave, after deprotection and purifn. by reverse-phase HPLC, the desired phostone which exhibited an IC50 of 5.05 ± 2.7 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFpsL7XO4CbVg90H21EOLACvtfcHk0lhDW7xk8q1SRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWgsr4%253D&md5=0e0f3aad50281cf1a397bc20133020cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900401-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900401-1%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DRogel%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520phostone%2520glycomimetic%2520of%2520the%2520endothelin%2520converting%2520enzyme%2520inhibitor%2520phosphoramidon%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2441%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stoianova, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, P. R.</span><span> </span><span class="NLM_article-title">P-Heterocyclic Building Blocks: Application to the Stereoselective Synthesis of P-Sugars</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5880</span><span class="NLM_x">–</span> <span class="NLM_lpage">5889</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0505122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5880-5889&author=D.+S.+Stoianovaauthor=A.+Whiteheadauthor=P.+R.+Hanson&title=P-Heterocyclic+Building+Blocks%3A+Application+to+the+Stereoselective+Synthesis+of+P-Sugars"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo0505122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0505122%26sid%3Dliteratum%253Aachs%26aulast%3DStoianova%26aufirst%3DD.%2BS.%26aulast%3DWhitehead%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DP.%2BR.%26atitle%3DP-Heterocyclic%2520Building%2520Blocks%253A%2520Application%2520to%2520the%2520Stereoselective%2520Synthesis%2520of%2520P-Sugars%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5880%26epage%3D5889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pirat, J.-L.; Virieux, D.; Volle, J.-N.; Clarion, L.; Bakalara, N.; Mersel, M.; Monbrun, J.; Cristau, H.-J.</span><span> </span><span class="NLM_article-title">New phosphorus containing heterocyclic compounds, sugar analogs, and compositions having anticancer activity containing the same</span>. PCT Int. Appl. WO 2009/004096 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.-L.+Pirat&author=D.+Virieux&author=J.-N.+Volle&author=L.+Clarion&author=N.+Bakalara&author=M.+Mersel&author=J.+Monbrun&author=H.-J.+Cristau&title=New+phosphorus+containing+heterocyclic+compounds%2C+sugar+analogs%2C+and+compositions+having+anticancer+activity+containing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DNew%2520phosphorus%2520containing%2520heterocyclic%2520compounds%252C%2520sugar%2520analogs%252C%2520and%2520compositions%2520having%2520anticancer%2520activity%2520containing%2520the%2520same%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midrier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drag, M.</span><span> </span><span class="NLM_article-title">Revisited Synthesis of Aryl-H-phosphinates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1055%2Fs-0030-1260109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Skur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=2490-2494&author=J.-N.+Volleauthor=D.+Filippiniauthor=C.+Midrierauthor=D.+Virieuxauthor=J.-L.+Piratauthor=M.+Sobeckiauthor=M.+Drag&title=Revisited+Synthesis+of+Aryl-H-phosphinates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Revisited synthesis of aryl-H-phosphinates</span></div><div class="casAuthors">Volle, Jean-Noel; Filippini, Damien; Midrier, Camille; Sobecki, Michal; Drag, Marcin; Virieux, David; Pirat, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2494</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A systematic study of the reaction conditions for the prepn. of pure aryl-H-phosphinate esters, originally developed by Sander and optimized by Petnehazy, is reported.  The influence of the reaction concn. was studied for the formation of phosphonite intermediates via direct addn. of tri-Et phosphite to the appropriate Grignard reagent.  Subsequent hydrolysis of the phosphonites under acidic conditions gives various aryl-H-phosphinates in high yields and purities.  E.g., reaction of 4-tolyl bromide with Mg turnings in THF followed by addn. of P(OEt)3 under reflux gave 4-MeC6H4P(OEt)2 (I) in 96% yield; I was dissolved in THF and treated with aq. soln. of HCl to obtain a pH of 2 and to give 60% yield of 4-MeC6H4P(O)(H)(OEt).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBxVOLvJiAbVg90H21EOLACvtfcHk0lhdBl-tN6H5EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Skur7I&md5=4b4fc2aca19b5ec24548a5afe7ba7673</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1260109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1260109%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DMidrier%26aufirst%3DC.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.-L.%26aulast%3DSobecki%26aufirst%3DM.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DRevisited%2520Synthesis%2520of%2520Aryl-H-phosphinates%26jtitle%3DSynthesis%26date%3D2011%26spage%3D2490%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cristau, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monbrun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span> </span><span class="NLM_article-title">First synthesis of P-aryl-phosphinosugars, organophosphorus analogues of C-arylglycosides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3741</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3741-3744&author=H.-J.+Cristauauthor=J.+Monbrunauthor=J.+Schleissauthor=D.+Virieuxauthor=J.-L.+Pirat&title=First+synthesis+of+P-aryl-phosphinosugars%2C+organophosphorus+analogues+of+C-arylglycosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCristau%26aufirst%3DH.-J.%26aulast%3DMonbrun%26aufirst%3DJ.%26aulast%3DSchleiss%26aufirst%3DJ.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DFirst%2520synthesis%2520of%2520P-aryl-phosphinosugars%252C%2520organophosphorus%2520analogues%2520of%2520C-arylglycosides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D3741%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dziuganowska, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J. L.</span><span> </span><span class="NLM_article-title">Dramatic effect of modified boranes in diastereoselective reduction of chiral cyclic α-ketophosphinates</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1039%2Fc2ra00799a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=816-818&author=D.+Filippiniauthor=S.+Loiseauauthor=N.+Bakalaraauthor=Z.+A.+Dziuganowskaauthor=A.+Van+der+Leeauthor=J.-N.+Volleauthor=D.+Virieuxauthor=J.+L.+Pirat&title=Dramatic+effect+of+modified+boranes+in+diastereoselective+reduction+of+chiral+cyclic+%CE%B1-ketophosphinates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dramatic effect of modified boranes in diastereoselective reduction of chiral cyclic α-ketophosphinates</span></div><div class="casAuthors">Filippini, Damien; Loiseau, Severine; Bakalara, Norbert; Dziuganowska, Zofia Anna; Van der Lee, Arie; Volle, Jean-Noel; Virieux, David; Pirat, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-818</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phostines have been recently described as compds. having antiproliferative properties.  Original synthesis of this new class of phosphinic analogs of pyranoses led to a mixt. of four diastereomers 3-6 with unequal bioactivities.  The most active compd. 4 was originally obtained from a mixt. of these four diastereomers by selective pptn., giving firstly two diastereomers 3 and 4, epimers at the carbon atom.  From the latter mixt. 3 and 4, oxidn. with Dess-Martin reagent afforded corresponding α-ketophosphinate 7, which by diastereoselective redn. using a chiral agent based on sodium borohydride and l-proline, gave preferentially the active diastereomer 4.  In addn., use of a multivalent cation also increased the diastereoselectivity favorably.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMqa0LABT8nrVg90H21EOLACvtfcHk0lhJFrGJflyWoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslWhuw%253D%253D&md5=e5e1790cc85dfff35334398f0f1cb474</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc2ra00799a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra00799a%26sid%3Dliteratum%253Aachs%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DLoiseau%26aufirst%3DS.%26aulast%3DBakalara%26aufirst%3DN.%26aulast%3DDziuganowska%26aufirst%3DZ.%2BA.%26aulast%3DVan%2Bder%2BLee%26aufirst%3DA.%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.%2BL.%26atitle%3DDramatic%2520effect%2520of%2520modified%2520boranes%2520in%2520diastereoselective%2520reduction%2520of%2520chiral%2520cyclic%2520%25CE%25B1-ketophosphinates%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D816%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cipolla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicotra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangrazio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, L.</span><span> </span><span class="NLM_article-title">Synthesis of Azasugars by Grignard Reaction on Glycosylamines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4679</span><span class="NLM_x">–</span> <span class="NLM_lpage">4690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=4679-4690&author=L.+Cipollaauthor=L.+Layauthor=F.+Nicotraauthor=C.+Pangrazioauthor=L.+Panza&title=Synthesis+of+Azasugars+by+Grignard+Reaction+on+Glycosylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCipolla%26aufirst%3DL.%26aulast%3DLay%26aufirst%3DL.%26aulast%3DNicotra%26aufirst%3DF.%26aulast%3DPangrazio%26aufirst%3DC.%26aulast%3DPanza%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520Azasugars%2520by%2520Grignard%2520Reaction%2520on%2520Glycosylamines%26jtitle%3DTetrahedron%26date%3D1995%26volume%3D51%26spage%3D4679%26epage%3D4690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Behr, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillerm, G.</span><span> </span><span class="NLM_article-title">Synthesis of 6-deoxy-homoDMDP and its C(5)-epimer: Absolute stereochemistry of natural products from Hyacinthus orientalis</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=111-113&author=J.+M.+Behrauthor=G.+Guillerm&title=Synthesis+of+6-deoxy-homoDMDP+and+its+C%285%29-epimer%3A+Absolute+stereochemistry+of+natural+products+from+Hyacinthus+orientalis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehr%26aufirst%3DJ.%2BM.%26aulast%3DGuillerm%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25206-deoxy-homoDMDP%2520and%2520its%2520C%25285%2529-epimer%253A%2520Absolute%2520stereochemistry%2520of%2520natural%2520products%2520from%2520Hyacinthus%2520orientalis%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2002%26volume%3D13%26spage%3D111%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Stupp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Bent, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taphoorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdahn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curschmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirimanoff, R. O.</span><span> </span><span class="NLM_article-title">Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1056%2FNEJMoa043330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=15758009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Wksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=987-996&author=R.+Stuppauthor=W.+P.+Masonauthor=M.+J.+Van+den+Bentauthor=M.+Wellerauthor=B.+Fisherauthor=M.+J.+Taphoornauthor=K.+Belangerauthor=A.+A.+Brandesauthor=C.+Marosiauthor=U.+Bogdahnauthor=J.+Curschmannauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=T.+Gorliaauthor=A.+Allgeierauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=E.+Eisenhauerauthor=R.+O.+Mirimanoff&title=Radiotherapy+plus+concomitant+and+adjuvant+Temozolomide+for+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma</span></div><div class="casAuthors">Stupp, Roger; Mason, Warren P.; van den Bent, Martin J.; Weller, Michael; Fisher, Barbara; Taphoorn, Martin J. B.; Belanger, Karl; Brandes, Alba A.; Marosi, Christine; Bogdahn, Ulrich; Curschmann, Jurgen; Janzer, Robert C.; Ludwin, Samuel K.; Gorlia, Thierry; Allgeier, Anouk; Lacombe, Denis; Cairncross, J. Gregory; Eisenhauer, Elizabeth; Mirimanoff, Rene O.; Forsyth, P.; Fulton, D.; Kirby, S.; Wong, R.; Fenton, D.; Fisher, B.; Cairncross, G.; Whitlock, P.; Belanger, K.; Burdette-Radoux, S.; Gertler, S.; Saunders, S.; Laing, K.; Siddiqui, J.; Martin, L. A.; Gulavita, S.; Perry, J.; Mason, W.; Thiessen, B.; Pai, H.; Alam, Z. Y.; Eisenstat, D.; Mingrone, W.; Hofer, S.; Pesce, G.; Curschmann, J.; Dietrich, P. Y.; Stupp, R.; Mirimanoff, R. O.; Thum, P.; Baumert, B.; Ryan, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">987-996</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal.  The current std. of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy.  In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety.  METHODS Patients with newly diagnosed, histol. confirmed glioblastoma were randomly assigned to receive radiotherapy alone (fractionated focal irradn. in daily fractions of 2 Gy given 5 days per wk for 6 wk, for a total of 60 Gy) or radiotherapy plus continuous daily temozolomide (75 mg per square meter of body-surface area per day, 7 days per wk from the first to the last day of radiotherapy), followed by six cycles of adjuvant temozolomide (150 to 200 mg per square meter for 5 days during each 28-day cycle).  The primary end point was overall survival.  RESULTS A total of 573 patients from 85 centers underwent randomization.  The median age was 56 years, and 84 % of patients had undergone debulking surgery.  At a median follow-up of 28 mo, the median survival was 14.6 mo with radiotherapy plus temozolomide and 12.1 mo with radiotherapy alone.  The unadjusted hazard ratio for death in the radiotherapy-plus-temozolomide group was 0.63 (95 % confidence interval, 0.52 to 0.75; P<0.001 by the log-rank test).  The two-year survival rate was 26.5 % with radiotherapy plus temozolomide and 10.4 % with radiotherapy alone.  Concomitant treatment with radiotherapy plus temozolomide resulted in grade 3 or 4 hematol. toxic effects in 7 % of patients.  Conclusions The addn. of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clin. meaningful and statistically significant survival benefit with minimal addnl. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNLD2mISWE7Vg90H21EOLACvtfcHk0lhJFrGJflyWoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Wksbk%253D&md5=28546eb2e78f7346974d7d029c9fa916</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa043330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa043330%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3DVan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DBogdahn%26aufirst%3DU.%26aulast%3DCurschmann%26aufirst%3DJ.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DMirimanoff%26aufirst%3DR.%2BO.%26atitle%3DRadiotherapy%2520plus%2520concomitant%2520and%2520adjuvant%2520Temozolomide%2520for%2520glioblastoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D987%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Koziara, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumper, R. J.</span><span> </span><span class="NLM_article-title">Paclitaxel nanoparticles for the potential treatment of brain tumors</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2004&pages=259-269&author=J.+M.+Koziaraauthor=P.+R.+Lockmanauthor=D.+D.+Allenauthor=R.+J.+Mumper&title=Paclitaxel+nanoparticles+for+the+potential+treatment+of+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoziara%26aufirst%3DJ.%2BM.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DMumper%26aufirst%3DR.%2BJ.%26atitle%3DPaclitaxel%2520nanoparticles%2520for%2520the%2520potential%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2004%26volume%3D99%26spage%3D259%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Acton, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risbood, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Anticancer specificity of some ellipticinium salts against human brain tumors in vitro</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2185</span><span class="NLM_x">–</span> <span class="NLM_lpage">2189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00040a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2185-2189&author=E.+M.+Actonauthor=V.+L.+Narayananauthor=P.+A.+Risboodauthor=R.+H.+Shoemakerauthor=D.+T.+Visticaauthor=M.+R.+Boyd&title=Anticancer+specificity+of+some+ellipticinium+salts+against+human+brain+tumors+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00040a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00040a010%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DE.%2BM.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DRisbood%26aufirst%3DP.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DVistica%26aufirst%3DD.%2BT.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DAnticancer%2520specificity%2520of%2520some%2520ellipticinium%2520salts%2520against%2520human%2520brain%2520tumors%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2185%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span> </span><span class="NLM_article-title">A gene expression database for the molecular pharmacology of cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2F73439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10700175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=236-244&author=U.+Scherfauthor=D.+T.+Rossauthor=M.+Walthamauthor=L.+H.+Smithauthor=J.+K.+Leeauthor=L.+Tanabeauthor=K.+W.+Kohnauthor=W.+C.+Reinholdauthor=T.+G.+Myersauthor=D.+T.+Andrewsauthor=D.+A.+Scudieroauthor=M.+B.+Eisenauthor=E.+A.+Sausvilleauthor=Y.+Pommierauthor=D.+Botsteinauthor=P.+O.+Brownauthor=J.+N.+Weinstein&title=A+gene+expression+database+for+the+molecular+pharmacology+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A gene expression database for the molecular pharmacology of cancer</span></div><div class="casAuthors">Scherf, Uwe; Ross, Douglas T.; Waltham, Mark; Smith, Lawrence H.; Lee, Jae K.; Tanabe, Lorraine; Kohn, Kurt W.; Reinhold, William C.; Myers, Timothy G.; Andrews, Darren T.; Scudiero, Dominic A.; Eisen, Michael B.; Sausville, Edward A.; Pommier, Yves; Botstein, David; Brown, Patrick O.; Weinstein, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to assess gene expression profiles in 60 human cancer cell lines used in a drug discovery screen by the National Cancer Institute.  Using these data, we linked bioinformatics and chemoinformatics by correlating gene expression and drug activity patterns in the NCI60 lines.  Clustering the cell lines on the basis of gene expression yielded relationships very different from those obtained by clustering the cell lines on the basis of their response to drugs.  Gene-drug relationships for the clin. agents 5-fluorouracil and L-asparaginase exemplify how variations in the transcript levels of particular genes relate to mechanisms of drug sensitivity and resistance.  This is the first study to integrate large databases on gene expression and mol. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLuoOC0y3Ag7Vg90H21EOLACvtfcHk0ljIyKv6HsckZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrk%253D&md5=602b56f8cb25953400646dd9f7df261e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F73439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73439%26sid%3Dliteratum%253Aachs%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DTanabe%26aufirst%3DL.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DAndrews%26aufirst%3DD.%2BT.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26atitle%3DA%2520gene%2520expression%2520database%2520for%2520the%2520molecular%2520pharmacology%2520of%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Rijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashkari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span> </span><span class="NLM_article-title">Systematic variation in gene expression patterns in human cancer cell lines</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2F73432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10700174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=227-235&author=D.+T.+Rossauthor=U.+Scherfauthor=M.+B.+Eisenauthor=C.+M.+Perouauthor=C.+Reesauthor=P.+Spellmanauthor=V.+Iyerauthor=S.+S.+Jeffreyauthor=M.+Van+de+Rijnauthor=M.+Walthamauthor=A.+Pergamenschikovauthor=J.+C.+Leeauthor=D.+Lashkariauthor=D.+Shalonauthor=T.+G.+Myersauthor=J.+N.+Weinsteinauthor=D.+Botsteinauthor=P.+O.+Brown&title=Systematic+variation+in+gene+expression+patterns+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic variation in gene expression patterns in human cancer cell lines</span></div><div class="casAuthors">Ross, Douglas T.; Scherf, Uwe; Eisen, Michael B.; Perou, Charles M.; Rees, Christian; Spellman, Paul; Iyer, Vishwanath; Jeffrey, Stefanie S.; Van de Rijn, Matt; Waltham, Mark; Pergamenschikov, Alexander; Lee, Jeffrey C. F.; Lashkari, Deval; Shalon, Dari; Myers, Timothy G.; Weinstein, John N.; Botstein, David; Brown, Patrick O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to explore the variation in expression of approx. 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs.  Classification of the cell lines based solely on the obsd. patterns of gene expression revealed a correspondence to the ostensible origins of the tumors from which the cell lines were derived.  The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect.  Specific features of the gene expression patterns appeared to be related to physiol. properties of the cell lines, such as their doubling time in culture, drug metab. or the interferon response.  Comparison of gene expression patterns in the cell lines to those obsd. in normal breast tissue or in breast tumor specimens revealed features of the expression patterns in the tumors that had recognizable counterparts in specific cell lines, reflecting the tumor, stromal and inflammatory components of the tumor tissue.  These results provided a novel mol. characterization of this important group of human cell lines and their relationships to tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhocezjCTNbVg90H21EOLACvtfcHk0ljIyKv6HsckZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D&md5=248ffa9428fa078fff0bdf45fddaecf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2F73432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73432%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DRees%26aufirst%3DC.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DVan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLashkari%26aufirst%3DD.%26aulast%3DShalon%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26atitle%3DSystematic%2520variation%2520in%2520gene%2520expression%2520patterns%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Blower, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verducci, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmittgen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span> </span><span class="NLM_article-title">MicroRNAs modulate the chemosensitivity of tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1158%2F1535-7163.MCT-07-0573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=18187804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1-9&author=P.+E.+Blowerauthor=J.+H.+Chungauthor=J.+S.+Verducciauthor=S.+Linauthor=J.+K.+Parkauthor=Z.+Daiauthor=C.+G.+Liuauthor=T.+D.+Schmittgenauthor=W.+C.+Reinholdauthor=C.+M.+Croceauthor=J.+N.+Weinsteinauthor=W.+Sadee&title=MicroRNAs+modulate+the+chemosensitivity+of+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNAs modulate the chemosensitivity of tumor cells</span></div><div class="casAuthors">Blower, Paul E.; Chung, Ji-Hyun; Verducci, Joseph S.; Lin, Shili; Park, Jong-Kook; Dai, Zunyan; Liu, Chang-Gong; Schmittgen, Thomas D.; Reinhold, William C.; Croce, Carlo M.; Weinstein, John N.; Sadee, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MicroRNAs are strongly implicated in such processes as development, carcinogenesis, cell survival, and apoptosis.  It is likely, therefore, that they can also modulate sensitivity and resistance to anticancer drugs in substantial ways.  To test this hypothesis, we studied the pharmacol. roles of three microRNAs previously implicated in cancer biol. (let-7i, mir-16, and mir-21) and also used in silico methods to test pharmacol. microRNA effects more broadly.  In the exptl. system, we increased the expression of individual microRNAs by transfecting their precursors (which are active) or suppressed the expression by transfection of antisense oligomers.  In three NCI-60 human cancer cell lines, a panel of 60 lines used for anticancer drug discovery, we assessed the growth-inhibitory potencies of 14 structurally diverse compds. with known anticancer activities.  Changing the cellular levels of let-7i, mir-16, and mir-21 affected the potencies of a no. of the anticancer agents by up to 4-fold.  The effect was most prominent with mir-21, with 10 of 28 cell-compd. pairs showing significant shifts in growth-inhibitory activity.  Varying mir-21 levels changed potencies in opposite directions depending on compd. class; indicating that different mechanisms det. toxic and protective effects.  In silico comparison of drug potencies with microRNA expression profiles across the entire NCI-60 panel revealed that ∼30 microRNAs, including mir-21, show highly significant correlations with numerous anticancer agents.  Ten of those microRNAs have already been implicated in cancer biol.  Our results support a substantial role for microRNAs in anticancer drug response, suggesting novel potential approaches to the improvement of chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4EPNNoVHMLVg90H21EOLACvtfcHk0ljtrSRKULO0MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyiuw%253D%253D&md5=29e2f300b5b56058cfd76444bca017ee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0573%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BE.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DVerducci%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%2BG.%26aulast%3DSchmittgen%26aufirst%3DT.%2BD.%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DSadee%26aufirst%3DW.%26atitle%3DMicroRNAs%2520modulate%2520the%2520chemosensitivity%2520of%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Blower, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verducci, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldjian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span> </span><span class="NLM_article-title">MicroRNA expression profiles for the NCI-60 cancer cell panel</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1483</span><span class="NLM_x">–</span> <span class="NLM_lpage">1491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1158%2F1535-7163.MCT-07-0009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=17483436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFalt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1483-1491&author=P.+E.+Blowerauthor=J.+S.+Verducciauthor=S.+Linauthor=J.+Zhouauthor=J.+H.+Chungauthor=Z.+Daiauthor=C.+G.+Liuauthor=W.+Reinholdauthor=P.+L.+Lorenziauthor=E.+P.+Kaldjianauthor=C.+M.+Croceauthor=J.+N.+Weinsteinauthor=W.+Sadee&title=MicroRNA+expression+profiles+for+the+NCI-60+cancer+cell+panel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA expression profiles for the NCI-60 cancer cell panel</span></div><div class="casAuthors">Blower, Paul E.; Verducci, Joseph S.; Lin, Shili; Zhou, Jin; Chung, Ji-Hyun; Dai, Zunyan; Liu, Chang-Gong; Reinhold, William; Lorenzi, Philip L.; Kaldjian, Eric P.; Croce, Carlo M.; Weinstein, John N.; Sadee, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1483-1491</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advances in the understanding of cancer cell biol. and response to drug treatment have benefited from new mol. technologies and methods for integrating information from multiple sources.  The NCI-60, a panel of 60 diverse human cancer cell lines, has been used by the National Cancer Institute to screen > 100,000 chem. compds. and natural product exts. for anticancer activity.  The NCI-60 has also been profiled for mRNA and protein expression, mutational status, chromosomal aberrations, and DNA copy no., generating an unparalleled public resource for integrated chemogenomic studies.  Recently, microRNAs have been shown to target particular sets of mRNAs, thereby preventing translation or accelerating mRNA turnover.  To complement the existing NCI-60 data sets, we have measured expression levels of microRNAs in the NCI-60 and incorporated the resulting data into the CellMiner program package for integrative anal.  Cell line groupings based on microRNA expression were generally consistent with tissue type and with cell line clustering based on mRNA expression.  However, mRNA expression seemed to be somewhat more informative for discriminating among tissue types than was microRNA expression.  In addn., we found that there does not seem to be a significant correlation between microRNA expression patterns and those of known target transcripts.  Comparison of microRNA expression patterns and compd. potency patterns showed significant correlations, suggesting that microRNAs may play a role in chemoresistance.  Combined with gene expression and other biol. data using multivariate anal., microRNA expression profiles may provide a crit. link for understanding mechanisms involved in chemosensitivity and chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6uaalpN_2jLVg90H21EOLACvtfcHk0ljtrSRKULO0MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFalt7k%253D&md5=6b9cc9a4e567ce321ea0590a0b6305eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0009%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BE.%26aulast%3DVerducci%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%2BG.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DKaldjian%26aufirst%3DE.%2BP.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DSadee%26aufirst%3DW.%26atitle%3DMicroRNA%2520expression%2520profiles%2520for%2520the%2520NCI-60%2520cancer%2520cell%2520panel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1483%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=627-638&author=J.+S.+Leeauthor=K.+Paullauthor=M.+Alvarezauthor=C.+Hoseauthor=A.+Monksauthor=M.+Greverauthor=A.+T.+Fojoauthor=S.+E.+Bates&title=Rhodamine+efflux+patterns+predict+P-glycoprotein+substrates+in+the+National+Cancer+Institute+drug+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DAlvarez%26aufirst%3DM.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DGrever%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DRhodamine%2520efflux%2520patterns%2520predict%2520P-glycoprotein%2520substrates%2520in%2520the%2520National%2520Cancer%2520Institute%2520drug%2520screen%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D627%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rutka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCulloch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. L.</span><span> </span><span class="NLM_article-title">Establishment and characterization of five cell lines derived from human malignant gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1007%2FBF00686798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=2829496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADyaL1c7ivFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=92-103&author=J.+T.+Rutkaauthor=J.+R.+Giblinauthor=D.+Y.+Doughertyauthor=H.+C.+Liuauthor=J.+R.+McCullochauthor=C.+W.+Bellauthor=R.+S.+Sternauthor=C.+B.+Wilsonauthor=M.+L.+Rosenblum&title=Establishment+and+characterization+of+five+cell+lines+derived+from+human+malignant+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment and characterization of five cell lines derived from human malignant gliomas</span></div><div class="casAuthors">Rutka J T; Giblin J R; Dougherty D Y; Liu H C; McCulloch J R; Bell C W; Stern R S; Wilson C B; Rosenblum M L</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-103</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">We established and characterized five cell lines derived from human malignant gliomas (four glioblastomas multiforme and one highly anaplastic astrocytoma).  All cell lines exhibited tumor cell morphology and growth kinetics, and anchorage-independent growth in soft agar.  Cytogenetic analysis revealed significant aneuploidy in all five cases as well as clonal chromosomal alterations unique to each cell line.  No cell line was tumorigenic in athymic mice.  Two of the cell lines were sensitive to carmustine (BCNU) in monolayer and soft-agar cultures.  Electron microscopy showed marked variability between cell lines in the number and structure of intracytoplasmic organelles; SF-126 formed collagen fibers in vitro.  Immunohistochemical analysis of the surgical specimens showed variable expression of glial fibrillary acidic protein (GFAP) in malignant astrocytes; positive immunostaining for glycoproteins of the extracellular matrix was found predominantly in perivascular regions.  In early-passage cultures, only cell line SF-295 expressed GFAP; at establishment, none of the cell lines expressed GFAF or glutamine synthetase.  Fibronectin and laminin were expressed by all cell lines in early-passage culture, but expression of these glycoproteins at establishment was variable.  Only SF-126 was positively identified by immunostains for procollagen III; this was also the only cell line in which DEAE-cellulose chromatography and SDS-PAGE demonstrated interstitial collagen synthesis.  These well-characterized glioma-derived cell lines may now serve as useful tools with which to study the cell biology of gliomas.  The synthesis of interstitial collagen by a glioma-derived cell line may suggest a derivation from vascular mesenchymal elements, either reactive or transformed, in the original heterogeneous malignant glioma, rather than from a glial precursor cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGNj0oPIY_zJcXNb62YGmbfW6udTcc2eYrpaz6i8vDrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7ivFOgug%253D%253D&md5=79368e7ca5c7a36f39259c04134b6290</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF00686798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00686798%26sid%3Dliteratum%253Aachs%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26aulast%3DGiblin%26aufirst%3DJ.%2BR.%26aulast%3DDougherty%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DMcCulloch%26aufirst%3DJ.%2BR.%26aulast%3DBell%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DR.%2BS.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DRosenblum%26aufirst%3DM.%2BL.%26atitle%3DEstablishment%2520and%2520characterization%2520of%2520five%2520cell%2520lines%2520derived%2520from%2520human%2520malignant%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D1987%26volume%3D75%26spage%3D92%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Audouy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez y Ribotta, M.</span><span> </span><span class="NLM_article-title">Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1999&pages=293-303&author=S.+Audouyauthor=J.+Malletauthor=A.+Privatauthor=M.+Gimenez+y+Ribotta&title=Adenovirus-mediated+suicide+gene+therapy+in+an+in+vitro+model+of+reactive+gliosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAudouy%26aufirst%3DS.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DPrivat%26aufirst%3DA.%26aulast%3DGimenez%2By%2BRibotta%26aufirst%3DM.%26atitle%3DAdenovirus-mediated%2520suicide%2520gene%2520therapy%2520in%2520an%2520in%2520vitro%2520model%2520of%2520reactive%2520gliosis%26jtitle%3DGlia%26date%3D1999%26volume%3D25%26spage%3D293%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+Application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2eYrpaz6i8vDrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520Application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Repetto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Peso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurita, J. L.</span><span> </span><span class="NLM_article-title">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2Fnprot.2008.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=18600217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1125-1131&author=G.+Repettoauthor=A.+del+Pesoauthor=J.+L.+Zurita&title=Neutral+red+uptake+assay+for+the+estimation+of+cell+viability%2Fcytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span></div><div class="casAuthors">Repetto, Guillermo; del Peso, Ana; Zurita, Jorge L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neutral red uptake assay provides a quant. estn. of the no. of viable cells in a culture.  It is one of the most used cytotoxicity tests with many biomedical and environmental applications.  It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes.  Most primary cells and cell lines from diverse origin may be successfully used.  Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period.  The plates are then incubated for 2 h with a medium contg. neutral red.  The cells are subsequently washed, the dye is extd. in each well and the absorbance is read using a spectrophotometer.  The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content).  Once the cells were treated, the assay can be completed in <3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcpd7QjH04rVg90H21EOLACvtfcHk0lgv_lLg4_O0Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D&md5=30461f51c2ad668a3cadb4843c93b43e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.75%26sid%3Dliteratum%253Aachs%26aulast%3DRepetto%26aufirst%3DG.%26aulast%3Ddel%2BPeso%26aufirst%3DA.%26aulast%3DZurita%26aufirst%3DJ.%2BL.%26atitle%3DNeutral%2520red%2520uptake%2520assay%2520for%2520the%2520estimation%2520of%2520cell%2520viability%252Fcytotoxicity%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1125%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qing Yuan, Hua-Wei Liu, Zhong-Jian Cai, <span class="NLM_string-name hlFld-ContribAuthor">Shun-Jun Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Direct 1,1-Bisphosphonation of Isocyanides: Atom- and Step-Economical Access to Bisphosphinoylaminomethanes. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (12)
                                     , 8495-8501. <a href="https://doi.org/10.1021/acsomega.1c00160" title="DOI URL">https://doi.org/10.1021/acsomega.1c00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00160%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDirect%252B1%25252C1-Bisphosphonation%252Bof%252BIsocyanides%25253A%252BAtom-%252Band%252BStep-Economical%252BAccess%252Bto%252BBisphosphinoylaminomethanes%26aulast%3DYuan%26aufirst%3DQing%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16012021%26date%3D01022021%26date%3D17032021%26volume%3D6%26issue%3D12%26spage%3D8495%26epage%3D8501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aurélie Gernet, Nicolas Sevrain, Jean-Noël Volle, Tahar Ayad, Jean-Luc Pirat, <span class="NLM_string-name hlFld-ContribAuthor">David Virieux</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-Oriented Synthesis toward Aryl- and Phosphoryl-Functionalized Imidazo[1,2-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (22)
                                     , 14730-14743. <a href="https://doi.org/10.1021/acs.joc.0c02059" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02059%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiversity-Oriented%252BSynthesis%252Btoward%252BAryl-%252Band%252BPhosphoryl-Functionalized%252BImidazo%25255B1%25252C2-a%25255Dpyridines%26aulast%3DGernet%26aufirst%3DAur%25C3%25A9lie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26082020%26date%3D09112020%26volume%3D85%26issue%3D22%26spage%3D14730%26epage%3D14743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dumei Ma, Shanshan Hu, Sirui Chen, Jiaoting Pan, Song Tu, Yingwu Yin, Yuxing Gao, <span class="NLM_string-name hlFld-ContribAuthor">Yufen Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Addition/Cyclization of (2-Hydroxyaryl)boronic Acids with Alkynylphosphonates: Access to Phosphacoumarins. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (20)
                                     , 8156-8160. <a href="https://doi.org/10.1021/acs.orglett.0c03151" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03151%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BAddition%25252FCyclization%252Bof%252B%2525282-Hydroxyaryl%252529boronic%252BAcids%252Bwith%252BAlkynylphosphonates%25253A%252BAccess%252Bto%252BPhosphacoumarins%26aulast%3DMa%26aufirst%3DDumei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18092020%26date%3D30092020%26volume%3D22%26issue%3D20%26spage%3D8156%26epage%3D8160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Hernández-Guerra, Alan R. Kennedy, Elisa I. León, Ángeles Martín, Inés Pérez-Martín, María S. Rodríguez, <span class="NLM_string-name hlFld-ContribAuthor">Ernesto Suárez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to Phosphasugars (2-oxo-1,2-oxaphosphacyclanes) Using the Anomeric Alkoxyl Radical β-Fragmentation Reaction as the Key Step. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (7)
                                     , 4861-4880. <a href="https://doi.org/10.1021/acs.joc.0c00059" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00059%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252BPhosphasugars%252B%2525282-oxo-1%25252C2-oxaphosphacyclanes%252529%252BUsing%252Bthe%252BAnomeric%252BAlkoxyl%252BRadical%252B%2525CE%2525B2-Fragmentation%252BReaction%252Bas%252Bthe%252BKey%252BStep%26aulast%3DHern%25C3%25A1ndez-Guerra%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09012020%26date%3D25032020%26date%3D16032020%26volume%3D85%26issue%3D7%26spage%3D4861%26epage%3D4880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Giri Raj Gnawali, Nigam P. Rath, <span class="NLM_string-name hlFld-ContribAuthor">Christopher D. Spilling</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Phostones via the Palladium-Catalyzed Ring Opening of Epoxy Vinyl Phosphonates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (13)
                                     , 8724-8730. <a href="https://doi.org/10.1021/acs.joc.9b00905" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00905%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BPhostones%252Bvia%252Bthe%252BPalladium-Catalyzed%252BRing%252BOpening%252Bof%252BEpoxy%252BVinyl%252BPhosphonates%26aulast%3DGnawali%26aufirst%3DGiri%2BRaj%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02042019%26date%3D19062019%26date%3D29052019%26volume%3D84%26issue%3D13%26spage%3D8724%26epage%3D8730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dumei Ma, Jiaoting Pan, Lu Yin, Pengxiang Xu, Yuxing Gao, Yingwu Yin, <span class="NLM_string-name hlFld-ContribAuthor">Yufen Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Direct Oxidative C–H Functionalization of Unactivated Cycloalkanes into Cycloalkyl Benzo[b]phosphole Oxides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (12)
                                     , 3455-3459. <a href="https://doi.org/10.1021/acs.orglett.8b01108" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01108%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BDirect%252BOxidative%252BC%2525E2%252580%252593H%252BFunctionalization%252Bof%252BUnactivated%252BCycloalkanes%252Binto%252BCycloalkyl%252BBenzo%25255Bb%25255Dphosphole%252BOxides%26aulast%3DMa%26aufirst%3DDumei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09042018%26date%3D29052018%26volume%3D20%26issue%3D12%26spage%3D3455%26epage%3D3459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Yang</span>, <span class="hlFld-ContribAuthor ">Tieqiao  Chen</span>, <span class="hlFld-ContribAuthor ">Yongbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuang-Feng  Yin</span>, and <span class="hlFld-ContribAuthor ">Li-Biao  Han</span>  . </span><span class="cited-content_cbyCitation_article-title">Mechanistic Studies on the Palladium-Catalyzed Cross Dehydrogenative Coupling of P(O)–H Compounds with Terminal Alkynes: Stereochemistry and Reactive Intermediates. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2015,</strong> <em>34 </em>
                                    (20)
                                     , 5095-5098. <a href="https://doi.org/10.1021/acs.organomet.5b00687" title="DOI URL">https://doi.org/10.1021/acs.organomet.5b00687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.5b00687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.5b00687%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DMechanistic%252BStudies%252Bon%252Bthe%252BPalladium-Catalyzed%252BCross%252BDehydrogenative%252BCoupling%252Bof%252BP%252528O%252529%2525E2%252580%252593H%252BCompounds%252Bwith%252BTerminal%252BAlkynes%25253A%252BStereochemistry%252Band%252BReactive%252BIntermediates%26aulast%3DYang%26aufirst%3DJia%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08082015%26date%3D29092015%26date%3D26102015%26volume%3D34%26issue%3D20%26spage%3D5095%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sibasish  Paul</span>, <span class="hlFld-ContribAuthor ">Subhadeep  Roy</span>, <span class="hlFld-ContribAuthor ">Luca  Monfregola</span>, <span class="hlFld-ContribAuthor ">Shiying  Shang</span>, <span class="hlFld-ContribAuthor ">Richard  Shoemaker</span>, and <span class="hlFld-ContribAuthor ">Marvin H.  Caruthers</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxidative Substitution of Boranephosphonate Diesters as a Route to Post-synthetically Modified DNA. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (9)
                                     , 3253-3264. <a href="https://doi.org/10.1021/ja511145h" title="DOI URL">https://doi.org/10.1021/ja511145h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja511145h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja511145h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DOxidative%252BSubstitution%252Bof%252BBoranephosphonate%252BDiesters%252Bas%252Ba%252BRoute%252Bto%252BPost-synthetically%252BModified%252BDNA%26aulast%3DPaul%26aufirst%3DSibasish%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D30102014%26date%3D26022015%26date%3D11032015%26date%3D13022015%26volume%3D137%26issue%3D9%26spage%3D3253%26epage%3D3264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludovic  Clarion</span>, <span class="hlFld-ContribAuthor ">Carine  Jacquard</span>, <span class="hlFld-ContribAuthor ">Odile  Sainte-Catherine</span>, <span class="hlFld-ContribAuthor ">Marc  Decoux</span>, <span class="hlFld-ContribAuthor ">Séverine  Loiseau</span>, <span class="hlFld-ContribAuthor ">Marc  Rolland</span>, <span class="hlFld-ContribAuthor ">Marc  Lecouvey</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Hugnot</span>, <span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>, and <span class="hlFld-ContribAuthor ">Norbert  Bakalara</span>  . </span><span class="cited-content_cbyCitation_article-title">C-Glycoside Mimetics Inhibit Glioma Stem Cell Proliferation, Migration, and Invasion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (20)
                                     , 8293-8306. <a href="https://doi.org/10.1021/jm500522y" title="DOI URL">https://doi.org/10.1021/jm500522y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500522y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500522y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DC-Glycoside%252BMimetics%252BInhibit%252BGlioma%252BStem%252BCell%252BProliferation%25252C%252BMigration%25252C%252Band%252BInvasion%26aulast%3DClarion%26aufirst%3DLudovic%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D02042014%26date%3D10102014%26date%3D23102014%26date%3D11092014%26volume%3D57%26issue%3D20%26spage%3D8293%26epage%3D8306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angélique  Ferry</span>, <span class="hlFld-ContribAuthor ">Gaëlle  Malik</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Xavier  Guinchard</span>, and <span class="hlFld-ContribAuthor ">David  Crich</span>  . </span><span class="cited-content_cbyCitation_article-title">Alternative Synthesis of P-Chiral Phosphonite-Borane Complexes: Application to the Synthesis of Phostone–Phostone Dimers. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (14)
                                     , 6858-6867. <a href="https://doi.org/10.1021/jo400864s" title="DOI URL">https://doi.org/10.1021/jo400864s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400864s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400864s%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAlternative%252BSynthesis%252Bof%252BP-Chiral%252BPhosphonite-Borane%252BComplexes%25253A%252BApplication%252Bto%252Bthe%252BSynthesis%252Bof%252BPhostone%2525E2%252580%252593Phostone%252BDimers%26aulast%3DFerry%26aufirst%3DAng%25C3%25A9lique%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22042013%26date%3D26062013%26date%3D19072013%26date%3D21062013%26volume%3D78%26issue%3D14%26spage%3D6858%26epage%3D6867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angélique  Ferry</span>, <span class="hlFld-ContribAuthor ">Xavier  Guinchard</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, and <span class="hlFld-ContribAuthor ">David  Crich</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Coupling Reactions of Six-Membered Cyclic P-Chiral Ammonium Phosphonite–Boranes; Reactive H-Phosphinate Equivalents for the Stereoselective Synthesis of Glycomimetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (29)
                                     , 12289-12301. <a href="https://doi.org/10.1021/ja305104b" title="DOI URL">https://doi.org/10.1021/ja305104b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja305104b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja305104b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BCoupling%252BReactions%252Bof%252BSix-Membered%252BCyclic%252BP-Chiral%252BAmmonium%252BPhosphonite%2525E2%252580%252593Boranes%25253B%252BReactive%252BH-Phosphinate%252BEquivalents%252Bfor%252Bthe%252BStereoselective%252BSynthesis%252Bof%252BGlycomimetics%26aulast%3DFerry%26aufirst%3DAng%25C3%25A9lique%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25052012%26date%3D16072012%26date%3D25072012%26date%3D29062012%26volume%3D134%26issue%3D29%26spage%3D12289%26epage%3D12301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrieh  Lashkari</span>, <span class="hlFld-ContribAuthor ">Mehdi  Shahraki</span>, <span class="hlFld-ContribAuthor ">Mahdieh  Darijani</span>, <span class="hlFld-ContribAuthor ">Fatemeh  Mahmoudi</span>. </span><span class="cited-content_cbyCitation_article-title">A density functional theory study of the synthesis of 3-phospholene oxide through the McCormack cycloaddition reaction. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (4)
                                     , 414-421. <a href="https://doi.org/10.1080/10426507.2020.1845682" title="DOI URL">https://doi.org/10.1080/10426507.2020.1845682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1845682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1845682%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Bdensity%252Bfunctional%252Btheory%252Bstudy%252Bof%252Bthe%252Bsynthesis%252Bof%252B3-phospholene%252Boxide%252Bthrough%252Bthe%252BMcCormack%252Bcycloaddition%252Breaction%26aulast%3DLashkari%26aufirst%3DSabrieh%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D4%26spage%3D414%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiu-Hong  Huang</span>, <span class="hlFld-ContribAuthor ">Qian-Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Yang</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Jin-Pei  Cheng</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Access to
              P
              -stereogenic compounds
              via
              desymmetrizing enantioselective bromination. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (12)
                                     , 4582-4587. <a href="https://doi.org/10.1039/D0SC07008D" title="DOI URL">https://doi.org/10.1039/D0SC07008D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC07008D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC07008D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DAccess%252Bto%252BP%252B-stereogenic%252Bcompounds%252Bvia%252Bdesymmetrizing%252Benantioselective%252Bbromination%26aulast%3DHuang%26aufirst%3DQiu-Hong%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D12%26spage%3D4582%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dumei  Ma</span>, <span class="hlFld-ContribAuthor ">Libo  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingwu  Yin</span>, <span class="hlFld-ContribAuthor ">Yuxing  Gao</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Spectroscopic studies of the interaction between phosphorus heterocycles and Cytochrome P450. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical Analysis</span><span> <strong>2020,</strong> <em>235 </em><a href="https://doi.org/10.1016/j.jpha.2020.12.004" title="DOI URL">https://doi.org/10.1016/j.jpha.2020.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpha.2020.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpha.2020.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520Analysis%26atitle%3DSpectroscopic%252Bstudies%252Bof%252Bthe%252Binteraction%252Bbetween%252Bphosphorus%252Bheterocycles%252Band%252BCytochrome%252BP450%26aulast%3DMa%26aufirst%3DDumei%26date%3D2020%26volume%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moaz M.  Abdou</span>. </span><span class="cited-content_cbyCitation_article-title">Synopsis of recent synthetic methods and biological applications of phosphinic acid derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (25)
                                     , 131251. <a href="https://doi.org/10.1016/j.tet.2020.131251" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131251%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynopsis%252Bof%252Brecent%252Bsynthetic%252Bmethods%252Band%252Bbiological%252Bapplications%252Bof%252Bphosphinic%252Bacid%252Bderivatives%26aulast%3DAbdou%26aufirst%3DMoaz%2BM.%26date%3D2020%26volume%3D76%26issue%3D25%26spage%3D131251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Franconetti</span>, <span class="hlFld-ContribAuthor ">Óscar  López</span>, <span class="hlFld-ContribAuthor ">José G.  Fernandez-Bolanos</span>. </span><span class="cited-content_cbyCitation_article-title">Carbohydrates: Potential Sweet Tools Against Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (8)
                                     , 1206-1242. <a href="https://doi.org/10.2174/0929867325666180719114150" title="DOI URL">https://doi.org/10.2174/0929867325666180719114150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180719114150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180719114150%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DCarbohydrates%25253A%252BPotential%252BSweet%252BTools%252BAgainst%252BCancer%26aulast%3DFranconetti%26aufirst%3DAntonio%26date%3D2020%26volume%3D27%26issue%3D8%26spage%3D1206%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Tamburrini</span>, <span class="hlFld-ContribAuthor ">Cinzia  Colombo</span>, <span class="hlFld-ContribAuthor ">Anna  Bernardi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of glycomimetics: Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 495-531. <a href="https://doi.org/10.1002/med.21625" title="DOI URL">https://doi.org/10.1002/med.21625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21625%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bglycomimetics%25253A%252BRecent%252Badvances%26aulast%3DTamburrini%26aufirst%3DAlice%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D495%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Péter  Bagi</span>, <span class="hlFld-ContribAuthor ">Réka  Herbay</span>, <span class="hlFld-ContribAuthor ">Nikolett  Péczka</span>, <span class="hlFld-ContribAuthor ">Zoltán  Mucsi</span>, <span class="hlFld-ContribAuthor ">István  Timári</span>, <span class="hlFld-ContribAuthor ">and György  Keglevich</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of 2-phospholene oxides by the isomerization of 3-phospholene oxides. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>16 </em>, 818-832. <a href="https://doi.org/10.3762/bjoc.16.75" title="DOI URL">https://doi.org/10.3762/bjoc.16.75</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.16.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.16.75%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPreparation%252Bof%252B2-phospholene%252Boxides%252Bby%252Bthe%252Bisomerization%252Bof%252B3-phospholene%252Boxides%26aulast%3DBagi%26aufirst%3DP%25C3%25A9ter%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D818%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali  Saleh</span>, <span class="hlFld-ContribAuthor ">Emilie  Marhuenda</span>, <span class="hlFld-ContribAuthor ">Christine  Fabre</span>, <span class="hlFld-ContribAuthor ">Zahra  Hassani</span>, <span class="hlFld-ContribAuthor ">Jan de  Weille</span>, <span class="hlFld-ContribAuthor ">Hassan  Boukhaddaoui</span>, <span class="hlFld-ContribAuthor ">Sophie  Guelfi</span>, <span class="hlFld-ContribAuthor ">Igor Lima  Maldonado</span>, <span class="hlFld-ContribAuthor ">Jean- Philippe  Hugnot</span>, <span class="hlFld-ContribAuthor ">Hugues  Duffau</span>, <span class="hlFld-ContribAuthor ">Luc  Bauchet</span>, <span class="hlFld-ContribAuthor ">David  Cornu</span>, <span class="hlFld-ContribAuthor ">Norbert  Bakalara</span>. </span><span class="cited-content_cbyCitation_article-title">A novel 3D nanofibre scaffold conserves the plasticity of glioblastoma stem cell invasion by regulating galectin-3 and integrin-β1 expression. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-51108-w" title="DOI URL">https://doi.org/10.1038/s41598-019-51108-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-51108-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-51108-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bnovel%252B3D%252Bnanofibre%252Bscaffold%252Bconserves%252Bthe%252Bplasticity%252Bof%252Bglioblastoma%252Bstem%252Bcell%252Binvasion%252Bby%252Bregulating%252Bgalectin-3%252Band%252Bintegrin-%2525CE%2525B21%252Bexpression%26aulast%3DSaleh%26aufirst%3DAli%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel  Hevey</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design. </span><span class="cited-content_cbyCitation_journal-name">Biomimetics</span><span> <strong>2019,</strong> <em>4 </em>
                                    (3)
                                     , 53. <a href="https://doi.org/10.3390/biomimetics4030053" title="DOI URL">https://doi.org/10.3390/biomimetics4030053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomimetics4030053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomimetics4030053%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomimetics%26atitle%3DBioisosteres%252Bof%252BCarbohydrate%252BFunctional%252BGroups%252Bin%252BGlycomimetic%252BDesign%26aulast%3DHevey%26aufirst%3DRachel%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D3%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Bousseau</span>, <span class="hlFld-ContribAuthor ">Marion  Marchand</span>, <span class="hlFld-ContribAuthor ">Raffaella  Soleti</span>, <span class="hlFld-ContribAuthor ">Luisa  Vergori</span>, <span class="hlFld-ContribAuthor ">Grégory  Hilairet</span>, <span class="hlFld-ContribAuthor ">Sylvain  Recoquillon</span>, <span class="hlFld-ContribAuthor ">Morgane  Le Mao</span>, <span class="hlFld-ContribAuthor ">Naig  Gueguen</span>, <span class="hlFld-ContribAuthor ">Salim  Khiati</span>, <span class="hlFld-ContribAuthor ">Ludovic  Clarion</span>, <span class="hlFld-ContribAuthor ">Norbert  Bakalara</span>, <span class="hlFld-ContribAuthor ">M. Carmen  Martinez</span>, <span class="hlFld-ContribAuthor ">Stéphane  Germain</span>, <span class="hlFld-ContribAuthor ">Guy  Lenaers</span>, <span class="hlFld-ContribAuthor ">Ramaroson  Andriantsitohaina</span>. </span><span class="cited-content_cbyCitation_article-title">Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2019,</strong> <em>33 </em>
                                    (5)
                                     , 5864-5875. <a href="https://doi.org/10.1096/fj.201801450RRR" title="DOI URL">https://doi.org/10.1096/fj.201801450RRR</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.201801450RRR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.201801450RRR%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DPhostine%252B3.1a%252Bas%252Ba%252Bpharmacological%252Bcompound%252Bwith%252Bantiangiogenic%252Bproperties%252Bagainst%252Bdiseases%252Bwith%252Bexcess%252Bvascularization%26aulast%3DBousseau%26aufirst%3DSimon%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D5%26spage%3D5864%26epage%3D5875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moaz M.  Abdou</span>, <span class="hlFld-ContribAuthor ">Paul M.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Eric  Amigues</span>, <span class="hlFld-ContribAuthor ">Magdalini  Matziari</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphinic acids: current status and potential for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 916-929. <a href="https://doi.org/10.1016/j.drudis.2018.11.016" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPhosphinic%252Bacids%25253A%252Bcurrent%252Bstatus%252Band%252Bpotential%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DAbdou%26aufirst%3DMoaz%2BM.%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D916%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Felipe dos Santos  Fernandes</span>, <span class="hlFld-ContribAuthor ">Barbara Colatto  Fernandes</span>, <span class="hlFld-ContribAuthor ">Valeria  Valente</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of small molecules targeting glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 8-26. <a href="https://doi.org/10.1016/j.ejmech.2018.12.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecules%252Btargeting%252Bglioblastoma%26aulast%3DFernandes%26aufirst%3DGuilherme%2BFelipe%2Bdos%2BSantos%26date%3D2019%26volume%3D164%26spage%3D8%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aishun  Ding</span>, <span class="hlFld-ContribAuthor ">Shijie  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Ruiwen  Jin</span>, <span class="hlFld-ContribAuthor ">Cong  Ye</span>, <span class="hlFld-ContribAuthor ">Jianhua  Hu</span>, <span class="hlFld-ContribAuthor ">Hao  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light-induced 4-phenylthioxanthone-catalyzed aerobic oxidation of triarylphosphines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (43)
                                     , 3880-3883. <a href="https://doi.org/10.1016/j.tetlet.2018.09.031" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DVisible%252Blight-induced%252B4-phenylthioxanthone-catalyzed%252Baerobic%252Boxidation%252Bof%252Btriarylphosphines%26aulast%3DDing%26aufirst%3DAishun%26date%3D2018%26volume%3D59%26issue%3D43%26spage%3D3880%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivana  Cacciatore</span>, <span class="hlFld-ContribAuthor ">Erika  Fornasari</span>, <span class="hlFld-ContribAuthor ">Lisa  Marinelli</span>, <span class="hlFld-ContribAuthor ">Piera  Eusepi</span>, <span class="hlFld-ContribAuthor ">Michele  Ciulla</span>, <span class="hlFld-ContribAuthor ">Ozlem  Ozdemir</span>, <span class="hlFld-ContribAuthor ">Abdulgani  Tatar</span>, <span class="hlFld-ContribAuthor ">Hasan  Turkez</span>, <span class="hlFld-ContribAuthor ">Antonio  Di Stefano</span>. </span><span class="cited-content_cbyCitation_article-title">Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 402-411. <a href="https://doi.org/10.1016/j.ejps.2017.08.030" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMemantine-derived%252Bdrugs%252Bas%252Bpotential%252Bantitumor%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bglioblastoma%26aulast%3DCacciatore%26aufirst%3DIvana%26date%3D2017%26volume%3D109%26spage%3D402%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachida  Babouri</span>, <span class="hlFld-ContribAuthor ">Ludovic  Clarion</span>, <span class="hlFld-ContribAuthor ">Marc  Rolland</span>, <span class="hlFld-ContribAuthor ">Arie  Van der Lee</span>, <span class="hlFld-ContribAuthor ">Zahia  Kabouche</span>, <span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Oxaphosphinane-Based Pseudodisaccharides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (36)
                                     , 5357-5369. <a href="https://doi.org/10.1002/ejoc.201700878" title="DOI URL">https://doi.org/10.1002/ejoc.201700878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700878%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BOxaphosphinane-Based%252BPseudodisaccharides%26aulast%3DBabouri%26aufirst%3DRachida%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D36%26spage%3D5357%26epage%3D5369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zahra  Hassani</span>, <span class="hlFld-ContribAuthor ">Ali  Saleh</span>, <span class="hlFld-ContribAuthor ">Soumaya  Turpault</span>, <span class="hlFld-ContribAuthor ">Salim  Khiati</span>, <span class="hlFld-ContribAuthor ">Willy  Morelle</span>, <span class="hlFld-ContribAuthor ">Jacques  Vignon</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Hugnot</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Uro-Coste</span>, <span class="hlFld-ContribAuthor ">Philippe  Legrand</span>, <span class="hlFld-ContribAuthor ">Marcel  Delaforge</span>, <span class="hlFld-ContribAuthor ">Séverine  Loiseau</span>, <span class="hlFld-ContribAuthor ">Ludovic  Clarion</span>, <span class="hlFld-ContribAuthor ">Marc  Lecouvey</span>, <span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>, <span class="hlFld-ContribAuthor ">Hugues  Duffau</span>, <span class="hlFld-ContribAuthor ">Norbert  Bakalara</span>. </span><span class="cited-content_cbyCitation_article-title">Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2017,</strong> <em>15 </em>
                                    (10)
                                     , 1376-1387. <a href="https://doi.org/10.1158/1541-7786.MCR-17-0120" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-17-0120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-17-0120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-17-0120%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DPhostine%252BPST3.1a%252BTargets%252BMGAT5%252Band%252BInhibits%252BGlioblastoma-Initiating%252BCell%252BInvasiveness%252Band%252BProliferation%26aulast%3DHassani%26aufirst%3DZahra%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D10%26spage%3D1376%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre  Fourgeaud</span>, <span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Vors</span>, <span class="hlFld-ContribAuthor ">Yves-Alain  Békro</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>. </span><span class="cited-content_cbyCitation_article-title">5-H-1,2-Oxaphosphole 2-oxides, key building blocks for diversity oriented chemical libraries. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (49)
                                     , 7912-7925. <a href="https://doi.org/10.1016/j.tet.2016.10.011" title="DOI URL">https://doi.org/10.1016/j.tet.2016.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D5-H-1%25252C2-Oxaphosphole%252B2-oxides%25252C%252Bkey%252Bbuilding%252Bblocks%252Bfor%252Bdiversity%252Boriented%252Bchemical%252Blibraries%26aulast%3DFourgeaud%26aufirst%3DPierre%26date%3D2016%26volume%3D72%26issue%3D49%26spage%3D7912%26epage%3D7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José  Viveros-Ceballos</span>, <span class="hlFld-ContribAuthor ">Mario  Ordóñez</span>, <span class="hlFld-ContribAuthor ">Francisco  Sayago</span>, <span class="hlFld-ContribAuthor ">Carlos  Cativiela</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of α-Amino-C-phosphinic Acids and Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (9)
                                     , 1141. <a href="https://doi.org/10.3390/molecules21091141" title="DOI URL">https://doi.org/10.3390/molecules21091141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21091141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21091141%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DStereoselective%252BSynthesis%252Bof%252B%2525CE%2525B1-Amino-C-phosphinic%252BAcids%252Band%252BDerivatives%26aulast%3DViveros-Ceballos%26aufirst%3DJos%25C3%25A9%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D9%26spage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Youla S.  Tsantrizos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Benzothiophene-Containing 10- and 11-Membered Cyclic Phostones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (22)
                                     , 3728-3736. <a href="https://doi.org/10.1002/ejoc.201600333" title="DOI URL">https://doi.org/10.1002/ejoc.201600333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600333%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBenzothiophene-Containing%252B10-%252Band%252B11-Membered%252BCyclic%252BPhostones%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D22%26spage%3D3728%26epage%3D3736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">Remi  Guillon</span>, <span class="hlFld-ContribAuthor ">Frédéric  Bancel</span>, <span class="hlFld-ContribAuthor ">Yves-Alain  Bekro</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphono- and Phosphinolactones in the Life Sciences. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 129-193. <a href="https://doi.org/10.1016/bs.aihch.2015.10.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.10.004%26sid%3Dliteratum%253Aachs%26atitle%3DPhosphono-%252Band%252BPhosphinolactones%252Bin%252Bthe%252BLife%252BSciences%26aulast%3DVolle%26aufirst%3DJean-No%25C3%25ABl%26date%3D2016%26spage%3D129%26epage%3D193%26pub%3DElsevier%26date%3D2016%26volume%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathieu  Dutartre</span>, <span class="hlFld-ContribAuthor ">Jérôme  Bayardon</span>, <span class="hlFld-ContribAuthor ">Sylvain  Jugé</span>. </span><span class="cited-content_cbyCitation_article-title">Applications and stereoselective syntheses of P-chirogenic phosphorus compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2016,</strong> <em>45 </em>
                                    (20)
                                     , 5771-5794. <a href="https://doi.org/10.1039/C6CS00031B" title="DOI URL">https://doi.org/10.1039/C6CS00031B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CS00031B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CS00031B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DApplications%252Band%252Bstereoselective%252Bsyntheses%252Bof%252BP-chirogenic%252Bphosphorus%252Bcompounds%26aulast%3DDutartre%26aufirst%3DMathieu%26date%3D2016%26date%3D2016%26volume%3D45%26issue%3D20%26spage%3D5771%26epage%3D5794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachida  Babouri</span>, <span class="hlFld-ContribAuthor ">Marc  Rolland</span>, <span class="hlFld-ContribAuthor ">Odile  Sainte-Catherine</span>, <span class="hlFld-ContribAuthor ">Zahia  Kabouche</span>, <span class="hlFld-ContribAuthor ">Marc  Lecouvey</span>, <span class="hlFld-ContribAuthor ">Norbert  Bakalara</span>, <span class="hlFld-ContribAuthor ">Jean-Noël  Volle</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>. </span><span class="cited-content_cbyCitation_article-title">α-Halogenated oxaphosphinanes: Synthesis, unexpected reactions and evaluation as inhibitors of cancer cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>104 </em>, 33-41. <a href="https://doi.org/10.1016/j.ejmech.2015.09.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.09.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.09.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B1-Halogenated%252Boxaphosphinanes%25253A%252BSynthesis%25252C%252Bunexpected%252Breactions%252Band%252Bevaluation%252Bas%252Binhibitors%252Bof%252Bcancer%252Bcell%252Bproliferation%26aulast%3DBabouri%26aufirst%3DRachida%26date%3D2015%26volume%3D104%26spage%3D33%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Kinbara</span>, <span class="hlFld-ContribAuthor ">Momoko  Ito</span>, <span class="hlFld-ContribAuthor ">Tohru  Abe</span>, <span class="hlFld-ContribAuthor ">Takehiro  Yamagishi</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-catalyzed C–P cross-coupling reactions of aryl iodides with H-phosphinates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (40)
                                     , 7614-7619. <a href="https://doi.org/10.1016/j.tet.2015.07.073" title="DOI URL">https://doi.org/10.1016/j.tet.2015.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DNickel-catalyzed%252BC%2525E2%252580%252593P%252Bcross-coupling%252Breactions%252Bof%252Baryl%252Biodides%252Bwith%2525C2%2525A0H-phosphinates%26aulast%3DKinbara%26aufirst%3DAtsushi%26date%3D2015%26volume%3D71%26issue%3D40%26spage%3D7614%26epage%3D7619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung Ho  Jun</span>, <span class="hlFld-ContribAuthor ">Salim  Javed</span>, <span class="hlFld-ContribAuthor ">Cornelius N.  Ndi</span>, <span class="hlFld-ContribAuthor ">Paul R.  Hanson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of P-, S-, Si-, B-, and Se-Heterocycles via Ring-Closing Metathesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 319-379. <a href="https://doi.org/10.1007/7081_2015_162" title="DOI URL">https://doi.org/10.1007/7081_2015_162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2015_162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2015_162%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BP-%25252C%252BS-%25252C%252BSi-%25252C%252BB-%25252C%252Band%252BSe-Heterocycles%252Bvia%252BRing-Closing%252BMetathesis%26aulast%3DJun%26aufirst%3DJung%2BHo%26date%3D2015%26date%3D2015%26spage%3D319%26epage%3D379%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSynthesis%252Bof%252BHeterocycles%252Bby%252BMetathesis%252BReactions%26aulast%3DPrunet%26aufirst%3DJo%25C3%25ABlle%26date%3D2017%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piera  Sozio</span>, <span class="hlFld-ContribAuthor ">Jole  Fiorito</span>, <span class="hlFld-ContribAuthor ">Viviana  Di Giacomo</span>, <span class="hlFld-ContribAuthor ">Antonio  Di Stefano</span>, <span class="hlFld-ContribAuthor ">Lisa  Marinelli</span>, <span class="hlFld-ContribAuthor ">Ivana  Cacciatore</span>, <span class="hlFld-ContribAuthor ">Amelia  Cataldi</span>, <span class="hlFld-ContribAuthor ">Stephanie  Pacella</span>, <span class="hlFld-ContribAuthor ">Hasan  Turkez</span>, <span class="hlFld-ContribAuthor ">Carmela  Parenti</span>, <span class="hlFld-ContribAuthor ">Antonio  Rescifina</span>, <span class="hlFld-ContribAuthor ">Agostino  Marrazzo</span>. </span><span class="cited-content_cbyCitation_article-title">Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>90 </em>, 1-9. <a href="https://doi.org/10.1016/j.ejmech.2014.11.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHaloperidol%252Bmetabolite%252BII%252Bprodrug%25253A%252BAsymmetric%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bon%252Brat%252BC6%252Bglioma%252Bcells%26aulast%3DSozio%26aufirst%3DPiera%26date%3D2015%26volume%3D90%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Rabasso</span>, <span class="hlFld-ContribAuthor ">Antoine  Fadel</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclopropanation of 1,2-dibromoethylphosphonate: a synthesis of β-aminocyclopropylphosphonic acid and derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (44)
                                     , 6068-6071. <a href="https://doi.org/10.1016/j.tetlet.2014.09.035" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCyclopropanation%252Bof%252B1%25252C2-dibromoethylphosphonate%25253A%252Ba%252Bsynthesis%252Bof%252B%2525CE%2525B2-aminocyclopropylphosphonic%252Bacid%252Band%252Bderivatives%26aulast%3DRabasso%26aufirst%3DNicolas%26date%3D2014%26volume%3D55%26issue%3D44%26spage%3D6068%26epage%3D6071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Hernández-Guerra</span>, <span class="hlFld-ContribAuthor ">María S.  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Ernesto  Suárez</span>. </span><span class="cited-content_cbyCitation_article-title">Fragmentation of Carbohydrate Anomeric Alkoxyl Radicals: Synthesis of Chiral Polyhydroxylated β-Iodo- and Alkenylorganophosphorus(V) Compounds. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (23)
                                     , 5033-5055. <a href="https://doi.org/10.1002/ejoc.201402387" title="DOI URL">https://doi.org/10.1002/ejoc.201402387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402387%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFragmentation%252Bof%252BCarbohydrate%252BAnomeric%252BAlkoxyl%252BRadicals%25253A%252BSynthesis%252Bof%252BChiral%252BPolyhydroxylated%252B%2525CE%2525B2-Iodo-%252Band%252BAlkenylorganophosphorus%252528V%252529%252BCompounds%26aulast%3DHern%25C3%25A1ndez-Guerra%26aufirst%3DDaniel%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D23%26spage%3D5033%26epage%3D5055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Brewster</span>, <span class="hlFld-ContribAuthor ">Marie-Christine  Vandergeten</span>, <span class="hlFld-ContribAuthor ">Florian  Montel</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of Heteraphosphacyclanes: Follow the Guide!. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (5)
                                     , 905-917. <a href="https://doi.org/10.1002/ejoc.201301299" title="DOI URL">https://doi.org/10.1002/ejoc.201301299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301299%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSyntheses%252Bof%252BHeteraphosphacyclanes%25253A%252BFollow%252Bthe%252BGuide%252521%26aulast%3DBrewster%26aufirst%3DRichard%26date%3D2014%26date%3D2013%26volume%3D2014%26issue%3D5%26spage%3D905%26epage%3D917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bénédicte  Dayde</span>, <span class="hlFld-ContribAuthor ">Claire  Pierra</span>, <span class="hlFld-ContribAuthor ">Gilles  Gosselin</span>, <span class="hlFld-ContribAuthor ">Dominique  Surleraux</span>, <span class="hlFld-ContribAuthor ">Amadou Tidjani  Ilagouma</span>, <span class="hlFld-ContribAuthor ">Coralie  Laborde</span>, <span class="hlFld-ContribAuthor ">Jean-Noel  Volle</span>, <span class="hlFld-ContribAuthor ">David  Virieux</span>, <span class="hlFld-ContribAuthor ">Jean-Luc  Pirat</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Unnatural Phosphonosugar Analogues. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (6)
                                     , 1333-1337. <a href="https://doi.org/10.1002/ejoc.201301543" title="DOI URL">https://doi.org/10.1002/ejoc.201301543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301543%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BUnnatural%252BPhosphonosugar%252BAnalogues%26aulast%3DDayde%26aufirst%3DB%25C3%25A9n%25C3%25A9dicte%26date%3D2014%26date%3D2013%26volume%3D2014%26issue%3D6%26spage%3D1333%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angélique  Ferry</span>, <span class="hlFld-ContribAuthor ">Jérémy  Stemper</span>, <span class="hlFld-ContribAuthor ">Angela  Marinetti</span>, <span class="hlFld-ContribAuthor ">Arnaud  Voituriez</span>, <span class="hlFld-ContribAuthor ">Xavier  Guinchard</span>. </span><span class="cited-content_cbyCitation_article-title">Thiophostone-Derived Brønsted Acids in the Organocatalyzed Transfer Hydrogenation of Quinolines: Influence of the P-Stereogenicity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (1)
                                     , 188-193. <a href="https://doi.org/10.1002/ejoc.201301253" title="DOI URL">https://doi.org/10.1002/ejoc.201301253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301253%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DThiophostone-Derived%252BBr%2525C3%2525B8nsted%252BAcids%252Bin%252Bthe%252BOrganocatalyzed%252BTransfer%252BHydrogenation%252Bof%252BQuinolines%25253A%252BInfluence%252Bof%252Bthe%252BP-Stereogenicity%26aulast%3DFerry%26aufirst%3DAng%25C3%25A9lique%26date%3D2014%26date%3D2013%26volume%3D2014%26issue%3D1%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Małecka</span>, <span class="hlFld-ContribAuthor ">Swastik  Mondal</span>, <span class="hlFld-ContribAuthor ">Sander  van Smaalen</span>, <span class="hlFld-ContribAuthor ">Carsten  Paulmann</span>. </span><span class="cited-content_cbyCitation_article-title">Charge density distribution of 3-(1-aminoethylidene)-2-methoxy-2-oxo-2,3-dihydro-2λ
              5
              -benzo[
              e
              ][1,2]oxaphosphinin-4-one. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials</span><span> <strong>2013,</strong> <em>69 </em>
                                    (6)
                                     , 621-628. <a href="https://doi.org/10.1107/S2052519213027267" title="DOI URL">https://doi.org/10.1107/S2052519213027267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2052519213027267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2052519213027267%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520B%2520Structural%2520Science%252C%2520Crystal%2520Engineering%2520and%2520Materials%26atitle%3DCharge%252Bdensity%252Bdistribution%252Bof%252B3-%2525281-aminoethylidene%252529-2-methoxy-2-oxo-2%25252C3-dihydro-2%2525CE%2525BB%252B5%252B-benzo%25255B%252Be%252B%25255D%25255B1%25252C2%25255Doxaphosphinin-4-one%26aulast%3DMa%25C5%2582ecka%26aufirst%3DMagdalena%26date%3D2013%26date%3D2013%26volume%3D69%26issue%3D6%26spage%3D621%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick-Denis  St-Cœur</span>, <span class="hlFld-ContribAuthor ">Dean  Ferguson</span>, <span class="hlFld-ContribAuthor ">Pier Jr  Morin</span>, <span class="hlFld-ContribAuthor ">Mohamed  Touaibia</span>. </span><span class="cited-content_cbyCitation_article-title">PF-8380 and Closely Related Analogs: Synthesis and Structure-Activity Relationship towards Autotaxin Inhibition and Glioma Cell Viability. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (2)
                                     , 91-97. <a href="https://doi.org/10.1002/ardp.201200395" title="DOI URL">https://doi.org/10.1002/ardp.201200395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201200395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201200395%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DPF-8380%252Band%252BClosely%252BRelated%252BAnalogs%25253A%252BSynthesis%252Band%252BStructure-Activity%252BRelationship%252Btowards%252BAutotaxin%252BInhibition%252Band%252BGlioma%252BCell%252BViability%26aulast%3DSt-C%25C5%2593ur%26aufirst%3DPatrick-Denis%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D2%26spage%3D91%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route to hydroxy-oxaphosphinanes <b>3.1</b>-<b>3.7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route to the α-<span class="smallcaps smallerCapital">d</span>-Amino-glucose Analogues <b>6a</b> and <b>7a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Deoxyphosphinosugar <b>9</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the α-<span class="smallcaps smallerCapital">d</span>-Glucose Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes of the α-<span class="smallcaps smallerCapital">d</span>-Glucose Analogues</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antiproliferative activities of <b>3.1a</b> and <b>3.1b</b>. Antiproliferative activities were measured by MTT reduction, 48 h after drug addition (<b>3.1a</b> and <b>3.1b</b>) on different cell lines on rat C6 glioblastoma cells (C6) and brain metastasis of prostatic cells (DU-145). OD 570 nm, optical density measured at 570 nm; C, concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oxaphosphinanes effect on NCI60 GP and effects comparison with paclitaxel on the CNS cell lines. (A and B) Growth percentage of NCI-60 cell lines after 48 h of incubation of 10 μM <b>3.1a</b> (A) or 10 μM <b>3.1b</b> (B) as quantified with sulforhodamine B assay. Gray circles represent NCI 60 CNS cell lines and cell lines used for the MTT test in the primary screening (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). (C) Oxaphosphinanes, TMZ, and paclitaxel effects on brain cell lines growth percentage. Comparison of CNS cell lines growth percentage with 10 μM <b>3.1a</b>, <b>3.1b</b>, TMZ, and paclitaxel. Black, <b>3.1a</b>; white, <b>3.1b</b>; black and gray, paclitaxel; and white and gray, TMZ. Nsc, nonsmall cell; CNS, central nervous system; 1, SF-295; 2, SNB-75; 3, U-251; 4, SF-268; 5, SNB-19; 6, SF-539; a, MDA-MB-435; b, DU-145; and c, MDA-MB-231.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the antiproliferative activities of phostines with clinical drugs on C6 cells. Neutral red incorporation in C6 cells was measured 48 h after product addition. The percentage of toxicity was calculated in comparison to vehicle. nt, no toxicity. Results in bold are above 50% of toxicity. OD, optical density.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the toxicity of OXP430.1 with clinical drugs on nonproliferative astrocytes. Astrocyte viability was quantified 48 h after drug addition on nonproliferative cells maintained in cell culture during 3 weeks after isolation from mouse pups cortical brain. (A and B) Graphics with means ± standard deviations (statview) show neutral red incorporation level (A) and Hoechst 33342 (5 μg/mL) cytofluor intensity measurement. The mean fluorescence was then calculated from three different wells per condition. (C) Dual labeling for PI and Hoechst was performed using the Cellomics array scan vti (Thermofisher). The object detection was fixed on the Hoechst 33342 channel, and the graph shows the percentage of Hoechst 33342 cells stained with PI. The control fluorescence intensities were measured on Triton X-100 (2%)-treated cells. The mean percentage of PI incorporation was calculated from three different wells per condition. OD, optical density; and FU, fluorescent unit. *, significant activity (<i>p</i> < 0.05); ***, significant activity (<i>p</i> < 0.001); and $, significant activity (<i>p</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxic activity of <b>3.1a</b> and <b>3.1b</b> on C6 cells. The graph shows the mean ± standard deviation (statview) optical density measured at 490 nm 48 h after product addition on C6 glial cells. $, significant activity (<i>p</i> < 0.0001); and ***, significant activity (<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/medium/jm-2011-01428a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time–course effect of <b>3.1a</b> on C6 cell growth. Compound <b>3.1a</b> was used at concentrations ranging between 100 nM and 100 μM, and impedance was measured 25 h after plating (<i>t</i> = 0) for 44 h. The electrode impedance is displayed as a cell index (CI) value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201428a/production/images/large/jm-2011-01428a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201428a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Bauchet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu-Daude, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro-Peray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigau, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinot, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallusseau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiebaut, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patru, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauchet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lionnet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faillot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taillandier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figarella-Branger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frappaz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campello, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reme-Saumon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretarre, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daures, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrousse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honnorat, J.</span><span> </span><span class="NLM_article-title">Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=725-735&author=L.+Bauchetauthor=H.+Mathieu-Daudeauthor=P.+Fabbro-Perayauthor=V.+Rigauauthor=M.+Fabbroauthor=O.+Chinotauthor=L.+Pallusseauauthor=C.+Carninauthor=K.+Laineauthor=A.+Schlamaauthor=A.+Thiebautauthor=M.+C.+Patruauthor=F.+Bauchetauthor=M.+Lionnetauthor=M.+Wagerauthor=T.+Faillotauthor=L.+Taillandierauthor=D.+Figarella-Brangerauthor=L.+Capelleauthor=H.+Loiseauauthor=D.+Frappazauthor=C.+Campelloauthor=C.+Kerrauthor=H.+Duffauauthor=M.+Reme-Saumonauthor=B.+Tretarreauthor=J.+P.+Dauresauthor=D.+Heninauthor=F.+Labrousseauthor=P.+Meneiauthor=J.+Honnorat&title=Oncological+patterns+of+care+and+outcome+for+952+patients+with+newly+diagnosed+glioblastoma+in+2004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBauchet%26aufirst%3DL.%26aulast%3DMathieu-Daude%26aufirst%3DH.%26aulast%3DFabbro-Peray%26aufirst%3DP.%26aulast%3DRigau%26aufirst%3DV.%26aulast%3DFabbro%26aufirst%3DM.%26aulast%3DChinot%26aufirst%3DO.%26aulast%3DPallusseau%26aufirst%3DL.%26aulast%3DCarnin%26aufirst%3DC.%26aulast%3DLaine%26aufirst%3DK.%26aulast%3DSchlama%26aufirst%3DA.%26aulast%3DThiebaut%26aufirst%3DA.%26aulast%3DPatru%26aufirst%3DM.%2BC.%26aulast%3DBauchet%26aufirst%3DF.%26aulast%3DLionnet%26aufirst%3DM.%26aulast%3DWager%26aufirst%3DM.%26aulast%3DFaillot%26aufirst%3DT.%26aulast%3DTaillandier%26aufirst%3DL.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCapelle%26aufirst%3DL.%26aulast%3DLoiseau%26aufirst%3DH.%26aulast%3DFrappaz%26aufirst%3DD.%26aulast%3DCampello%26aufirst%3DC.%26aulast%3DKerr%26aufirst%3DC.%26aulast%3DDuffau%26aufirst%3DH.%26aulast%3DReme-Saumon%26aufirst%3DM.%26aulast%3DTretarre%26aufirst%3DB.%26aulast%3DDaures%26aufirst%3DJ.%2BP.%26aulast%3DHenin%26aufirst%3DD.%26aulast%3DLabrousse%26aufirst%3DF.%26aulast%3DMenei%26aufirst%3DP.%26aulast%3DHonnorat%26aufirst%3DJ.%26atitle%3DOncological%2520patterns%2520of%2520care%2520and%2520outcome%2520for%2520952%2520patients%2520with%2520newly%2520diagnosed%2520glioblastoma%2520in%25202004%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D725%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Van Meir, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadjipanayis, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, J. J.</span><span> </span><span class="NLM_article-title">Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma</span> <span class="citation_source-journal">CA Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2010&pages=166-193&author=E.+G.+Van+Meirauthor=C.+G.+Hadjipanayisauthor=A.+D.+Nordenauthor=H.+K.+Shuauthor=P.+Y.+Wenauthor=J.+J.+Olson&title=Exciting+new+advances+in+neuro-oncology%3A+The+avenue+to+a+cure+for+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DHadjipanayis%26aufirst%3DC.%2BG.%26aulast%3DNorden%26aufirst%3DA.%2BD.%26aulast%3DShu%26aufirst%3DH.%2BK.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26atitle%3DExciting%2520new%2520advances%2520in%2520neuro-oncology%253A%2520The%2520avenue%2520to%2520a%2520cure%2520for%2520malignant%2520glioma%26jtitle%3DCA%2520Cancer%2520J.%2520Clin.%26date%3D2010%26volume%3D60%26spage%3D166%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gerstner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorensen, G.</span><span> </span><span class="NLM_article-title">Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=466-472&author=E.+R.+Gerstnerauthor=P.+J.+Chenauthor=P.+Y.+Wenauthor=R.+K.+Jainauthor=T.+T.+Batchelorauthor=G.+Sorensen&title=Infiltrative+patterns+of+glioblastoma+spread+detected+via+diffusion+MRI+after+treatment+with+cediranib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerstner%26aufirst%3DE.%2BR.%26aulast%3DChen%26aufirst%3DP.%2BJ.%26aulast%3DWen%26aufirst%3DP.%2BY.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DBatchelor%26aufirst%3DT.%2BT.%26aulast%3DSorensen%26aufirst%3DG.%26atitle%3DInfiltrative%2520patterns%2520of%2520glioblastoma%2520spread%2520detected%2520via%2520diffusion%2520MRI%2520after%2520treatment%2520with%2520cediranib%26jtitle%3DNeuro-Oncology%26date%3D2010%26volume%3D12%26spage%3D466%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fraum, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisl, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, F. M.</span><span> </span><span class="NLM_article-title">Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy</span> <span class="citation_source-journal">J. Neurooncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1007%2Fs11060-011-0579-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=287-289&author=T.+J.+Fraumauthor=T.+N.+Kreislauthor=J.+Sulauthor=H.+A.+Fineauthor=F.+M.+Iwamoto&title=Ischemic+stroke+and+intracranial+hemorrhage+in+glioma+patients+on+antiangiogenic+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs11060-011-0579-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11060-011-0579-4%26sid%3Dliteratum%253Aachs%26aulast%3DFraum%26aufirst%3DT.%2BJ.%26aulast%3DKreisl%26aufirst%3DT.%2BN.%26aulast%3DSul%26aufirst%3DJ.%26aulast%3DFine%26aufirst%3DH.%2BA.%26aulast%3DIwamoto%26aufirst%3DF.%2BM.%26atitle%3DIschemic%2520stroke%2520and%2520intracranial%2520hemorrhage%2520in%2520glioma%2520patients%2520on%2520antiangiogenic%2520therapy%26jtitle%3DJ.%2520Neurooncol.%26date%3D2011%26volume%3D105%26spage%3D287%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Uhm, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballman, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheithauer, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakhill, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeckle, K. A.</span><span> </span><span class="NLM_article-title">Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074</span> <span class="citation_source-journal">Int. J. Radiat. Oncol. Biol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2Fj.ijrobp.2010.01.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20510539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVWhsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=347-353&author=J.+H.+Uhmauthor=K.+V.+Ballmanauthor=W.+Wuauthor=C.+Gianniniauthor=J.+C.+Kraussauthor=J.+C.+Bucknerauthor=C.+D.+Jamesauthor=B.+W.+Scheithauerauthor=R.+J.+Behrensauthor=P.+J.+Flynnauthor=P.+L.+Schaeferauthor=S.+R.+Dakhillauthor=K.+A.+Jaeckle&title=Phase+II+Evaluation+of+Gefitinib+in+Patients+With+Newly+Diagnosed+Grade+4+Astrocytoma%3A+Mayo%2FNorth+Central+Cancer+Treatment+Group+Study+N0074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074</span></div><div class="casAuthors">Uhm, Joon H.; Ballman, Karla V.; Wu, Wenting; Giannini, Caterina; Krauss, J. C.; Buckner, Jan C.; James, C. D.; Scheithauer, Bernd W.; Behrens, Robert J.; Flynn, Patrick J.; Schaefer, Paul L.; Dakhill, Shaker R.; Jaeckle, Kurt A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">347-353</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: Amplification of the epidermal growth factor receptor (EGFR) gene represents one of the most frequent gene alterations in glioblastoma (GBM).  In the current study, we evaluated gefitinib, a potent EGFR inhibitor, in the treatment of adults with newly diagnosed GBM.  Methods and Materials: Ninety-eight patients (96 evaluable) were accrued between May 18, 2001, and August 2, 2002.  All were newly diagnosed GBM patients who were clin. and radiog. stable/improved after radiation treatment (enrollment within 5 wk of radiation completion).  No prior chemotherapy was permitted.  EGFR amplification/mutation, as assessed by fluorescence in situ hybridization and immunohistochem., was not required for treatment with gefitinib but was studied when tissues were available.  Gefitinib was administered at 500 mg each day; for patients receiving dexamethasone or enzyme-inducing (CYP3A4) agents, dose was escalated to a max. of 1,000 mg QD.  Treatment cycles were repeated at 4-wk intervals with brain magnetic resonance imaging at 8-wk intervals.  Results: Overall survival (OS; calcd. from time of initial surgery) at 1 yr (primary end point) with gefitinib was 54.2%, which was not statistically different compared with that of historical control population (48.9%, data from three previous Phase III North Central Cancer Treatment Group studies of newly diagnosed GBM patients).  Progression-free survival (PFS) at 1 yr post-RT (16.7%) was also not significantly different to that of historical controls (30.3%).  Clin. outcome was not affected by EGFR status (amplification or vIII mutation).  Fatigue (41%), rash (62%), and loose stools (58%) constituted the most frequent adverse events, the majority of these being limited to Grade 1/2.  Of note, the occurrence of drug-related adverse effects, such as loose stools was assocd. with improved OS.  Conclusions: In our evaluation of nearly 100 patients with newly diagnosed GBM, treatment with adjuvant gefitinib post-radiation was not assocd. with significant improvement in OS or PFS.  However, patients who experienced gefitinib-assocd. adverse effects (rash/diarrhea) did demonstrate improved OS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobKy1I_o-zo7Vg90H21EOLACvtfcHk0lisIP2lbsGbAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVWhsbg%253D&md5=8ac738591fb4a3b9735c33335772f6bd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2010.01.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2010.01.070%26sid%3Dliteratum%253Aachs%26aulast%3DUhm%26aufirst%3DJ.%2BH.%26aulast%3DBallman%26aufirst%3DK.%2BV.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGiannini%26aufirst%3DC.%26aulast%3DKrauss%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DJ.%2BC.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DScheithauer%26aufirst%3DB.%2BW.%26aulast%3DBehrens%26aufirst%3DR.%2BJ.%26aulast%3DFlynn%26aufirst%3DP.%2BJ.%26aulast%3DSchaefer%26aufirst%3DP.%2BL.%26aulast%3DDakhill%26aufirst%3DS.%2BR.%26aulast%3DJaeckle%26aufirst%3DK.%2BA.%26atitle%3DPhase%2520II%2520Evaluation%2520of%2520Gefitinib%2520in%2520Patients%2520With%2520Newly%2520Diagnosed%2520Grade%25204%2520Astrocytoma%253A%2520Mayo%252FNorth%2520Central%2520Cancer%2520Treatment%2520Group%2520Study%2520N0074%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%2520Biol.%2520Phys.%26date%3D2011%26volume%3D80%26spage%3D347%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Neyns, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joosens, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouttens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baurain, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Hondt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauven, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaskis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">In't Veld, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michotte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, J.</span><span> </span><span class="NLM_article-title">Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1596</span><span class="NLM_x">–</span> <span class="NLM_lpage">1603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1093%2Fannonc%2Fmdp032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=19491283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADC%252BD1MrnsVGrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1596-1603&author=B.+Neynsauthor=J.+Sadonesauthor=E.+Joosensauthor=F.+Bouttensauthor=L.+Verbekeauthor=J.+F.+Baurainauthor=L.+D%27Hondtauthor=T.+Strauvenauthor=C.+Chaskisauthor=P.+In%27t+Veldauthor=A.+Michotteauthor=J.+De+Greve&title=Stratified+phase+II+trial+of+cetuximab+in+patients+with+recurrent+high-grade+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma</span></div><div class="casAuthors">Neyns B; Sadones J; Joosens E; Bouttens F; Verbeke L; Baurain J-F; D'Hondt L; Strauven T; Chaskis C; In't Veld P; Michotte A; De Greve J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology / ESMO</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1596-603</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with recurrent high-grade glioma (HGG) after failure of surgery, radiation therapy, and chemotherapy.  PATIENTS AND METHODS:  In this two-arm, open-label, phase II study patients were stratified according to their epidermal growth factor receptor (EGFR) gene amplification status.  Cetuximab was administered intravenously at a dose of 400 mg/m(2) on week 1 followed by weekly dose of 250 mg/m(2).  The primary end point for this study was the response rate in both study arms separately.  RESULTS:  Fifty-five eligible patients (28 with and 27 without EGFR amplification) tolerated cetuximab well.  Three patients (5.5%) had a partial response and 16 patients (29.6%) had stable disease.  The median time to progression was 1.9 months [95% confidence interval (CI) 1.6-2.2 months].  Whereas the progression-free survival (PFS) was <6 months in the majority (n = 50/55) of patients, five patients (9.2%) had a PFS on cetuximab of >9 months.  Median overall survival was 5.0 months (95% CI 4.2-5.9 months).  No significant correlation was found between response, survival and EGFR amplification.  CONCLUSIONS:  Cetuximab was well tolerated but had limited activity in this patient population with progressive HGG.  A minority of patients may derive a more durable benefit but were not prospectively identified by EGFR gene copy number.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxYDzxmlDzEJHZzFRCXxVKfW6udTcc2eanGtxyPTKg7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrnsVGrtg%253D%253D&md5=8669d86d78fc3eed5c36cd1fc187d802</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdp032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdp032%26sid%3Dliteratum%253Aachs%26aulast%3DNeyns%26aufirst%3DB.%26aulast%3DSadones%26aufirst%3DJ.%26aulast%3DJoosens%26aufirst%3DE.%26aulast%3DBouttens%26aufirst%3DF.%26aulast%3DVerbeke%26aufirst%3DL.%26aulast%3DBaurain%26aufirst%3DJ.%2BF.%26aulast%3DD%2527Hondt%26aufirst%3DL.%26aulast%3DStrauven%26aufirst%3DT.%26aulast%3DChaskis%26aufirst%3DC.%26aulast%3DIn%2527t%2BVeld%26aufirst%3DP.%26aulast%3DMichotte%26aufirst%3DA.%26aulast%3DDe%2BGreve%26aufirst%3DJ.%26atitle%3DStratified%2520phase%2520II%2520trial%2520of%2520cetuximab%2520in%2520patients%2520with%2520recurrent%2520high-grade%2520glioma%26jtitle%3DAnn.%2520Oncol.%26date%3D2009%26volume%3D20%26spage%3D1596%26epage%3D1603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erridge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattamaneni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. M.</span><span> </span><span class="NLM_article-title">Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">4601</span><span class="NLM_x">–</span> <span class="NLM_lpage">4608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1200%2FJCO.2009.27.1932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20855843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaitLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=4601-4608&author=M.+Bradaauthor=S.+Stenningauthor=R.+Gabeauthor=L.+C.+Thompsonauthor=D.+Levyauthor=R.+Ramplingauthor=S.+Erridgeauthor=F.+Saranauthor=R.+Gattamaneniauthor=K.+Hopkinsauthor=S.+Beallauthor=V.+P.+Collinsauthor=S.+M.+Lee&title=Temozolomide+versus+procarbazine%2C+lomustine%2C+and+vincristine+in+recurrent+high-grade+glioma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma</span></div><div class="casAuthors">Brada, Michael; Stenning, Sally; Gabe, Rhian; Thompson, Lindsay C.; Levy, David; Rampling, Roy; Erridge, Sara; Saran, Frank; Gattamaneni, Rao; Hopkins, Kirsten; Beall, Sarah; Collins, V. Peter; Lee, Siow-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4601-4608</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Temozolomide (TMZ) is an alkylating agent licensed for treatment of high-grade glioma (HGG).  No prospective comparison with nitrosourea-based chemotherapy exists.  We report, to our knowledge, the first randomized trial of procarbazine, lomustine, and vincristine (PCV) vs. TMZ in chemotherapy-naive patients with recurrent HGG.  447 Patients were randomly assigned to PCV (224 patients) or TMZ (sub-random assignment: TMZ-5 [200 mg/m2 for 5 days, 112 patients] or TMZ-21 [100 mg/m2 for 21 days, 111 patients]) for up to 9 mo or until progression.  The primary outcomes were survival (PCV v TMZ) and 12-wk progression-free survival (PFS; TMZ-5 v TMZ-21).  This study is registered as ISRCTN83176944.  Percentages of patients completing 9 mo of treatment in the PCV, TMZ-5, and TMZ-21 arms were 17%, 26%, and 13%, resp.  Major toxicity was similar across all three groups.  With a median follow-up time of 12 mo and 382 deaths, there was no clear survival benefit when comparing PCV with TMZ (hazard ratio [HR], 0.91; 95% CI, 0.74 to 1.11; P = .350).  For TMZ-5 vs. TMZ-21, 12-wk PFS rates were similar (63.6% and 65.7%, resp.; P = .745), but TMZ-5 improved overall PFS (HR, 1.38; 95% CI, 1.05 to 1.82; P = .023), survival (HR, 1.32; 95% CI, 0.99 to 1.75; P = .056), and global quality of life (49% v 19% improved > 10 points at 6 mo, resp.; P = .005).  Although TMZ (both arms combined) did not show a clear benefit compared with PCV, comparison of the TMZ schedules demonstrated that the 21-day schedule was inferior to the 5-day schedule in this setting.  This challenges the current understanding of increasing TMZ dose-intensity by prolonged scheduling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDovaGyNg9pbVg90H21EOLACvtfcHk0licLg63aRSFsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaitLzP&md5=98656df63521332f218da925cecb4e37</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.27.1932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.27.1932%26sid%3Dliteratum%253Aachs%26aulast%3DBrada%26aufirst%3DM.%26aulast%3DStenning%26aufirst%3DS.%26aulast%3DGabe%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BC.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DRampling%26aufirst%3DR.%26aulast%3DErridge%26aufirst%3DS.%26aulast%3DSaran%26aufirst%3DF.%26aulast%3DGattamaneni%26aufirst%3DR.%26aulast%3DHopkins%26aufirst%3DK.%26aulast%3DBeall%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DV.%2BP.%26aulast%3DLee%26aufirst%3DS.%2BM.%26atitle%3DTemozolomide%2520versus%2520procarbazine%252C%2520lomustine%252C%2520and%2520vincristine%2520in%2520recurrent%2520high-grade%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D4601%26epage%3D4608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Westphal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilt, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivares, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warnke, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaaskelainen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, Z.</span><span> </span><span class="NLM_article-title">A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma</span> <span class="citation_source-journal">Neuro-Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=79-88&author=M.+Westphalauthor=D.+C.+Hiltauthor=E.+Borteyauthor=P.+Delavaultauthor=R.+Olivaresauthor=P.+C.+Warnkeauthor=I.+R.+Whittleauthor=J.+Jaaskelainenauthor=Z.+Ram&title=A+phase+3+trial+of+local+chemotherapy+with+biodegradable+carmustine+%28BCNU%29+wafers+%28Gliadel+wafers%29+in+patients+with+primary+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestphal%26aufirst%3DM.%26aulast%3DHilt%26aufirst%3DD.%2BC.%26aulast%3DBortey%26aufirst%3DE.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DOlivares%26aufirst%3DR.%26aulast%3DWarnke%26aufirst%3DP.%2BC.%26aulast%3DWhittle%26aufirst%3DI.%2BR.%26aulast%3DJaaskelainen%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DZ.%26atitle%3DA%2520phase%25203%2520trial%2520of%2520local%2520chemotherapy%2520with%2520biodegradable%2520carmustine%2520%2528BCNU%2529%2520wafers%2520%2528Gliadel%2520wafers%2529%2520in%2520patients%2520with%2520primary%2520malignant%2520glioma%26jtitle%3DNeuro-Oncology%26date%3D2003%26volume%3D5%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sabbah, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foehrenbach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutertre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nioche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeDreuille, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellegou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faillot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desgeorges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoliani, Y. S.</span><span> </span><span class="NLM_article-title">Multimodal anatomic, functional, and metabolic brain imaging for tumor resection</span> <span class="citation_source-journal">Clin. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS0899-7071%2801%2900313-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=11814745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADC%252BD387gtVeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=6-12&author=P.+Sabbahauthor=H.+Foehrenbachauthor=G.+Dutertreauthor=C.+Niocheauthor=O.+DeDreuilleauthor=N.+Bellegouauthor=J.+F.+Manginauthor=C.+Levequeauthor=T.+Faillotauthor=J.+F.+Gaillardauthor=M.+Desgeorgesauthor=Y.+S.+Cordoliani&title=Multimodal+anatomic%2C+functional%2C+and+metabolic+brain+imaging+for+tumor+resection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodal anatomic, functional, and metabolic brain imaging for tumor resection</span></div><div class="casAuthors">Sabbah P; Foehrenbach H; Dutertre G; Nioche C; DeDreuille O; Bellegou N; Mangin J F; Leveque C; Faillot T; Gaillard J F; Desgeorges M; Cordoliani Y S</div><div class="citationInfo"><span class="NLM_cas:title">Clinical imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-12</span>
        ISSN:<span class="NLM_cas:issn">0899-7071</span>.
    </div><div class="casAbstract">OBJECTIVE:  Improvement of neurosurgical techniques with a more detailed description of brain tumors and their functional environment.  METHODS:  We performed: (1) anatomical magnetic resonance imaging (MRI) for reference, (2) functional sequences dedicated to the adjacent cortical structures (sensorimotor, visual, language paradigms), and (3) thallium 201 cerebral tomoscintigraphy to visualize active tumor invasion.  Data were transferred to a workstation for automatic registration.  RESULTS:  All data were combined into one synthetic image showing the foci of high proliferative activity, which have to be completely resected, and the peritumoral functional structures, which have to be spared in order to minimize postoperative sequelae.  This trimodal image is entered into a surgical neuronavigation computer for preoperative planning in order to outline tumoral target and functional risk areas.  All this information is displayed in the operative microscope (Zeiss MKM) optically linked to MR images.  This multimodality technique diminishes operative time by reducing electrocorticography and improves the operative short-term outcome.  CONCLUSION:  Multimodal imaging is useful for optimization of neurosurgical tumor resection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTaLZS5Qc80OGmbXvSEQle5fW6udTcc2eZXGG2pTYSJX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387gtVeqsQ%253D%253D&md5=f1957874961165695df6ddc9e172cc28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0899-7071%2801%2900313-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0899-7071%252801%252900313-8%26sid%3Dliteratum%253Aachs%26aulast%3DSabbah%26aufirst%3DP.%26aulast%3DFoehrenbach%26aufirst%3DH.%26aulast%3DDutertre%26aufirst%3DG.%26aulast%3DNioche%26aufirst%3DC.%26aulast%3DDeDreuille%26aufirst%3DO.%26aulast%3DBellegou%26aufirst%3DN.%26aulast%3DMangin%26aufirst%3DJ.%2BF.%26aulast%3DLeveque%26aufirst%3DC.%26aulast%3DFaillot%26aufirst%3DT.%26aulast%3DGaillard%26aufirst%3DJ.%2BF.%26aulast%3DDesgeorges%26aufirst%3DM.%26aulast%3DCordoliani%26aufirst%3DY.%2BS.%26atitle%3DMultimodal%2520anatomic%252C%2520functional%252C%2520and%2520metabolic%2520brain%2520imaging%2520for%2520tumor%2520resection%26jtitle%3DClin.%2520Imaging%26date%3D2002%26volume%3D26%26spage%3D6%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Stummer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichlmeier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanella, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reulen, H. J.</span><span> </span><span class="NLM_article-title">Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS1470-2045%2806%2970665-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=16648043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFWlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=392-401&author=W.+Stummerauthor=U.+Pichlmeierauthor=T.+Meinelauthor=O.+D.+Wiestlerauthor=F.+Zanellaauthor=H.+J.+Reulen&title=Fluorescence-guided+surgery+with+5-aminolevulinic+acid+for+resection+of+malignant+glioma%3A+a+randomised+controlled+multicentre+phase+III+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicenter phase III trial</span></div><div class="casAuthors">Stummer, Walter; Pichlmeier, Uwe; Meinel, Thomas; Wiestler, Otmar Dieter; Zanella, Friedhelm; Reulen, Hans-Juergen; Oppel, F.; Brune, A.; Lanksch, W.; Woiciechowsky, C.; Brock, M.; Vesper, J.; Tonn, J-C.; Goetz, C.; Mayfrank, L.; Oertel, M. F.; Seifert, V.; Franz, K.; Bink, A.; Schackert, G.; Pinzer, T.; Hassler, W.; Bani, A.; Meisel, H-J.; Kern, B. C.; Mehdorn, H. M.; Nabavi, A.; Brawanski, A.; Ullrich, W. W.; Boeker, D. K.; Winking, M.; Weber, F.; Langenbach, U.; Kaehler, U.; Arnold, H.; Knopp, U.; Grumme, T.; Stretz, T.; Stolke, D.; Wiedemayer, H.; Turowski, B.; Pietsch, T.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">5-Aminolevulinic acid is a non-fluorescent prodrug that leads to intracellular accumulation of fluorescent porphyrins in malignant gliomas-a finding that is under investigation for intraoperative identification and resection of these tumors.  We aimed to assess the effect of fluorescence-guided resection with 5-aminolevulinic acid on surgical radicality, progression-free survival, overall survival, and morbidity.  Three hundred and twenty-two patients aged 23-73 years with suspected malignant glioma amenable to complete resection of contrast-enhancing tumor were randomly assigned to 20 mg/kg bodyweight 5-aminolevulinic acid for fluorescence-guided resection (n = 161) or to conventional microsurgery with white light (n = 161).  The primary endpoints were the no. of patients without contrast-enhancing tumor on early MRI (ie, that obtained within 72 h after surgery) and 6-mo progression-free survival as assessed by MRI.  Secondary endpoints were vol. of residual tumor on postoperative MRI, overall survival, neurol. deficit, and toxic effects.  We report the results of an interim anal. with 270 patients in the full-anal. population (139 assigned 5-aminolevulinic acid, 131 assigned white light), which excluded patients with ineligible histol. and radiol. findings as assessed by central reviewers who were masked as to treatment allocation; the interim anal. resulted in termination of the study as defined by the protocol.  Primary and secondary endpoints were analyzed by intention to treat in the full-anal. population.  The study is registered at as NCT00241670.  Median follow-up was 35.4 mo (95% CI 1.0-56.7).  Contrast-enhancing tumor was reseted completely in 90 (65%) of 139 patients assigned 5-aminolevulinic acid compared with 47 (36%) of 131 assigned white light (difference between groups 29% [95% CI 17-40], p < 0.0001).  Patients allocated 5-aminolevulinic acid had higher 6-mo progression free survival than did those allocated white light (41.0% [32.8-49.2] vs. 21.1% [14.0-28.2]; difference between groups 19.9% [9.1-30.7], p = 0.0003, Z test).  Groups did not differ in the frequency of severe adverse events or adverse events in any organ system class reported within 7 days after surgery.  Tumor fluorescence derived from 5-aminolevulinic acid enables more complete resection of contrast-enhancing tumor, leading to improved progression-free survival in patients with malignant glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJkwoN_7C6LbVg90H21EOLACvtfcHk0lgDHUTrFCkumA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFWlsb0%253D&md5=5f3656046a38c1f4324e4b7715d3995f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2806%2970665-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252806%252970665-9%26sid%3Dliteratum%253Aachs%26aulast%3DStummer%26aufirst%3DW.%26aulast%3DPichlmeier%26aufirst%3DU.%26aulast%3DMeinel%26aufirst%3DT.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DZanella%26aufirst%3DF.%26aulast%3DReulen%26aufirst%3DH.%2BJ.%26atitle%3DFluorescence-guided%2520surgery%2520with%25205-aminolevulinic%2520acid%2520for%2520resection%2520of%2520malignant%2520glioma%253A%2520a%2520randomised%2520controlled%2520multicentre%2520phase%2520III%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2006%26volume%3D7%26spage%3D392%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawczyk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaloyanov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span> </span><span class="NLM_article-title">Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1438</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1039%2Fb919345f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=20204219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislKntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=1438-1444&author=J.-N.+Volleauthor=D.+Filippiniauthor=B.+Krawczykauthor=N.+Kaloyanovauthor=A.+Van+der+Leeauthor=T.+Mauriceauthor=J.-L.+Piratauthor=D.+Virieux&title=Drug+discovery%3A+Phosphinolactone%2C+in+vivo+bioisostere+of+the+lactol+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery: phosphinolactone, in vivo bioisostere of the lactol group</span></div><div class="casAuthors">Volle, Jean-Noel; Filippini, Damien; Krawczy, Bartlomiej; Kaloyanov, Nikolay; Van der Lee, Arie; Maurice, Tangui; Pirat, Jean-Luc; Virieux, David</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1438-1444</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In drug discovery, structural modifications over the lead mol. are often crucial for the development of a drug.  Herein, we reported the first in vivo bioisosteric effect of phosphinolactone function in relation to the lactol group constituting the bioactive mol.: Hydroxybupropion.  The prepn. of phosphinolactone analogs and their antidepressant evaluation towards forced swimming test in mice showed that biol. activity was regained and even strengthen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-dzJEtQC5FLVg90H21EOLACvtfcHk0lgKpFLdo4k2QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislKntbs%253D&md5=a642757a7a871a9d8f7606a6e6f7b458</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1039%2Fb919345f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb919345f%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DKrawczyk%26aufirst%3DB.%26aulast%3DKaloyanov%26aufirst%3DN.%26aulast%3DVan%2Bder%2BLee%26aufirst%3DA.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DPirat%26aufirst%3DJ.-L.%26aulast%3DVirieux%26aufirst%3DD.%26atitle%3DDrug%2520discovery%253A%2520Phosphinolactone%252C%2520in%2520vivo%2520bioisostere%2520of%2520the%2520lactol%2520group%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D1438%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span> </span><span class="NLM_article-title">Chemical properties and reactions of phosphine chalcogenides</span>. In  <span class="citation_source-book">The Chemistry of Organophosphorus Compounds</span>; <span class="NLM_contrib-group">Hartley, F. R.</span>, Ed.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">Chichester</span>,<span class="NLM_x"> </span><span class="NLM_year">1992</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">2</span>, pp  <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=287-408&author=F.+R.+Hartley&title=The+Chemistry+of+Organophosphorus+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DChemical%2520properties%2520and%2520reactions%2520of%2520phosphine%2520chalcogenides%26btitle%3DThe%2520Chemistry%2520of%2520Organophosphorus%2520Compounds%26aulast%3DHartley%26aufirst%3DF.%2BR.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1992%26volume%3D2%26spage%3D287%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hernández, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastre, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hommer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordillo, B.</span><span> </span><span class="NLM_article-title">Conformational analysis of six-membered ring dioxaphosphinanes. Part 1: Anancomeric thiophosphates</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">10927</span><span class="NLM_x">–</span> <span class="NLM_lpage">10941</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=10927-10941&author=J.+Hern%C3%A1ndezauthor=R.+Ramosauthor=N.+Sastreauthor=R.+Mezaauthor=H.+Hommerauthor=M.+Salasauthor=B.+Gordillo&title=Conformational+analysis+of+six-membered+ring+dioxaphosphinanes.+Part+1%3A+Anancomeric+thiophosphates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DR.%26aulast%3DSastre%26aufirst%3DN.%26aulast%3DMeza%26aufirst%3DR.%26aulast%3DHommer%26aufirst%3DH.%26aulast%3DSalas%26aufirst%3DM.%26aulast%3DGordillo%26aufirst%3DB.%26atitle%3DConformational%2520analysis%2520of%2520six-membered%2520ring%2520dioxaphosphinanes.%2520Part%25201%253A%2520Anancomeric%2520thiophosphates%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D10927%26epage%3D10941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wadsworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, W. D.</span><span> </span><span class="NLM_article-title">Bicyclic phosphites</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00863a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1962&pages=610-617&author=S.+Wadsworthauthor=W.+D.+Emmons&title=Bicyclic+phosphites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja00863a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00863a022%26sid%3Dliteratum%253Aachs%26aulast%3DWadsworth%26aufirst%3DS.%26aulast%3DEmmons%26aufirst%3DW.%2BD.%26atitle%3DBicyclic%2520phosphites%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1962%26volume%3D84%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monbrun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarion, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span> </span><span class="NLM_article-title">Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-Aryl-3,5-diphenyl-[1,4,2]-oxazaphosphinanes</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">–</span> <span class="NLM_lpage">1408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=1402-1408&author=J.-N.+Volleauthor=D.+Virieuxauthor=M.+Starckauthor=J.+Monbrunauthor=L.+Clarionauthor=J.-L.+Pirat&title=Chiral+phosphinyl+analogues+of+2-C-arylmorpholinols%3A+2-Aryl-3%2C5-diphenyl-%5B1%2C4%2C2%5D-oxazaphosphinanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DStarck%26aufirst%3DM.%26aulast%3DMonbrun%26aufirst%3DJ.%26aulast%3DClarion%26aufirst%3DL.%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DChiral%2520phosphinyl%2520analogues%2520of%25202-C-arylmorpholinols%253A%25202-Aryl-3%252C5-diphenyl-%255B1%252C4%252C2%255D-oxazaphosphinanes%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2006%26volume%3D17%26spage%3D1402%26epage%3D1408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">McDonald, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H. Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmquist, C. R.</span><span> </span><span class="NLM_article-title">Rhodium-catalysed alkaline cyclotrimerization strategies for 6-arylglycoside synthesis</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">6605</span><span class="NLM_x">–</span> <span class="NLM_lpage">6606</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00129a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=6605-6606&author=F.+E.+McDonaldauthor=H.+Y.+H.+Zhuauthor=C.+R.+Holmquist&title=Rhodium-catalysed+alkaline+cyclotrimerization+strategies+for+6-arylglycoside+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja00129a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00129a030%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonald%26aufirst%3DF.%2BE.%26aulast%3DZhu%26aufirst%3DH.%2BY.%2BH.%26aulast%3DHolmquist%26aufirst%3DC.%2BR.%26atitle%3DRhodium-catalysed%2520alkaline%2520cyclotrimerization%2520strategies%2520for%25206-arylglycoside%2520synthesis%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D6605%26epage%3D6606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harvey, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simiand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, S. G.</span><span> </span><span class="NLM_article-title">Synthesis of Cyclic Phosphonate Analogs of Ribose and arabinose</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6722</span><span class="NLM_x">–</span> <span class="NLM_lpage">6725</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9706382" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVentL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=6722-6725&author=T.+C.+Harveyauthor=C.+Simiandauthor=L.+Weilerauthor=S.+G.+Withers&title=Synthesis+of+Cyclic+Phosphonate+Analogs+of+Ribose+and+arabinose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Cyclic Phosphonate Analogs of Ribose and Arabinose</span></div><div class="casAuthors">Harvey, Thomas C.; Simiand, Cecile; Weiler, Larry; Withers, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6722-6725</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclic phosphonates of ribose and arabinose (phostones) were synthesized by a Lewis acid-catalyzed addn. of tri-Me phosphite to the partially protected D-threose I to give the acyclic phosphonate mixt. II.  This Abramov reaction was moderately stereoselective (3:1).  A base-catalyzed cyclization of the mixt. of II gave the four isomeric phosphonates III.  Two of the isomers could be crystd. from the reaction mixt.  The X-ray data and soln. NMR data indicate that these phostones and their derivs. exist exclusively in a chair conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz3dfTYwoONLVg90H21EOLACvtfcHk0lhISuLBTZ0DTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVentL4%253D&md5=9143fcd75cef548f7bbf131096d00b67</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo9706382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9706382%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DT.%2BC.%26aulast%3DSimiand%26aufirst%3DC.%26aulast%3DWeiler%26aufirst%3DL.%26aulast%3DWithers%26aufirst%3DS.%2BG.%26atitle%3DSynthesis%2520of%2520Cyclic%2520Phosphonate%2520Analogs%2520of%2520Ribose%2520and%2520arabinose%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D6722%26epage%3D6725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogel, O.</span><span> </span><span class="NLM_article-title">Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2FS0960-894X%2899%2900401-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10476884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2441-2446&author=S.+Hanessianauthor=O.+Rogel&title=Synthesis+of+a+phostone+glycomimetic+of+the+endothelin+converting+enzyme+inhibitor+phosphoramidon"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon</span></div><div class="casAuthors">Hanessian, Stephen; Rogel, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2441-2446</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The phostone analog of phosphoramidon, an inhibitor of endothelin converting enzyme, was synthesized from L-rhamnose.  Coupling of the cyclic phosphonic acid with the dipeptide H-Leu-Trp-OMe gave, after deprotection and purifn. by reverse-phase HPLC, the desired phostone which exhibited an IC50 of 5.05 ± 2.7 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFpsL7XO4CbVg90H21EOLACvtfcHk0lhISuLBTZ0DTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWgsr4%253D&md5=0e0f3aad50281cf1a397bc20133020cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900401-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900401-1%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DRogel%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520a%2520phostone%2520glycomimetic%2520of%2520the%2520endothelin%2520converting%2520enzyme%2520inhibitor%2520phosphoramidon%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2441%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stoianova, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, P. R.</span><span> </span><span class="NLM_article-title">P-Heterocyclic Building Blocks: Application to the Stereoselective Synthesis of P-Sugars</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5880</span><span class="NLM_x">–</span> <span class="NLM_lpage">5889</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0505122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5880-5889&author=D.+S.+Stoianovaauthor=A.+Whiteheadauthor=P.+R.+Hanson&title=P-Heterocyclic+Building+Blocks%3A+Application+to+the+Stereoselective+Synthesis+of+P-Sugars"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjo0505122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0505122%26sid%3Dliteratum%253Aachs%26aulast%3DStoianova%26aufirst%3DD.%2BS.%26aulast%3DWhitehead%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DP.%2BR.%26atitle%3DP-Heterocyclic%2520Building%2520Blocks%253A%2520Application%2520to%2520the%2520Stereoselective%2520Synthesis%2520of%2520P-Sugars%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5880%26epage%3D5889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pirat, J.-L.; Virieux, D.; Volle, J.-N.; Clarion, L.; Bakalara, N.; Mersel, M.; Monbrun, J.; Cristau, H.-J.</span><span> </span><span class="NLM_article-title">New phosphorus containing heterocyclic compounds, sugar analogs, and compositions having anticancer activity containing the same</span>. PCT Int. Appl. WO 2009/004096 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.-L.+Pirat&author=D.+Virieux&author=J.-N.+Volle&author=L.+Clarion&author=N.+Bakalara&author=M.+Mersel&author=J.+Monbrun&author=H.-J.+Cristau&title=New+phosphorus+containing+heterocyclic+compounds%2C+sugar+analogs%2C+and+compositions+having+anticancer+activity+containing+the+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DNew%2520phosphorus%2520containing%2520heterocyclic%2520compounds%252C%2520sugar%2520analogs%252C%2520and%2520compositions%2520having%2520anticancer%2520activity%2520containing%2520the%2520same%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Midrier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drag, M.</span><span> </span><span class="NLM_article-title">Revisited Synthesis of Aryl-H-phosphinates</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1055%2Fs-0030-1260109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Skur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=2490-2494&author=J.-N.+Volleauthor=D.+Filippiniauthor=C.+Midrierauthor=D.+Virieuxauthor=J.-L.+Piratauthor=M.+Sobeckiauthor=M.+Drag&title=Revisited+Synthesis+of+Aryl-H-phosphinates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Revisited synthesis of aryl-H-phosphinates</span></div><div class="casAuthors">Volle, Jean-Noel; Filippini, Damien; Midrier, Camille; Sobecki, Michal; Drag, Marcin; Virieux, David; Pirat, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2494</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A systematic study of the reaction conditions for the prepn. of pure aryl-H-phosphinate esters, originally developed by Sander and optimized by Petnehazy, is reported.  The influence of the reaction concn. was studied for the formation of phosphonite intermediates via direct addn. of tri-Et phosphite to the appropriate Grignard reagent.  Subsequent hydrolysis of the phosphonites under acidic conditions gives various aryl-H-phosphinates in high yields and purities.  E.g., reaction of 4-tolyl bromide with Mg turnings in THF followed by addn. of P(OEt)3 under reflux gave 4-MeC6H4P(OEt)2 (I) in 96% yield; I was dissolved in THF and treated with aq. soln. of HCl to obtain a pH of 2 and to give 60% yield of 4-MeC6H4P(O)(H)(OEt).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbBxVOLvJiAbVg90H21EOLACvtfcHk0lgDlYnwiIcd8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Skur7I&md5=4b4fc2aca19b5ec24548a5afe7ba7673</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1260109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1260109%26sid%3Dliteratum%253Aachs%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DMidrier%26aufirst%3DC.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.-L.%26aulast%3DSobecki%26aufirst%3DM.%26aulast%3DDrag%26aufirst%3DM.%26atitle%3DRevisited%2520Synthesis%2520of%2520Aryl-H-phosphinates%26jtitle%3DSynthesis%26date%3D2011%26spage%3D2490%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cristau, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monbrun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleiss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J.-L.</span><span> </span><span class="NLM_article-title">First synthesis of P-aryl-phosphinosugars, organophosphorus analogues of C-arylglycosides</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3741</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=3741-3744&author=H.-J.+Cristauauthor=J.+Monbrunauthor=J.+Schleissauthor=D.+Virieuxauthor=J.-L.+Pirat&title=First+synthesis+of+P-aryl-phosphinosugars%2C+organophosphorus+analogues+of+C-arylglycosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCristau%26aufirst%3DH.-J.%26aulast%3DMonbrun%26aufirst%3DJ.%26aulast%3DSchleiss%26aufirst%3DJ.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.-L.%26atitle%3DFirst%2520synthesis%2520of%2520P-aryl-phosphinosugars%252C%2520organophosphorus%2520analogues%2520of%2520C-arylglycosides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D3741%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Filippini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakalara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dziuganowska, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volle, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virieux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirat, J. L.</span><span> </span><span class="NLM_article-title">Dramatic effect of modified boranes in diastereoselective reduction of chiral cyclic α-ketophosphinates</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1039%2Fc2ra00799a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=816-818&author=D.+Filippiniauthor=S.+Loiseauauthor=N.+Bakalaraauthor=Z.+A.+Dziuganowskaauthor=A.+Van+der+Leeauthor=J.-N.+Volleauthor=D.+Virieuxauthor=J.+L.+Pirat&title=Dramatic+effect+of+modified+boranes+in+diastereoselective+reduction+of+chiral+cyclic+%CE%B1-ketophosphinates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dramatic effect of modified boranes in diastereoselective reduction of chiral cyclic α-ketophosphinates</span></div><div class="casAuthors">Filippini, Damien; Loiseau, Severine; Bakalara, Norbert; Dziuganowska, Zofia Anna; Van der Lee, Arie; Volle, Jean-Noel; Virieux, David; Pirat, Jean-Luc</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">816-818</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phostines have been recently described as compds. having antiproliferative properties.  Original synthesis of this new class of phosphinic analogs of pyranoses led to a mixt. of four diastereomers 3-6 with unequal bioactivities.  The most active compd. 4 was originally obtained from a mixt. of these four diastereomers by selective pptn., giving firstly two diastereomers 3 and 4, epimers at the carbon atom.  From the latter mixt. 3 and 4, oxidn. with Dess-Martin reagent afforded corresponding α-ketophosphinate 7, which by diastereoselective redn. using a chiral agent based on sodium borohydride and l-proline, gave preferentially the active diastereomer 4.  In addn., use of a multivalent cation also increased the diastereoselectivity favorably.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMqa0LABT8nrVg90H21EOLACvtfcHk0lgDlYnwiIcd8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslWhuw%253D%253D&md5=e5e1790cc85dfff35334398f0f1cb474</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fc2ra00799a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2ra00799a%26sid%3Dliteratum%253Aachs%26aulast%3DFilippini%26aufirst%3DD.%26aulast%3DLoiseau%26aufirst%3DS.%26aulast%3DBakalara%26aufirst%3DN.%26aulast%3DDziuganowska%26aufirst%3DZ.%2BA.%26aulast%3DVan%2Bder%2BLee%26aufirst%3DA.%26aulast%3DVolle%26aufirst%3DJ.-N.%26aulast%3DVirieux%26aufirst%3DD.%26aulast%3DPirat%26aufirst%3DJ.%2BL.%26atitle%3DDramatic%2520effect%2520of%2520modified%2520boranes%2520in%2520diastereoselective%2520reduction%2520of%2520chiral%2520cyclic%2520%25CE%25B1-ketophosphinates%26jtitle%3DRSC%2520Adv.%26date%3D2012%26volume%3D2%26spage%3D816%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cipolla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lay, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicotra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangrazio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, L.</span><span> </span><span class="NLM_article-title">Synthesis of Azasugars by Grignard Reaction on Glycosylamines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4679</span><span class="NLM_x">–</span> <span class="NLM_lpage">4690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1995&pages=4679-4690&author=L.+Cipollaauthor=L.+Layauthor=F.+Nicotraauthor=C.+Pangrazioauthor=L.+Panza&title=Synthesis+of+Azasugars+by+Grignard+Reaction+on+Glycosylamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCipolla%26aufirst%3DL.%26aulast%3DLay%26aufirst%3DL.%26aulast%3DNicotra%26aufirst%3DF.%26aulast%3DPangrazio%26aufirst%3DC.%26aulast%3DPanza%26aufirst%3DL.%26atitle%3DSynthesis%2520of%2520Azasugars%2520by%2520Grignard%2520Reaction%2520on%2520Glycosylamines%26jtitle%3DTetrahedron%26date%3D1995%26volume%3D51%26spage%3D4679%26epage%3D4690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Behr, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillerm, G.</span><span> </span><span class="NLM_article-title">Synthesis of 6-deoxy-homoDMDP and its C(5)-epimer: Absolute stereochemistry of natural products from Hyacinthus orientalis</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=111-113&author=J.+M.+Behrauthor=G.+Guillerm&title=Synthesis+of+6-deoxy-homoDMDP+and+its+C%285%29-epimer%3A+Absolute+stereochemistry+of+natural+products+from+Hyacinthus+orientalis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehr%26aufirst%3DJ.%2BM.%26aulast%3DGuillerm%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25206-deoxy-homoDMDP%2520and%2520its%2520C%25285%2529-epimer%253A%2520Absolute%2520stereochemistry%2520of%2520natural%2520products%2520from%2520Hyacinthus%2520orientalis%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2002%26volume%3D13%26spage%3D111%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Stupp, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Bent, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taphoorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marosi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdahn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curschmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzer, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorlia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhauer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirimanoff, R. O.</span><span> </span><span class="NLM_article-title">Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1056%2FNEJMoa043330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=15758009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Wksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=987-996&author=R.+Stuppauthor=W.+P.+Masonauthor=M.+J.+Van+den+Bentauthor=M.+Wellerauthor=B.+Fisherauthor=M.+J.+Taphoornauthor=K.+Belangerauthor=A.+A.+Brandesauthor=C.+Marosiauthor=U.+Bogdahnauthor=J.+Curschmannauthor=R.+C.+Janzerauthor=S.+K.+Ludwinauthor=T.+Gorliaauthor=A.+Allgeierauthor=D.+Lacombeauthor=J.+G.+Cairncrossauthor=E.+Eisenhauerauthor=R.+O.+Mirimanoff&title=Radiotherapy+plus+concomitant+and+adjuvant+Temozolomide+for+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma</span></div><div class="casAuthors">Stupp, Roger; Mason, Warren P.; van den Bent, Martin J.; Weller, Michael; Fisher, Barbara; Taphoorn, Martin J. B.; Belanger, Karl; Brandes, Alba A.; Marosi, Christine; Bogdahn, Ulrich; Curschmann, Jurgen; Janzer, Robert C.; Ludwin, Samuel K.; Gorlia, Thierry; Allgeier, Anouk; Lacombe, Denis; Cairncross, J. Gregory; Eisenhauer, Elizabeth; Mirimanoff, Rene O.; Forsyth, P.; Fulton, D.; Kirby, S.; Wong, R.; Fenton, D.; Fisher, B.; Cairncross, G.; Whitlock, P.; Belanger, K.; Burdette-Radoux, S.; Gertler, S.; Saunders, S.; Laing, K.; Siddiqui, J.; Martin, L. A.; Gulavita, S.; Perry, J.; Mason, W.; Thiessen, B.; Pai, H.; Alam, Z. Y.; Eisenstat, D.; Mingrone, W.; Hofer, S.; Pesce, G.; Curschmann, J.; Dietrich, P. Y.; Stupp, R.; Mirimanoff, R. O.; Thum, P.; Baumert, B.; Ryan, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">987-996</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal.  The current std. of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy.  In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety.  METHODS Patients with newly diagnosed, histol. confirmed glioblastoma were randomly assigned to receive radiotherapy alone (fractionated focal irradn. in daily fractions of 2 Gy given 5 days per wk for 6 wk, for a total of 60 Gy) or radiotherapy plus continuous daily temozolomide (75 mg per square meter of body-surface area per day, 7 days per wk from the first to the last day of radiotherapy), followed by six cycles of adjuvant temozolomide (150 to 200 mg per square meter for 5 days during each 28-day cycle).  The primary end point was overall survival.  RESULTS A total of 573 patients from 85 centers underwent randomization.  The median age was 56 years, and 84 % of patients had undergone debulking surgery.  At a median follow-up of 28 mo, the median survival was 14.6 mo with radiotherapy plus temozolomide and 12.1 mo with radiotherapy alone.  The unadjusted hazard ratio for death in the radiotherapy-plus-temozolomide group was 0.63 (95 % confidence interval, 0.52 to 0.75; P<0.001 by the log-rank test).  The two-year survival rate was 26.5 % with radiotherapy plus temozolomide and 10.4 % with radiotherapy alone.  Concomitant treatment with radiotherapy plus temozolomide resulted in grade 3 or 4 hematol. toxic effects in 7 % of patients.  Conclusions The addn. of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clin. meaningful and statistically significant survival benefit with minimal addnl. toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdNLD2mISWE7Vg90H21EOLACvtfcHk0lgDsvor7x8ahQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Wksbk%253D&md5=28546eb2e78f7346974d7d029c9fa916</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa043330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa043330%26sid%3Dliteratum%253Aachs%26aulast%3DStupp%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DW.%2BP.%26aulast%3DVan%2Bden%2BBent%26aufirst%3DM.%2BJ.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DTaphoorn%26aufirst%3DM.%2BJ.%26aulast%3DBelanger%26aufirst%3DK.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DMarosi%26aufirst%3DC.%26aulast%3DBogdahn%26aufirst%3DU.%26aulast%3DCurschmann%26aufirst%3DJ.%26aulast%3DJanzer%26aufirst%3DR.%2BC.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DGorlia%26aufirst%3DT.%26aulast%3DAllgeier%26aufirst%3DA.%26aulast%3DLacombe%26aufirst%3DD.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DEisenhauer%26aufirst%3DE.%26aulast%3DMirimanoff%26aufirst%3DR.%2BO.%26atitle%3DRadiotherapy%2520plus%2520concomitant%2520and%2520adjuvant%2520Temozolomide%2520for%2520glioblastoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D987%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Koziara, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumper, R. J.</span><span> </span><span class="NLM_article-title">Paclitaxel nanoparticles for the potential treatment of brain tumors</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2004&pages=259-269&author=J.+M.+Koziaraauthor=P.+R.+Lockmanauthor=D.+D.+Allenauthor=R.+J.+Mumper&title=Paclitaxel+nanoparticles+for+the+potential+treatment+of+brain+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoziara%26aufirst%3DJ.%2BM.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DMumper%26aufirst%3DR.%2BJ.%26atitle%3DPaclitaxel%2520nanoparticles%2520for%2520the%2520potential%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2004%26volume%3D99%26spage%3D259%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Acton, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risbood, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Anticancer specificity of some ellipticinium salts against human brain tumors in vitro</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2185</span><span class="NLM_x">–</span> <span class="NLM_lpage">2189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00040a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2185-2189&author=E.+M.+Actonauthor=V.+L.+Narayananauthor=P.+A.+Risboodauthor=R.+H.+Shoemakerauthor=D.+T.+Visticaauthor=M.+R.+Boyd&title=Anticancer+specificity+of+some+ellipticinium+salts+against+human+brain+tumors+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00040a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00040a010%26sid%3Dliteratum%253Aachs%26aulast%3DActon%26aufirst%3DE.%2BM.%26aulast%3DNarayanan%26aufirst%3DV.%2BL.%26aulast%3DRisbood%26aufirst%3DP.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DVistica%26aufirst%3DD.%2BT.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DAnticancer%2520specificity%2520of%2520some%2520ellipticinium%2520salts%2520against%2520human%2520brain%2520tumors%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2185%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span> </span><span class="NLM_article-title">A gene expression database for the molecular pharmacology of cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2F73439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10700175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=236-244&author=U.+Scherfauthor=D.+T.+Rossauthor=M.+Walthamauthor=L.+H.+Smithauthor=J.+K.+Leeauthor=L.+Tanabeauthor=K.+W.+Kohnauthor=W.+C.+Reinholdauthor=T.+G.+Myersauthor=D.+T.+Andrewsauthor=D.+A.+Scudieroauthor=M.+B.+Eisenauthor=E.+A.+Sausvilleauthor=Y.+Pommierauthor=D.+Botsteinauthor=P.+O.+Brownauthor=J.+N.+Weinstein&title=A+gene+expression+database+for+the+molecular+pharmacology+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A gene expression database for the molecular pharmacology of cancer</span></div><div class="casAuthors">Scherf, Uwe; Ross, Douglas T.; Waltham, Mark; Smith, Lawrence H.; Lee, Jae K.; Tanabe, Lorraine; Kohn, Kurt W.; Reinhold, William C.; Myers, Timothy G.; Andrews, Darren T.; Scudiero, Dominic A.; Eisen, Michael B.; Sausville, Edward A.; Pommier, Yves; Botstein, David; Brown, Patrick O.; Weinstein, John N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-244</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to assess gene expression profiles in 60 human cancer cell lines used in a drug discovery screen by the National Cancer Institute.  Using these data, we linked bioinformatics and chemoinformatics by correlating gene expression and drug activity patterns in the NCI60 lines.  Clustering the cell lines on the basis of gene expression yielded relationships very different from those obtained by clustering the cell lines on the basis of their response to drugs.  Gene-drug relationships for the clin. agents 5-fluorouracil and L-asparaginase exemplify how variations in the transcript levels of particular genes relate to mechanisms of drug sensitivity and resistance.  This is the first study to integrate large databases on gene expression and mol. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLuoOC0y3Ag7Vg90H21EOLACvtfcHk0lh93mUM9kpmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrk%253D&md5=602b56f8cb25953400646dd9f7df261e</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F73439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73439%26sid%3Dliteratum%253Aachs%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DTanabe%26aufirst%3DL.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DAndrews%26aufirst%3DD.%2BT.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26atitle%3DA%2520gene%2520expression%2520database%2520for%2520the%2520molecular%2520pharmacology%2520of%2520cancer%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Rijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashkari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span> </span><span class="NLM_article-title">Systematic variation in gene expression patterns in human cancer cell lines</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2F73432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=10700174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=227-235&author=D.+T.+Rossauthor=U.+Scherfauthor=M.+B.+Eisenauthor=C.+M.+Perouauthor=C.+Reesauthor=P.+Spellmanauthor=V.+Iyerauthor=S.+S.+Jeffreyauthor=M.+Van+de+Rijnauthor=M.+Walthamauthor=A.+Pergamenschikovauthor=J.+C.+Leeauthor=D.+Lashkariauthor=D.+Shalonauthor=T.+G.+Myersauthor=J.+N.+Weinsteinauthor=D.+Botsteinauthor=P.+O.+Brown&title=Systematic+variation+in+gene+expression+patterns+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic variation in gene expression patterns in human cancer cell lines</span></div><div class="casAuthors">Ross, Douglas T.; Scherf, Uwe; Eisen, Michael B.; Perou, Charles M.; Rees, Christian; Spellman, Paul; Iyer, Vishwanath; Jeffrey, Stefanie S.; Van de Rijn, Matt; Waltham, Mark; Pergamenschikov, Alexander; Lee, Jeffrey C. F.; Lashkari, Deval; Shalon, Dari; Myers, Timothy G.; Weinstein, John N.; Botstein, David; Brown, Patrick O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to explore the variation in expression of approx. 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs.  Classification of the cell lines based solely on the obsd. patterns of gene expression revealed a correspondence to the ostensible origins of the tumors from which the cell lines were derived.  The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect.  Specific features of the gene expression patterns appeared to be related to physiol. properties of the cell lines, such as their doubling time in culture, drug metab. or the interferon response.  Comparison of gene expression patterns in the cell lines to those obsd. in normal breast tissue or in breast tumor specimens revealed features of the expression patterns in the tumors that had recognizable counterparts in specific cell lines, reflecting the tumor, stromal and inflammatory components of the tumor tissue.  These results provided a novel mol. characterization of this important group of human cell lines and their relationships to tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhocezjCTNbVg90H21EOLACvtfcHk0ljCx9NKcwQMdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D&md5=248ffa9428fa078fff0bdf45fddaecf4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2F73432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73432%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DRees%26aufirst%3DC.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DVan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DLashkari%26aufirst%3DD.%26aulast%3DShalon%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26atitle%3DSystematic%2520variation%2520in%2520gene%2520expression%2520patterns%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Blower, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verducci, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmittgen, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span> </span><span class="NLM_article-title">MicroRNAs modulate the chemosensitivity of tumor cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1158%2F1535-7163.MCT-07-0573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=18187804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1-9&author=P.+E.+Blowerauthor=J.+H.+Chungauthor=J.+S.+Verducciauthor=S.+Linauthor=J.+K.+Parkauthor=Z.+Daiauthor=C.+G.+Liuauthor=T.+D.+Schmittgenauthor=W.+C.+Reinholdauthor=C.+M.+Croceauthor=J.+N.+Weinsteinauthor=W.+Sadee&title=MicroRNAs+modulate+the+chemosensitivity+of+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNAs modulate the chemosensitivity of tumor cells</span></div><div class="casAuthors">Blower, Paul E.; Chung, Ji-Hyun; Verducci, Joseph S.; Lin, Shili; Park, Jong-Kook; Dai, Zunyan; Liu, Chang-Gong; Schmittgen, Thomas D.; Reinhold, William C.; Croce, Carlo M.; Weinstein, John N.; Sadee, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MicroRNAs are strongly implicated in such processes as development, carcinogenesis, cell survival, and apoptosis.  It is likely, therefore, that they can also modulate sensitivity and resistance to anticancer drugs in substantial ways.  To test this hypothesis, we studied the pharmacol. roles of three microRNAs previously implicated in cancer biol. (let-7i, mir-16, and mir-21) and also used in silico methods to test pharmacol. microRNA effects more broadly.  In the exptl. system, we increased the expression of individual microRNAs by transfecting their precursors (which are active) or suppressed the expression by transfection of antisense oligomers.  In three NCI-60 human cancer cell lines, a panel of 60 lines used for anticancer drug discovery, we assessed the growth-inhibitory potencies of 14 structurally diverse compds. with known anticancer activities.  Changing the cellular levels of let-7i, mir-16, and mir-21 affected the potencies of a no. of the anticancer agents by up to 4-fold.  The effect was most prominent with mir-21, with 10 of 28 cell-compd. pairs showing significant shifts in growth-inhibitory activity.  Varying mir-21 levels changed potencies in opposite directions depending on compd. class; indicating that different mechanisms det. toxic and protective effects.  In silico comparison of drug potencies with microRNA expression profiles across the entire NCI-60 panel revealed that ∼30 microRNAs, including mir-21, show highly significant correlations with numerous anticancer agents.  Ten of those microRNAs have already been implicated in cancer biol.  Our results support a substantial role for microRNAs in anticancer drug response, suggesting novel potential approaches to the improvement of chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4EPNNoVHMLVg90H21EOLACvtfcHk0ljCx9NKcwQMdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyiuw%253D%253D&md5=29e2f300b5b56058cfd76444bca017ee</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0573%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BE.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DVerducci%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DJ.%2BK.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%2BG.%26aulast%3DSchmittgen%26aufirst%3DT.%2BD.%26aulast%3DReinhold%26aufirst%3DW.%2BC.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DSadee%26aufirst%3DW.%26atitle%3DMicroRNAs%2520modulate%2520the%2520chemosensitivity%2520of%2520tumor%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Blower, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verducci, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldjian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croce, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span> </span><span class="NLM_article-title">MicroRNA expression profiles for the NCI-60 cancer cell panel</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1483</span><span class="NLM_x">–</span> <span class="NLM_lpage">1491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1158%2F1535-7163.MCT-07-0009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=17483436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFalt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1483-1491&author=P.+E.+Blowerauthor=J.+S.+Verducciauthor=S.+Linauthor=J.+Zhouauthor=J.+H.+Chungauthor=Z.+Daiauthor=C.+G.+Liuauthor=W.+Reinholdauthor=P.+L.+Lorenziauthor=E.+P.+Kaldjianauthor=C.+M.+Croceauthor=J.+N.+Weinsteinauthor=W.+Sadee&title=MicroRNA+expression+profiles+for+the+NCI-60+cancer+cell+panel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA expression profiles for the NCI-60 cancer cell panel</span></div><div class="casAuthors">Blower, Paul E.; Verducci, Joseph S.; Lin, Shili; Zhou, Jin; Chung, Ji-Hyun; Dai, Zunyan; Liu, Chang-Gong; Reinhold, William; Lorenzi, Philip L.; Kaldjian, Eric P.; Croce, Carlo M.; Weinstein, John N.; Sadee, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1483-1491</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Advances in the understanding of cancer cell biol. and response to drug treatment have benefited from new mol. technologies and methods for integrating information from multiple sources.  The NCI-60, a panel of 60 diverse human cancer cell lines, has been used by the National Cancer Institute to screen > 100,000 chem. compds. and natural product exts. for anticancer activity.  The NCI-60 has also been profiled for mRNA and protein expression, mutational status, chromosomal aberrations, and DNA copy no., generating an unparalleled public resource for integrated chemogenomic studies.  Recently, microRNAs have been shown to target particular sets of mRNAs, thereby preventing translation or accelerating mRNA turnover.  To complement the existing NCI-60 data sets, we have measured expression levels of microRNAs in the NCI-60 and incorporated the resulting data into the CellMiner program package for integrative anal.  Cell line groupings based on microRNA expression were generally consistent with tissue type and with cell line clustering based on mRNA expression.  However, mRNA expression seemed to be somewhat more informative for discriminating among tissue types than was microRNA expression.  In addn., we found that there does not seem to be a significant correlation between microRNA expression patterns and those of known target transcripts.  Comparison of microRNA expression patterns and compd. potency patterns showed significant correlations, suggesting that microRNAs may play a role in chemoresistance.  Combined with gene expression and other biol. data using multivariate anal., microRNA expression profiles may provide a crit. link for understanding mechanisms involved in chemosensitivity and chemoresistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6uaalpN_2jLVg90H21EOLACvtfcHk0lgzotmXYdXdCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFalt7k%253D&md5=6b9cc9a4e567ce321ea0590a0b6305eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0009%26sid%3Dliteratum%253Aachs%26aulast%3DBlower%26aufirst%3DP.%2BE.%26aulast%3DVerducci%26aufirst%3DJ.%2BS.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%2BG.%26aulast%3DReinhold%26aufirst%3DW.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DKaldjian%26aufirst%3DE.%2BP.%26aulast%3DCroce%26aufirst%3DC.%2BM.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DSadee%26aufirst%3DW.%26atitle%3DMicroRNA%2520expression%2520profiles%2520for%2520the%2520NCI-60%2520cancer%2520cell%2520panel%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1483%26epage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grever, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=627-638&author=J.+S.+Leeauthor=K.+Paullauthor=M.+Alvarezauthor=C.+Hoseauthor=A.+Monksauthor=M.+Greverauthor=A.+T.+Fojoauthor=S.+E.+Bates&title=Rhodamine+efflux+patterns+predict+P-glycoprotein+substrates+in+the+National+Cancer+Institute+drug+screen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DAlvarez%26aufirst%3DM.%26aulast%3DHose%26aufirst%3DC.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DGrever%26aufirst%3DM.%26aulast%3DFojo%26aufirst%3DA.%2BT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DRhodamine%2520efflux%2520patterns%2520predict%2520P-glycoprotein%2520substrates%2520in%2520the%2520National%2520Cancer%2520Institute%2520drug%2520screen%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D627%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rutka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCulloch, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. L.</span><span> </span><span class="NLM_article-title">Establishment and characterization of five cell lines derived from human malignant gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1007%2FBF00686798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=2829496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADyaL1c7ivFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=92-103&author=J.+T.+Rutkaauthor=J.+R.+Giblinauthor=D.+Y.+Doughertyauthor=H.+C.+Liuauthor=J.+R.+McCullochauthor=C.+W.+Bellauthor=R.+S.+Sternauthor=C.+B.+Wilsonauthor=M.+L.+Rosenblum&title=Establishment+and+characterization+of+five+cell+lines+derived+from+human+malignant+gliomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment and characterization of five cell lines derived from human malignant gliomas</span></div><div class="casAuthors">Rutka J T; Giblin J R; Dougherty D Y; Liu H C; McCulloch J R; Bell C W; Stern R S; Wilson C B; Rosenblum M L</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-103</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">We established and characterized five cell lines derived from human malignant gliomas (four glioblastomas multiforme and one highly anaplastic astrocytoma).  All cell lines exhibited tumor cell morphology and growth kinetics, and anchorage-independent growth in soft agar.  Cytogenetic analysis revealed significant aneuploidy in all five cases as well as clonal chromosomal alterations unique to each cell line.  No cell line was tumorigenic in athymic mice.  Two of the cell lines were sensitive to carmustine (BCNU) in monolayer and soft-agar cultures.  Electron microscopy showed marked variability between cell lines in the number and structure of intracytoplasmic organelles; SF-126 formed collagen fibers in vitro.  Immunohistochemical analysis of the surgical specimens showed variable expression of glial fibrillary acidic protein (GFAP) in malignant astrocytes; positive immunostaining for glycoproteins of the extracellular matrix was found predominantly in perivascular regions.  In early-passage cultures, only cell line SF-295 expressed GFAP; at establishment, none of the cell lines expressed GFAF or glutamine synthetase.  Fibronectin and laminin were expressed by all cell lines in early-passage culture, but expression of these glycoproteins at establishment was variable.  Only SF-126 was positively identified by immunostains for procollagen III; this was also the only cell line in which DEAE-cellulose chromatography and SDS-PAGE demonstrated interstitial collagen synthesis.  These well-characterized glioma-derived cell lines may now serve as useful tools with which to study the cell biology of gliomas.  The synthesis of interstitial collagen by a glioma-derived cell line may suggest a derivation from vascular mesenchymal elements, either reactive or transformed, in the original heterogeneous malignant glioma, rather than from a glial precursor cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGNj0oPIY_zJcXNb62YGmbfW6udTcc2ebhF4C1ZsYU1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7ivFOgug%253D%253D&md5=79368e7ca5c7a36f39259c04134b6290</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF00686798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00686798%26sid%3Dliteratum%253Aachs%26aulast%3DRutka%26aufirst%3DJ.%2BT.%26aulast%3DGiblin%26aufirst%3DJ.%2BR.%26aulast%3DDougherty%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DMcCulloch%26aufirst%3DJ.%2BR.%26aulast%3DBell%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DR.%2BS.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DRosenblum%26aufirst%3DM.%2BL.%26atitle%3DEstablishment%2520and%2520characterization%2520of%2520five%2520cell%2520lines%2520derived%2520from%2520human%2520malignant%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D1987%26volume%3D75%26spage%3D92%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Audouy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez y Ribotta, M.</span><span> </span><span class="NLM_article-title">Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1999&pages=293-303&author=S.+Audouyauthor=J.+Malletauthor=A.+Privatauthor=M.+Gimenez+y+Ribotta&title=Adenovirus-mediated+suicide+gene+therapy+in+an+in+vitro+model+of+reactive+gliosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAudouy%26aufirst%3DS.%26aulast%3DMallet%26aufirst%3DJ.%26aulast%3DPrivat%26aufirst%3DA.%26aulast%3DGimenez%2By%2BRibotta%26aufirst%3DM.%26atitle%3DAdenovirus-mediated%2520suicide%2520gene%2520therapy%2520in%2520an%2520in%2520vitro%2520model%2520of%2520reactive%2520gliosis%26jtitle%3DGlia%26date%3D1999%26volume%3D25%26spage%3D293%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Mosmann, T.</span><span> </span><span class="NLM_article-title">Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1016%2F0022-1759%2883%2990303-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=6606682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1983&pages=55-63&author=T.+Mosmann&title=Rapid+colorimetric+assay+for+cellular+growth+and+survival%3A+Application+to+proliferation+and+cytotoxicity+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</span></div><div class="casAuthors">Mosmann T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">55-63</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation.  The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells.  This method can therefore be used to measure cytotoxicity, proliferation or activation.  The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision.  No washing steps are used in the assay.  The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope.  We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBbRLMWf0dI3thwrmtH4OBfW6udTcc2eYjQEJj4sPiFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FovFSmtw%253D%253D&md5=c1116f4ca7a7d2b79fab2a0bd2c2d439</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2883%2990303-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252883%252990303-4%26sid%3Dliteratum%253Aachs%26aulast%3DMosmann%26aufirst%3DT.%26atitle%3DRapid%2520colorimetric%2520assay%2520for%2520cellular%2520growth%2520and%2520survival%253A%2520Application%2520to%2520proliferation%2520and%2520cytotoxicity%2520assays%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1983%26volume%3D65%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Repetto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Peso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurita, J. L.</span><span> </span><span class="NLM_article-title">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm201428a&amp;key=10.1038%2Fnprot.2008.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201428a&amp;key=18600217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201428a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1125-1131&author=G.+Repettoauthor=A.+del+Pesoauthor=J.+L.+Zurita&title=Neutral+red+uptake+assay+for+the+estimation+of+cell+viability%2Fcytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Neutral red uptake assay for the estimation of cell viability/cytotoxicity</span></div><div class="casAuthors">Repetto, Guillermo; del Peso, Ana; Zurita, Jorge L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neutral red uptake assay provides a quant. estn. of the no. of viable cells in a culture.  It is one of the most used cytotoxicity tests with many biomedical and environmental applications.  It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes.  Most primary cells and cell lines from diverse origin may be successfully used.  Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period.  The plates are then incubated for 2 h with a medium contg. neutral red.  The cells are subsequently washed, the dye is extd. in each well and the absorbance is read using a spectrophotometer.  The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content).  Once the cells were treated, the assay can be completed in <3 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCcpd7QjH04rVg90H21EOLACvtfcHk0ljf4xDQjlkS3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotFakurk%253D&md5=30461f51c2ad668a3cadb4843c93b43e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2008.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2008.75%26sid%3Dliteratum%253Aachs%26aulast%3DRepetto%26aufirst%3DG.%26aulast%3Ddel%2BPeso%26aufirst%3DA.%26aulast%3DZurita%26aufirst%3DJ.%2BL.%26atitle%3DNeutral%2520red%2520uptake%2520assay%2520for%2520the%2520estimation%2520of%2520cell%2520viability%252Fcytotoxicity%26jtitle%3DNat.%2520Protoc.%26date%3D2008%26volume%3D3%26spage%3D1125%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a href="/doi/suppl/10.1021/jm201428a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31564"></div></div></div></div></div><hr /></hr><p class="last">All spectra and analyses. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201428a/suppl_file/jm201428a_si_001.pdf">jm201428a_si_001.pdf (4.22 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201428a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm201428a%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201428a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679999683d743dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
